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1 Abstract  
The functions of neural circuits underlying learning and memory processes in the adult 
brain are determined by the interplay between the activity and the structure of the neurons 
forming them. Moreover, learning and memory processes rely upon a tight balance 
between the ability of synaptic connections to undergo adaptive changes and their 
stabilization. Particularly, the overall neuronal architecture of the mature brain is 
remarkably stable, implying that a set of molecules is regulating the balance between 
stability and plasticity of mature neuronal networks. In my work I investigated the role in 
regulating structural plasticity at dendritic spines of two molecules known to either restrict 
(Nogo-A) or promote (BDNF) synaptic plasticity. The myelin associated protein Nogo-A 
has been shown to limit functional and structural recovery after an injury in the adult 
central nervous system (CNS) and has recently been implicated as a suppressor of 
activity-dependent synaptic plasticity. I analysed whether Nogo-A signalling modulates the 
spine actin cytoskeleton to control structural plasticity at dendritic spines of CA3 
hippocampal pyramidal cells. Interfering with Nogo-A signalling by loss-of-function 
experiments rapidly and transiently increased F-actin stability and resulted in an increase 
in dendritic spine length. In contrast, a gain-of-function experiment by applying an 
inhibitory Nogo-A peptide (Nogo-A-∆20) resulted in a transient increase in dynamic 
F-actin. To understand the physiological relevance of Nogo-A in regulating structural 
plasticity, spatial learning and memory were analysed by comparing the performance of 
wild type versus nogo-a knockout (KO) mice in the Morris water maze. Nogo-a KO mice 
showed a behavioural advantage in forming a spatial reference memory in the early 
acquisition phase together with a transitory increase in dendritic spine density. These 
results indicate that Nogo-A functions as a molecular regulator of learning and memory 
processes by restricting structural plasticity in the hippocampus upon learning. 
Remarkably, these data may provide a mechanism for the action of Nogo-A in regulating 
spatial and temporal specificity of structural plasticity in maintaining the balance between 
plasticity and stability for the proper functions of the mature CNS network. As an example 
of a positive regulator and mediator of activity-dependent synaptic plasticity, I investigated 
the neurotrophin Brain-derived neurotrophic factor (BDNF). Here I specifically addressed 
the role of BDNF signalling in modulating the architecture of primary hippocampal neurons 
and their dendritic spines using a series of gain- and loss-of-function approaches in 
hippocampal cultures. I showed that the effects exerted by BDNF on the dendritic 
architecture of hippocampal neurons are dependent on the neuron's maturation stage. 
Moreover, BDNF is specifically required for the activity-dependent maintenance of 
dendritic spine density as well as their mature spine morphology in excitatory hippocampal 
neurons. 
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Zusammenfassung 
Die Funktion neuronaler Netzwerke im adulten Gehirn wird bestimmt durch das 
Wechselspiel von Aktivität und Struktur und ihrer Fähigkeit zur funktionellen und 
strukturellen Plastizität, was als Grundlage für Lern- und Erinnerungsvorgänge gilt. 
Grundsätzlich kann angenommen werden, dass die Morphologie bei der Mehrheit der 
Synapsen im adulten Gehirn sehr stabil ist, so dass Moleküle, welche die Stabilität 
(Nogo-A) und Plastizität (BDNF) von Neuronen in einem Gleichgewicht halten, hier eine 
besonders wichtige Rolle erfüllen. Das Myelin assoziierte Protein Nogo-A schränkt sowohl 
funktionelle als auch strukturelle Plastizität im adulten zentralen Nervensystem (ZNS) ein. 
In dieser Studie wurde untersucht, ob der Nogo-A Signalweg das Aktincytoskelett reguliert 
und somit einen Einfluss auf die strukturelle Plastizität von dendritischen spines 
hippocampaler CA3 Neurone nimmt. Die Inhibition des Nogo-A Signalweges führte zu 
einer schnellen und transienten Stabilisierung des Aktinzytoskelettes und zu einem 
Anstieg der Länge der spines. Bei einer Aktivierung durch Zugabe des Nogo-A-∆20 
Peptides hingegen, kam es zu einem Anstieg der Aktin-dynamik. Um die physiologische 
Bedeutung von Nogo-A in der Regulierung von struktureller Plastizität bei Lern- und 
Gedächtnisvorgängen zu untersuchen, wurden Wild type mit nogo-a knockout (KO) 
Mäusen im Morris water maze test verglichen. Nogo-a KO Mäuse wiesen eine schnellere 
Bildung des räumlichen Referenzgedächtnisses auf, was mit einem transienten Anstieg 
der spine-Dichte pyramidaler CA3 Neurone einherging. Es zeigte sich demnach, dass 
Nogo-A als molekularer Regulator von Lern- und Gedächtnisvorgängen agieren könnte, 
indem es strukturelle Plastizität im Hippocampus einschränkt. Bemerkenswerterweise 
zeigen diese Ergebnisse einen Mechanismus auf, wie Nogo-A ein Gleichgewicht 
zwischen Stabilität und Plastizität aufrechterhalten könnte, um die Funktionalität des 
adulten ZNS zu gewährleisten. Im zweiten Teil meiner Arbeit wurde am Beispiel eines 
positiven Regulators und Mediators synaptischer Plastizität das Neurotrophin Brain-
derived neurotrophic factor (BDNF) untersucht. Im Mittelpunkt meiner Versuche standen 
die Auswirkungen der Aktivierung bzw. die Inhibierung des BDNF-TrkB Signalweges in 
adulten hippocampalen Pyramidenneuronen auf die Dichte, Morphologie und das 
Aktinzytoskelett dendritischer spines. Die Ergebnisse zeigten, dass die Regulation der 
dendritischen Komplexität durch BDNF vom Entwicklungszustand der Neurone abhängig 
ist. Des Weiteren zeigte sich, dass BDNF in hippocampalen Neuronen für die 
aktivitätsabhängige Aufrechterhaltung sowohl der Anzahl als auch der Form dendritischer 
spines nötig ist. Damit sind die Effekte von BDNF hochspezifisch und beeinflussen nur 
wenige Parameter neuronaler Funktion und Struktur.  
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2 Introduction 
Since the first drawings of neuronal cells made by Santiago Ramón y Cajal at the end of 
the 19th century, scientist have been interested in understanding whether and how the 
diverse and highly complex architecture of neurons is connected to their function as well 
as to higher cognitive processes performed by the central nervous system (CNS). Already 
at that historically early time point the analysis of the morphology of dendritic and axonal 
processes resulted in the initial understanding about the functional organisation of the 
different brain areas leading to some fundamental hypothesis about how advanced 
cognitive processes are working. In the 1950s, the development of new 
electrophysiological and electron microscopy methods resulted in the identification of the 
synapses as the site at which neurons communicate. Synapses are highly dynamic 
structures shown to change their function and their morphology in response to alterations 
in neuronal activity in a process known as synaptic plasticity. Both functional and 
structural plasticity have been strongly correlated to learning and memory processes in 
the brain. On the other hand time-series experiments have revealed that the mature CNS 
network is remarkably stable. These observations raise the following question: what are 
the molecular mechanisms regulating the tight balance between stability and plasticity of 
the neuronal network in the adult CNS? In this context I analysed the role of the brain-
derived neurotrophic factor (BDNF), a well-known plasticity promoting molecule and of the 
inhibitory protein Nogo-A in modulating structural plasticity at dendritic spines. 
 
2.1 Structural and functional synaptic plasticity 
The correct function of neural circuits depends upon both function and structure of 
neurons. Already Spencer (1862), Tanzi (1893) and Cajal (1893) speculated that memory 
storage requires changes of existing neuronal processes, rather than the addition of new 
neuronal cells. Later, Donald O. Hebb further developed this idea by postulating that 
alterations in synaptic strength, as well as formation of new synapses may mediate 
memory storage (Hebb, 1949). He suggested that synapses get strengthened whenever 
correlated neuronal activity occurring a pre- and a postsynaptic neuron leads to 
biochemical and / or structural modifications altering the communication between 
connected neurons. These activity-dependent functional and structural changes at 
synapses are called synaptic plasticity and are correlated to learning and memory 
processes (Bliss and Collingridge, 1993; Holtmaat and Svoboda, 2009; Kandel, 2001; 
Xu et al., 2009; Yang et al., 2009a). The best described form of functional synaptic 
plasticity - long-term potentiation (LTP) was discovered in the hippocampus by Bliss and 
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Lømo in 1973 (Bliss and Lomo, 1973) and reflects an activity-dependent long lasting 
increase in synaptic strength. Synaptic plasticity is involved in encoding and storage, 
distinct patterns of neural activity, where LTP together with long-term depression (LTD, 
weakening of synaptic contacts) might be a cellular model of learning and memory 
processes (Bliss and Collingridge, 1993; Kandel, 2001; Martin et al., 2000). The molecular 
mechanisms mediating the strengthening of glutamatergic synapses involve two 
receptors: the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 
(AMPAR) and the N-methyl-D-aspartate receptor (NMDAR). A strong stimulus leads, via 
Na+ influx through AMPARs into the post synapse and its depolarization to an activation of 
the NMDARs (Mg2+ ion is expelled) and consequently to a strong influx of Ca2+ ions. The 
following activation of protein kinases and second messengers results in a higher 
efficiency of ionic conductance by AMPAR phosphorylation, followed by the insertion of 
new AMPARs at the membrane and local protein synthesis (for review see: Derkach et al., 
2007). Moreover, a long lasting increase in synaptic strength is achieved by alterations in 
the expression of specific genes leading to the accumulation of mRNAs and proteins at 
active synapses supporting functional and structural plasticity (for review see: Citri and 
Malenka, 2008; Malenka and Bear, 2004). The description of the structural composition of 
synapses was a further step towards understanding the basis of structural synaptic 
plasticity. Most excitatory synapses consist of a presynaptic axonal bouton and 
postsynaptic protrusion, known as a dendritic spine (Figure 1). 
The idea that dendritic spines are stable structures was questioned by Crick when he 
proposed that spines change their morphology in response to synaptic stimulation (Crick, 
1982). These anatomical changes of dendritic spines are supposed to be correlated to a 
more efficient transmission of electrical current between neurons. Indeed, the volume of 
the spine head is directly proportional to the size of the post synaptic density (PSD) which 
in turn correlates to the number of postsynaptic receptors (Nusser et al., 1998) and to the 
number of docked vesicles at the presynapse (Schikorski and Stevens, 1999; for review 
see: Holtmaat and Svoboda, 2009). Furthermore, a series of ultrastructure studies 
showed that actin is highly abundant in spines, suggesting that it may contribute to their 
anatomical changes (Fifková and Delay, 1982; Matus et al., 1982). 
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More recently time-lapse imaging techniques combined with electrophysiological 
stimulation showed that the alterations in spine morphology are correlated to changes in 
neuronal activity in primary cultures (Boyer et al., 1998; Papa et al., 1995; Segal, 1996). 
Nevertheless, this observation was questioned because spines might easily change their 
shape due to the lack of the neuropil in the primary culture (Edwards, 1998). A series of 
studies revealed that the induction of LTP in hippocampal slices leads to the appearance 
of new spines at the apical dendrites of CA1 pyramidal neurons (Engert and Bonhoeffer, 
1999; Maletic-Savatic et al., 1999), whereas induction of LTD is followed by the 
disappearance or shrinkage of existing spines (Nägerl et al., 2004; Zhou et al., 2004). The 
changes in spine numbers occurs within 30 minutes from the stimulation and cannot 
     Dendritic spines 
 
 
 
 
 
 
 
 
 
 
present at a much lower density. This raises the question of what is the function of 
spines? Already Cajal speculated that spines increase the surface area of dendrites 
(Ramón y Cajal, 1899). Indeed, it was shown that spines serve to enhance synaptic 
connectivity (Peters and Kaiserman-Abramof, 1969; Shepherd, 1996; Yuste, 2013). 
Moreover, spines form electrical compartments that modify synaptic potentials and 
biochemical compartments that implement input-specific synaptic plasticity (for review 
see: Yuste, 2011). Interestingly, the spine neck controls calcium diffusion and 
electrically filters synaptic potentiation (Araya et al., 2006; Tønnesen et al., 2014; 
Yuste et al., 2000).  
Figure 1: Dendritic spines 
A Cajal’s hand drawings of 
dendritic spines. Adapted 
from Yuste, 2011.           
B Micrograph showing 
hippocampal dendrite 
covered with spines.    
Scale bar 5 µm. 
Dendritic spines are small protrusions that emerge from 
the dendritic shaft of most principal neurons in the brain 
and are characterized by a large diversity in size and 
shape (Figure 1A and B). They consist of a small cub-
like had (~ 1 µm in diameter), connected by a thin neck 
(~0.2 µm) to the underlying dendrite and are up to 3 
micrometres in length. Spines can be morphologically 
categorized into three types: stubby, mushroom and thin 
spines (Peters and Kaiserman-Abramof, 1970). Spines 
are found in many species and are particular abundant in 
the CNS of vertebrates. The high conservation of 
dendritic spines throughout the species and the different 
brain regions suggests that they must be essential for 
brain functions. Most excitatory neurons carry spines 
whereas inhibitory interneurons don’t or these are  
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cause the initial strengthening of synapses arising within minutes. Finally, two-photon 
imaging together with glutamate uncaging helped to examine the relationship between 
spine plasticity and LTP. Kasai and colleagues reported that synaptic enhancement is 
correlated with an increased spine head volume (Matsuzaki et al., 2004a) and in the 
appearance of new dendritic spines (Kwon and Sabatini, 2011). Overall, the strengthening 
of synaptic contacts involves structural plasticity of dendritic spines and axonal boutons 
and has been correlated to functional changes at synapses (Bourne et al., 2013; Engert 
and Bonhoeffer, 1999; Maletic-Savatic, 1999; Toni et al., 1999). Interestingly, they are 
supposed to underlie learning and memory processes (Hofer et al., 2009; Holtmaat et al., 
2006; Xu et al., 2009; Yang et al., 2009). To monitor easily functional and structural 
changes in neuronal networks in vitro model systems have been developed like 
hippocampal or cortical cultures. Particularly useful in this context are for example 
cultivated brain slices which preserve the neuronal circuitry and are comparable to the in 
vivo conditions. 
 
2.2 The hippocampus 
The neuroanatomists Camillo Golgi (1886), Ramón y Cajal (1911) and Lorente de Nó 
(1934) were the first to describe a unique group of millions of neurons highly organized 
into laminar and circuits deep within the medial temporal lobe – the hippocampus. The 
Hippocampus is a bilateral bulb-like shaped brain region, deep underneath the neocortex. 
It is one of the most intensively studied brain regions used to investigate how neuronal 
circuits operate in the CNS. Anatomically, the hippocampal can be divided into two main 
sub regions: the dentate gyrus (DG) and the cornu ammonis (Amun's horns; CA) 
consisting of CA1, CA2, CA3 and CA4. The hippocampal formation has been shown to 
mediate the transition from short to long-term memory (Alvarez et al., 1994). Indeed, 
patients who underwent a bilateral hippocampal resection (previously performed to treat 
medication-resistant generalized seizures) suffer from anterograde amnesia (Scoville and 
Milner, 1957, 2000). In particular the hippocampus is crucial for the formation and recall of 
spatial, contextual, and episodic memory (Burgess et al., 2002; Eichenbaum, 2004; Squire 
et al., 2004) by integrating sensory and spatial information from the entorhinal cortex (EC) 
to create context-specific representations (Knierim et al., 2006; Manns and Eichenbaum, 
2006; Suzuki et al., 1997). The formation and recall of these memories is supposed to be 
processed by a tri-synaptic circuit reciprocally connecting the EC to the hippocampal 
network (Andersen et al., 1971). The EC layer II (ECII) project via the perforant path to the 
dentate gyrus (DG). In turn, the granule cells of the DG send their axonal projections, the 
mossy fibres to the proximal part of the CA3 neuron dendrites. Finally the axonal 
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projections from CA3, the Schaffer collaterals terminate primarily onto the apical and in 
part onto the basal dendrites of CA1 cells (Ishizuka et al., 1990; Li et al., 1994). The 
simple and unique projection pattern as well as the laminar organisation of the 
hippocampus (stratum oriens (so), stratum pyramidale (sp), stratum radiatum (sr), stratum 
lacunosum-moleculare (sl-m)), allow using transversal slices (where the main circuitry is 
preserved) to study in vitro the hippocampal function and morphology. The hippocampus 
contains two major cell types: small granule neurons in the DG and pyramidal neurons in 
the CA region. Pyramidal neurons are characterized by their characteristic pyramidal-
shaped soma and their distinct dendritic tree: several short and complex basal dendrites 
emerge from the base and one large apical dendritic tree grows from the apex of the 
soma. Particularly of interest in this study is the CA3 region of the hippocampus, which is 
characterized by pyramidal neurons which are quite variable in their dendritic length: small 
neurons have a total dendritic length of 8-10 mm whereas large cells (located distal in the 
CA3 region) display a total length of 16-18 mm (Ishizuka et al., 1995). Their proximal 
dendritic compartment carries special synapses - the mossy fibre-CA3 synapses are 
characterized by large pre-synaptic boutons (mossy fibre terminals) and large dendritic 
spines (thorny excrescences) providing a powerful excitation to CA3 neurons (Gonzales et 
al., 2001). Interestingly, the anatomical and physiological characteristic of the CA3 region 
are essential in the encoding of novel information involving associations between cues 
and spatial locations (for review see Kesner, 2007). Of particular interest in my study are 
molecules mediating and regulating functional and structural plasticity at dendritic spines 
of CA3 pyramidal neurons. The investigation of these molecules in relation to learning 
processes is still a central question in neuroscience.  
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2.3 Extra and intercellular modulators of functional and                   
structural plasticity 
2.3.1 BDNF and its role in regulating neuronal morphology  
Neurotrophins belong to the group of neurotrophic factors and with the discovery of the 
first neurotrophin the Nerve growth factor (NGF) Levi-Montalcini revolutionized our current 
understanding of the role of molecular guidance cues during neuronal development 
(Cohen et al., 1954; Levi-Montalcini, 1987). Hans Thoenen set a further landmark in our 
understanding on neurotrophins function by postulating that neurotrophins play a role in 
activity-dependent synaptic plasticity (Thoenen, 1991; Zafra et al., 1990). Indeed, further 
studies confirmed that neurotrophins are essential for multiple aspects of structural and 
functional plasticity (reviews (Chao, 2003; Huang and Reichardt, 2001; McAllister et al., 
1999). Three further neurotrophins have been described: the Brain-derived Neurotrophic 
Factor (BDNF) and neurotrophin 3 and 4 (NT-3, NT-4). Next, I highlight BDNF and its 
signalling pathway in the CNS (Figure 2). The effects exerted by BDNF result from its 
binding to two different receptors: TrkB receptor tyrosine kinase B (TrkB) and pan 
neurotrophin receptor p75NTR. BDNF is initially synthesized as precursor proBDNF, the 
pro-domain is then proteolytically cleaved and the mature BDNF is secreted to promote 
neuronal survival and enhance synaptic plasticity by activating the receptor tyrosine 
kinase B (TrkB; Klein et al., 1990). Whether proBDNF is released from neurons and what 
is its physiological function is still controversial (Dieni et al., 2012; Matsumoto et al., 2008; 
Yang et al., 2009b), nevertheless, proBDNF has been shown to bind with a high affinity to 
the p75NTR thereby negatively regulating synaptic plasticity and inducing apoptosis (Lu et 
al., 2005; Teng et al., 2005).  
The binding of BDNF dimers to TrkB receptors triggers ligand-induced receptor 
dimerization and transphosphorylation of specific tyrosine residues of intracellular kinase 
domains resulting in diverse cellular responses (Figure 2). Three main intracellular 
pathways are activated resulting in neuronal survival and differentiation via the 
phosphatidylinositol- 3 kinase (PI3K) pathway; in differentiation and neurite growth via the 
mitogen-activated kinase (MAPK) pathway; and in activity-dependent synaptic plasticity 
via the PLCɣ pathway (Figure 2; Bibel, 2000; Blum and Konnerth, 2005; Minichiello, 
2009). The BDNF-TrkB signalling (Figure 2) has been implicated in numerous processes 
of functional and structural synaptic plasticity by regulating protein synthesis via the 
transcription factor cAMP response element binding protein (CREB; for reviews see: 
Gottmann et al., 2009; Park and Poo, 2012; Zagrebelsky and Korte, 2013). 
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Figure 2: BDNF-TrkB receptor downstream signalling pathways. 
Homodimeric BDNF induces the dimerization of the TrkB receptors and a phosphorylation of the 
tyrosine (Y
515
) creates the binding site for Shc (Src homology 2/α-collagen-related protein), 
whereas tyrosin (Y
816
) forms the adaptor site for PLC-ɣ. The activated signalling pathways (1) 
PI3K-, (2) MAPK-,(3) PLC-ɣ-pathways mediate the effects of BDNF on neuronal survival, growth, 
differentiation and, synaptic transmission and LTP as well as gene expression. P, phosphorylation; 
PI3K, phosphatidylinositol 3-kinase; Akt, Akt kinase; Ras, small GTP-binding protein Ras; CaM, 
calmodulin; CaMK (Ca
2+
-CaM-dependent kinase II and IV); DAG, diacylglycerol; IP3, inositol 1,4,5-
trisphosphate; Ca
2+
, intracellular Calcium , CREB, cAMP response element-binding protein.            
(Adapted from: Blum and Konnerth, 2005). 
 
The role of BDNF has been extensively analysed in vitro upon the application of 
exogenous BDNF. The data obtained support the notion that BDNF is involved in 
regulating the fine-tuning of the cortical network during development by selectively 
enhancing dendritic growth in an activity-dependent manner (Horch et al., 1999; 
Mcallister, 1995; McAllister et al., 1996). Application of exogenous BDNF to developing 
primary hippocampal neurons has been results in a significant increase in the number of 
primary neurites as well as an increase in neurite complexity and length (Ji et al., 2005; 
Kwon and Sabatini, 2011). Likewise, dendritic spine density and morphology of mature 
primary hippocampal neurons are significantly altered via BDNF application (Ji et al., 
2005, 2010). Interestingly, an acute and fast delivery of BDNF increases the number of 
mushroom like spines, whereas a gradual and slow BDNF application induces more thin-
like spines (Ji et al., 2010). This is supposed to be due to the consolidation of existing 
synapses and the formation of new synapses, respectively (Lu et al., 2013).        
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Similarly, mature organotypic hippocampal neurons treated with BDNF show a significant 
increase in dendritic spine density and in the number of synapses (Tyler and Pozzo-miller, 
2003, 2001). Also a long lasting BDNF overexpression increases the spine turnover in 
layer 2/3 pyramidal neurons of the visual cortex (Horch et al., 1999), as well as the 
recruitment of PSD-95 to synapses, possibly leading to an increase in spine number and 
size (Yoshii and Constantine-paton, 2007). Functional changes at synapses have been 
correlated to structural alteration at dendritic spines. Among the molecular candidates, 
supposed to link functional and structural changes the activity-dependently secreted 
BDNF has a prominent position. A study performed in hippocampal slice cultures pairing 
postsynaptic spikes and two-photon glutamate uncaging at single spines resulted both in 
LTP induction and in an increase of the spine head volume (Tanaka et al., 2008). The 
spine head enlargement is prevented by the blockade of the BDNF-TrkB signalling. 
Moreover, presynaptic stimulation (glutamate uncaging) plus the addition of exogenous 
BDNF has been shown to induce an increase in the spine head in the absence of 
postsynaptic spikes (Tanaka et al., 2008). This suggests that activity-dependent BDNF 
secretion mediates both LTP and spine growth. Taken together, the in vitro studies 
described above strongly support the notion that, in the hippocampus exogenous BDNF 
promotes dendritic formation and growth during development and regulates functional as 
well as structural plasticity at spines of mature neurons.  
But as strong as the evidence for a role of BDNF in modulating dendritic architecture 
might appear, the preparation techniques (Danzer et al., 2004) and the culture conditions 
(Chapleau et al., 2008) have been shown to influence the expression levels as well as the 
cellular response to BDNF, possibly confounding the analysis under these conditions. 
Suggestive for a role of BDNF in vivo is the correlation between the physiological 
variability in BDNF expression levels in the mouse dentate gyrus and the dendritic spine 
density in granule cells (Stranahan, 2011). Moreover, a reduction in BDNF serum levels is 
associated with a reduction in hippocampal volume in aging humans (Erickson et al., 
2011) as well as in dendritic complexity and spine density in senescent rats (von Bohlen 
und Halbach, 2010). The in vivo role of BDNF has been very difficult to evaluate in the 
postnatal brain as bdnf−/− mouse mutants die too early for the role of BDNF to be 
assessed after its increased post-natal expression caused by neuronal activity (Hong et 
al., 2008; Zafra et al., 1990). The analysis of bdnf+/− mouse mutants, showing reduced 
BDNF levels, provided evidence that in vivo BDNF plays an important role in the induction 
of LTP in the hippocampus (Korte et al., 1995, 1996), the acquisition of extinction learning 
(Psotta et al., 2013) and in the structural rearrangement of adult cortical circuitry upon 
increased sensory input (Genoud et al., 2004; Korte et al., 1995). On the other hand, in 
bdnf+/− mice synapse density and spine morphology are indistinguishable from those in 
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WT mice (Genoud et al., 2004; Korte et al., 1996) and a compensatory increase in TrkB 
receptor expression occurs (Carretón et al., 2012), leaving open the question of whether 
BDNF modulates dendritic and spine architecture in vivo. Thus, a number of studies have 
been performed using different conditional gene targeted mouse lines and Cre-loxP 
mediated excision of bdnf (Rios et al., 2001; Gorski et al., 2003; Baquet et al., 2004; He et 
al., 2004; Chan et al., 2006; Monteggia et al., 2007; Unger et al., 2007; Rauskolb et al., 
2010). Surprisingly, the effects on excitatory neurons in the hippocampus and cortex of a 
global BDNF deprivation throughout the CNS is extremely mild when compared to the 
effects observed upon a BDNF application in vitro. In a study from 2010 Rauskolb et al. 
showed that in a Tau-cre-loxP-BDNF-KO mouse (BDNF is deleted in all CNS neurons) the 
volume of the cortex is only slightly reduced and the one of the hippocampus unchanged. 
Accordingly, dendritic complexity of CA1 pyramidal cells is only mildly reduced and no 
changes could be observed in dendritic spine density. The spine type distribution in Tau-
BDNF-KO neurons is significantly shifted towards a more immature phenotype pointing to 
a specific role of BDNF in the maintenance of mature dendritic spines in the adult 
hippocampus (Rauskolb et al., 2010). These results are consistent with the observation 
that the conditional deletion of TrkB in the hippocampus does not affect the gross dendritic 
morphology of CA1 pyramidal neurons (Luikart et al., 2005; Minichiello et al., 1999). It is 
noteworthy that while most of the published data supporting a role for BDNF in modulating 
dendrite and dendritic spine morphology derive from in vitro experiments applying 
exogenous BDNF, the role for endogenous BDNF in this context is still unclear. Moreover, 
in vivo the effects of endogenous BDNF in modulating the structure of neurons seem to be 
extremely specific, depending on the developmental stage, the brain area as well as the 
cell-type.  
Overall, neurotrophins are essential for multiple aspects of structural and functional 
plasticity in the adult CNS. BDNF is a prime candidate in order to ensure that changes in 
synaptic function are followed by changes in structure of neurons as cellular correlates of 
learning and memory formation (Zagrebelsky and Korte, 2013). To ensure spatial and 
temporal specificity of plastic changes and preventing interference between different 
memories events a set of molecules are needed to regulate the balance between stability 
and plasticity of neuronal networks. Interestingly, recent studies indicate that a myelin 
associated protein restricting structural and functional plasticity in the adult CNS. 
  
Introduction | 12 
 
2.3.2 Nogo-A and its role in regulating neuronal morphology  
The myelin associated neurite growth inhibitor Nogo-A is well known as an inhibitor of 
axonal sprouting and regeneration following injury in the adult CNS. In the adult brain, 
Nogo-A is mainly expressed in oligodendrocytes but also in neurons of highly plastic CNS 
regions such as the olfactory bulb, hippocampus or the cortex (Huber et al., 2002; Hunt et 
al., 2002; Meier et al., 2003; Mingorance et al., 2004; Richard et al., 2005; Zagrebelsky et 
al., 2010). The key question is: what are the physiological functions of Nogo-A proteins in 
the intact adult CNS? Recent studies have uncovered novel functions of Nogo-A and its 
receptors in the naïve CNS. A remarkable feature seems to be the stabilization of the 
CNS wiring by regulating structural and functional plasticity (synapse maturation, long-
term synapse stability and activity-dependent synaptic plasticity). Nogo-A belongs to the 
reticulon family of proteins and is one splice variant of the reticulon-4 gene (rtn4). By 
alternative splicing or different promoter usage the rtn4 gene encode two further protein 
isoforms: Nogo-B and Nogo-C (Chen et al., 2000; GrandPré et al., 2000; Prinjha et al., 
2000). All three isoforms share the same 180-200 amino acids (aa) long carboxyl 
terminus, the reticulon homology domain (RTN) consisting of two membrane-anchored 
hydrophobic regions linked by a hydrophilic-loop, the Nogo-66 domain (Figure 3A). The 
Nogo-66 domain represents one of the regions exhibiting inhibitory activity. However, no 
homology can be found between the NH2-terminal regions of the three RTN proteins 
(Kempf and Schwab, 2013; Oertle and Schwab, 2003). Nogo-A carries a long 800 aa 
NH2-terminal region containing a second inhibitory domain, Nogo-A-Δ20 specific for 
Nogo-A (Oertle et al., 2003). In the adult CNS Nogo proteins are localized predominantly 
(90%) in the endoplasmatic reticulum, however, Nogo-A was also found at the cell surface 
of oligodendrocytes and neurons (Oertle et al., 2003; Dodd et al., 2005).  
 
2.3.3 Mechanisms of Nogo-A mediated signalling 
The two major inhibitory domains Nogo-66 and Nogo-A-Δ20 were used to screen for 
potential Nogo receptors and up to now several interaction partners were characterized as 
summarised below (Figure 3B). For the Nogo-66 domain two receptors have been 
identified: the Nogo-66-receptor 1 (NgR1; Fournier et al., 2001) and the paired 
immunoglobulin-like receptor B (PirB; Atwal et al., 2008). NgR1 is anchored via a 
Glycosylphosphatidylinositol-(GPI) domain and lacks an own intracellular signalling 
domain (Venkatesh et al., 2005).  
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Figure 3: Molecular mechanisms related to Nogo-A signalling.  
A Schematic structure of the Nogo protein isoforms Nogo-A. The inhibitory domain Nogo-A-∆20 
and Nogo-66 are indicated in red, transmembrane domains (TM) in dark grey. The Reticulon 
homology domain (RTN) is common to all three Nogo isoforms (black arrow). The Nogo-A-specific 
domain is encoded by the exon 3. B The transmembrane protein Nogo-A interacts with the Nogo-
A-∆20 domain with the S1PR2 and the Nogo-66 domain to Nogo receptor 1 (NgR1), which forms a 
complex with the transmembrane proteins LINGO1, and p75 or TROY. This binding leads, through 
still unknown intermediates, to an activation of the RhoA dependent pathways. The S1PR2 
activates also RhoA via the G-protein G-13, the rhoGEF LARG. In addition to NgR1, Nogo-66 can 
interact with paired immunoglobulin-like receptor B (PirB), myelin-associated glycoprotein (MAG) 
and oligodendrocyte myelin glycoprotein (OMgp) interact also with NgR1 and PirB. (Adapted from: 
Schwab, 2010; Schwab and Strittmatter, 2014). 
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For signal transduction the NgR1interacts with co-receptors like the P75NTR or the related 
tumor necrosis factor alpha (TNF-α) receptor superfamily member 19 (TROY; Park et al., 
2005; Shao et al., 2005). A second interaction partner of NgR1 is the leucine-rich repeat 
and Ig domain-containing Nogo receptor-interacting protein 1 (LINGO-1; Mi et al., 2004). 
Nogo-A is part of a family of neurite growth inhibitors including the myelin-associated 
glycoprotein (MAG), oligodendrocyte myelin glycoprotein (OMgp; Figure 3B) and the 
chondroitin sulfate proteoglycans also shown to bind the NgR1 (Domeniconi et al., 2002; 
Wang et al., 2002a; Imagama et al., 2011; Silver and Miller, 2004). The second inhibitory 
domain Nogo-A-Δ20 has just recently been shown to bind to the sphingosine1-phosphate 
receptor 2 (S1PR2; Kempf et al., 2014). S1PR2 is a G protein-coupled receptor (GPCR) 
and belongs to a subfamily of five S1PRs (Figure 3B). The activation of S1PR2 by Nogo-A 
leads to neurite retraction, via the G proteins Gi/o, Gq, or G12/13 and the RhoA pathway 
resulting in a destabilization of the actin cytoskeleton within growth cones (Kempf et al., 
2014; Singh and Hall, 2008; Spiegel and Milstien, 2003). Also NgR1 stimulation results in 
the regulation of the actin cytoskeleton in the growth cones as well as to changes in 
functional and structural plasticity. It is noteworthy that Nogo-A and the NgR1 has been 
found to be localized both at pre- and post-synaptic sites (Lee et al., 2008; Liu et al., 2003; 
Wang et al., 2002b).  
 
2.3.4 Nogo-A restricts structural and functional plasticity     
in the adult naïve CNS 
The first evidence that Nogo-A regulates activity-dependent plasticity processes were 
obtained when ocular dominance (OD) plasticity in the visual cortex was studied. It was 
hypothesized that Nogo-A signalling via the NgR1 receptor may limit plasticity in the intact 
CNS by stabilizing activity-dependent anatomical rearrangements. During the postnatal 
critical period (CP) neuronal circuits are refined in an experience-dependent manner. 
Alterations of sensory input (e.g. monocular deprivation, MD) occurring during this time 
result in changes in plasticity in the visual cortex and to a relative shift in OD toward the 
non-deprived eye (Hubel and Wiesel, 1962). After the end of the CP, mature neuronal 
circuits have been shown to be structurally more stable. Changes in response to MD can 
no longer occur (Hubel and Wiesel, 1962). This was also verified for mice showing a CP 
time window ranging from postnatal day 19 to 32 (Gordon and Stryker, 1996). Genetic 
deletion of Nogo-A or its receptors induces a significant expansion of the CP into 
adulthood (McGee et al., 2005; Syken et al., 2006). Taken together, these studies suggest 
that Nogo-A and their receptors restrict plasticity at the end of the CP and thereby ensure 
long-term network stability in vivo.  
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In the adult CNS synaptic plasticity (LTP / LTD) have been shown to be modified by 
guidance-related molecules like the Ephrin/Eph and Semaphorin/Plexin families (Shen 
and Cowan, 2010). As mentioned above also Nogo-A as well as NgR1 are expressed at 
both synaptic sites and may be potential candidates to influence synaptic plasticity (Aloy 
et al., 2006; Lee et al., 2008; Liu et al., 2003; Wang et al., 2002b). Indeed, studies 
analysing the role of Nogo-A and its receptors on synaptic plasticity (NgR1 and S1P2R) 
showed a restriction of long-term potentiation upon their activation (Delekate et al., 2011; 
Kempf et al., 2014; Lee et al., 2008; Mironova and Giger, 2013; Raiker et al., 2010). 
Interestingly, constitutive nogo-a or ngR1-KO mice didn’t support previous results which 
might be due to genetic and/or developmental compensatory mechanisms. In nogo-a 
deficient mice Nogo-B as well as myelin-associated inhibitors like MAG and OMgp are 
upregulated and can still interact with their receptors providing a possible compensatory 
mechanism. (Delekate et al., 2011; Karlén et al., 2009; Lee et al., 2008; Raiker et al., 
2010; Simonen et al., 2003). The Nogo receptor family consists of three isoforms, the loss 
of any one member is sufficient to reveal their inhibitory influence in vitro, whereas loss of 
all three NgRs is required in vivo (Wills et al., 2012). In line with this, a behavioural 
characterizations of nogo-a KO mice show normal anxiety-related behaviour, pain 
sensitivity, startle reactivity, spatial learning, and associative learning (Willi et al., 2009). 
However, a recent study used a microRNA-mediated acute down regulation of Nogo-A in 
transgenic rats to show that Nogo-A plays an important role in synaptic plasticity. The 
transgenic rats exhibited defects in cognition, sensory motor gating and social behaviour 
that are suggestive of schizophrenia-like behavioural phenotypes (Tews et al., 2013). In 
summary, these results open the possibility that Nogo-A signalling restricts different forms 
of synaptic strengthening in the adult CNS. Recent observations showed that Nogo-A and 
its receptors regulate also structural plasticity in the hippocampus and the cortex. Acute 
neutralisation of Nogo-A in mature organotypic hippocampal slice cultures leads to an 
alteration of axonal and dendritic complexity and a shift in dendritic spine distribution 
towards a less mature and more plastic type (Craveiro et al., 2008; Zagrebelsky et al., 
2010). This implicates Nogo-A as a candidate to be involved in stabilizing the architecture 
of hippocampal neurons. This was also confirmed in vivo for the Nogo-A knockout and 
Nogo-A overexpressing transgenic mice for Purkinje cells in the cerebellum (Petrinovic et 
al., 2013). Indeed, also in vivo the knock-down of neuronal Nogo-A leads to an increase of 
filopodia-like protrusions of pyramidal neurons layer V of the neocortex (Pradhan et al., 
2010). That Nogo-A signalling via the Nogo receptor 1 restricts anatomical plasticity was 
also reported in a study using the NgR1/2/3 triple knockout to study synaptogenesis (Wills 
et al., 2012) as well as the NgR1 knockout (Akbik et al., 2013) to analyse experience-
dependent plasticity in the somatosensory cortex. Indeed, NgR1 was revealed to regulate 
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the experience-dependent turnover of dendritic spine and axonal varicosities in the 
somatosensory cortex (Akbik et al., 2013). Interestingly, transgenic mice overexpressing 
NgR1 show impaired long-term spatial memory (Karlén et al., 2009). Nogo-A actively 
suppresses anatomical plasticity in the adult CNS via a down regulation of growth-
associated genes and transcription factors (Bareyre et al., 2002; Craveiro et al., 2008; 
Joset et al., 2010; Zagrebelsky et al., 1998). On the other hand, Nogo-A has been shown 
to regulate the actin cytoskeleton to induce growth cone collapse (Hsieh et al., 2006; 
Montani et al., 2009). Whether the regulation of actin dynamics within dendritic spines is 
required for the Nogo-A induced structural stabilization in the mature CNS remains an 
open question and was addressed in the study presented her. 
 
2.4 The actin cytoskeleton within dendritic spines 
Neurons keep their shape and architecture through the cytoskeleton. At the same time 
modifications in cytoskeleton dynamics are required for functional and structural changes 
(e.g. upon activity). Microtubules, neurofilaments and microfilaments are the three 
structural components of the neuronal cytoskeleton. Dendritic and axonal branches 
consists of a dense network of microtubules, which not only provides structural stability 
but also anchors organelles and serves as a track for the transport of cargoes (for review 
see: Conde and Cáceres, 2009). Also the actin microfilaments are found both in dendrites 
and axons and are particularly abundant at pre- and postsynaptic sites as well as in 
growth cones. Electron micrographs of spines showed a mesh like branched network in 
the spine heads and long linear bundles of actin filaments in the spine neck extending 
from the base towards the PSD (Fifková and Delay, 1982; Korobova and Svitkina, 2010). 
The actin treadmilling depends on the polymerisation of monomeric globular-actin (G-
actin) at the barbed ends and its depolymerisation at the pointed ends of polymeric 
filamentous-actin (F-actin; Pollard and Borisy, 2003). Indeed, polymerisation or 
depolymerisation of the actin cytoskeleton are responsible for spontaneous and activity-
driven remodelling of the spine structure(Bonhoeffer and Yuste, 2002; Dailey and Smith, 
1996; Fischer et al., 1998; Hering and Sheng, 2001; Honkura et al., 2008; Izeddin et al., 
2011). Interestingly, also long-lasting alterations of the synaptic efficacy have been shown 
to depend on the actin cytoskeleton (Kim and Lisman, 1999; Krucker et al., 2000). For 
example, a LTP like stimulus promotes actin polymerization and shifts the equilibrium of 
F- and G- actin towards F-actin associated with an enlargement of the spine volume 
(Okamoto et al., 2004; Matsusaki 2004, Fukazawa et al., 2003). Conversely, a stimulus 
known to weaken synaptic efficacy and to induce LTD (low-frequency stimulation) shifts 
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the ratio towards G-actin and causes actin loss and dendritic spine shrinkage (Okamoto et 
al., 2004; Zhou et al., 2004). Fluorescence recovery after photobleaching (FRAP) at single 
spines revealed that 85% of the actin cytoskeleton within spines is highly dynamic (Star et 
al., 2002) and that actin exists in distinct and locally restricted fractions (Honkura et al., 
2008; Star et al., 2002). The ‘cytoskeleton shell’ of a spine (spine tip and periphery) is 
highly dynamic with a G- and F-actin turnover with a half-live (turnover time) of tens of 
seconds and characterized by morphological changes. In contrast, the spinoskeleton 
‘core’ (centre and base of the spine) is more stable with a turnover time over tens of 
minutes (Honkura et al., 2008; Tatavarty et al., 2009). Taken together, these studies 
indicate that the actin cytoskeleton within dendritic spines supports the mobility as well as 
the stability of the spine size and shape. This raises the following question: what are the 
molecules regulating the structure and organisation of the actin cytoskeleton in such a 
precise way? Actin-binding proteins (ABPs) localizing to discrete regions within the spine 
contribute to the distinct regional specification of the actin fractions (Rácz and Weinberg, 
2013). The spectrum of ABPs is multifaceted as can be deduced from the following list: 
Capping proteins: 
The barbed and pointed end of F-actin can be capped by Eps8 or adducin and 
tropomodulin, thereby, preventing the incorporation of new G-actin or depolymerisation 
respectively stabilizing the F-actin filament (Kuhlman et al., 1996; Stamatakou et al., 
2013)). The capping activity for example of Eps8 is required for keeping a mature 
mushroom like spine morphology (Menna et al., 2013).  
Depolymerisation: 
ADF/cofilin decreases F-actin length by increasing the rate of depolymerisation of G-actin 
from the pointed end. This leads to the acceleration of F-actin treadmilling (Bamburg et 
al., 1980; Carlier et al., 1997). In vitro it was demonstrated that a low ratio of cofilin to actin 
subunits (less than 1%) results in F-actin severing of single long actin filament into several 
shorter ones (Andrianantoandro and Pollard, 2006; Bamburg and Bernstein, 2010). 
ADF/cofilin is required for changes of the spine head and stabilization during synaptic 
activity (Hotulainen et al., 2009; Van Troys et al., 2008). The postnatal knockout of cofilin 
demonstrates that cofilin is necessary to maintain an equilibrium between G- and F-actin 
in dendritic spines as well as stable spine density (Rust et al., 2010). 
ADP/ATP exchanger: 
The nucleotide exchange factor profilin enhances the exchange of ADP to ATP-actin and 
promotes F-actin polymerization (Goldschmidt-Clermont et al., 1992; Kovar et al., 2006). 
Profilin play also an important role in maintaining spine structure stability during synaptic 
plasticity (Ackermann and Matus, 2003; Michaelsen et al., 2010). Profilin containing 
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spines were shown to be lager in comparison to spines without profilin (Pilo Boyl et al., 
2007). 
Crosslinking proteins: 
Cross-linking proteins like the Arp2/3 complex organize the actin cytoskeleton into three-
dimensional bundles or networks. The Arp2/3 complex enhances actin nucleation and 
induces the branching and cross-linking of actin filaments (Mullins et al., 1998; Welch et 
al., 1998) which is required for spine maintenance and head growth. The nucleation of 
new actin branches is induced by the cortactin a nucleation factor class II that binds F-
actin and the Arp2/3 complex (Uruno et al., 2001; Weaver et al., 2001). Postnatal loss of 
the Arp2/3 subunit ArpC3 or cortactin results in an altered actin turnover and a decrease 
in the number of spines (Hering and Sheng, 2003; Kim et al., 2013).  
Motor proteins: 
The actin-based molecular motor protein myosin can be included in the actin-binding 
proteins. Their function is to move organelles along F-actin or move F-actin filaments 
themselves (Kneussel and Wagner, 2013; Sellers, 2000). Various types of myosin forms 
have been identified as well as their localization in spine heads (Bridgman, 2004; Morales 
and Fifková, 1989). Myosin II for example is required for a proper spine head and neck 
morphology (Ryu et al., 2006). 
(For reviews see: Cingolani and Goda, 2008; Hotulainen and Hoogenraad, 2010; Kennedy 
et al., 2005; Lamprecht, 2014; Pollard and Borisy, 2003; Schubert and Dotti, 2007; Sekino 
et al., 2007; Tada and Sheng, 2006). 
The long-term stability of dendritic spines in the mature CNS is dependent on the control 
of the actin cytoskeleton dynamics, which in turn are regulated by many intra- and extra-
cellular molecules like Nogo-A and BDNF. Signal transduction cascades via (1) Rho 
GTPases (RhoA, Rac1, and Cdc42) control (2) Rho effectors (ROCK, PAK, WAVE1 and 
N-WASP) which in turn control (3) ABPs (ADF/cofilin, Profilin, Arp2/3, Eps8 and MyosinII) 
to regulate cytoskeletal rearrangements (Figure 4). Indeed, the activation of Rho GTPases 
is required for the activity-dependent changes in spine size and structure (Murakoshi et 
al., 2011). A direct or indirect (via AMPA receptor blocking) activation of Rho-A causes a 
reduction in dendritic spine density, while Rho-A inhibition increases spine density (Kang 
et al., 2009; Tashiro et al., 2000; Yuste et al., 2000). Rho-A signalling through Rho-
associated protein kinase (ROCK) stimulates LIM kinase (LIMK) to phosphorylate 
ADF/cofilin (Figure 4) leading to an inhibition of its actin severing activity and finally to a 
stability of dendritic spines (Arber et al., 1998; Murakoshi et al., 2011). 
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Figure 4: Nogo-A and BDNF signalling pathways involved in regulating actin at the synapse. 
Nogo-A signalling leads via the activation of the S1P2R, NgR1 (LINGO and P75NTR or TROY) or 
BDNF signalling via the TrkB receptor to a regulation of Rho GTPases like RhoA, Rac1 and Cdc42. 
Which in turn regulate Rho effectors like ROCK, PAK, WAVE1 and N-WASP regulate the actin 
binding proteins (ABPs) ADF/cofilin, Profilin, Arp2/3, Eps8 and MyosinII to control actin remodeling 
within dendritic spines. Further discussion and details are provided in the text (adapted from Dillon 
and Goda, 2005). 
 
This modulation of actin dynamics via ADF/cofilin, regulated by LIMK and slingshot-
phosphatase (SSH) during synaptic plasticity (Figure 4), also regulate postsynaptic 
receptor trafficking by AMPAR insertion in the PSD (Gu et al., 2010). AMPA receptor 
localization at the surface plays a crucial role in synaptic plasticity. LTP leads to an 
increase in the number of postsynaptic AMPA receptors (O’Brien et al., 1998; Shi et al., 
1999). High-frequency stimulation / theta-burst stimulation (TBS) in hippocampal slices 
increases F-actin content within dendritic spine, which is prevented by blocking TrkB 
signalling and increased by the application of exogenous BDNF (Rex et al., 2007). 
Interestingly, an increased actin polymerisation was induced via Rac1- p21- activated 
kinase (PAK) - cofilin pathway which is required for the development of late LTP (L-LTP; 
Fukazawa et al., 2003; Rex et al., 2007) and is associated with increased spine size and 
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stability. Moreover, the GTPase Ras is activated via BDNF-TrkB signalling and thereby 
increases spine stability and spine enlargement (Yasuda et al., 2006). The exogenous 
application of BDNF in immature hippocampal neurons after 12 DIV leads to a gradual 
cortactin accumulation within the spine head and thereby may stabilize the actin 
cytoskeleton (Iki et al., 2005). Taken together, BDNF-TrkB signalling regulates activity-
induced molecular pathways to stabilize the actin cytoskeleton and thereby maintaining 
dendritic spines stability. While it was clearly shown that Nogo-A and NgR1 signalling 
modulate dendritic spine shape and size (Lee et al., 2008; Zagrebelsky et al., 2010), the 
question of whether they regulate the actin cytoskeleton dynamics within spines is still 
open. The analysis of the Nogo-A signalling pathway in growth cones revealed an 
activation of the Rho-A/ROCK pathway resulting in a destabilization of the actin 
cytoskeleton via the phosphorylation of the LIMK and thereby the activation of cofilin 
(Nash et al., 2009; Niederöst et al., 2002; for reviews see: Kempf and Schwab, 2013; 
Mironova and Giger, 2013; Schwab, 2010). The Nogo-A-Δ20 domain signals via the 
S1PR2 (Kempf et al., 2014) which regulate the actin cytoskeleton of growth cones by G 
protein G13 signalling through Rho GEF LARG, and RhoA activation (Singh and Hall, 
2008; Spiegel and Milstien, 2003; Toman et al., 2004). Overall, both inhibitory domains of 
Nogo-A regulate the actin cytoskeleton within growth cones via the activation of 
RhoA/ROCK and the inhibition of Rac1 pathway (Niederöst et al., 2002). This suggests 
that the actin cytoskeleton of dendritic spines could be a major target for Nogo-A 
signalling to maintain a mature spine architecture (for review see: Mironova & Giger, 
2013). BDNF is able to regulate functional and structural plasticity and thereby might act 
as a plasticity promoting factor, in contrast Nogo-A function as a plasticity inhibitor by 
restricting plasticity. Together they could act in a yin–yang like mechanism by keeping the 
balance between plasticity and stability in the CNS. 
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2.5 Aim of this study 
The functions of neural networks during development as well as in the adult brain are 
determined by the architecture of neurons and of the synaptic structures connecting them. 
The fine tuning of neural circuits relies upon both functional and structural plastic 
processes and is supposed to be crucial for the integration and storage of information in 
the brain, including learning and memory processes. Changes in dendritic spine 
architecture are correlated to the strength of their synapse and depend on the remodelling 
of the actin spinoskeleton. On the other hand after the end of development the overall 
neuronal morphology is remarkably stable and thereby is supposed to enable the storage 
of long-term memories. Still largely unknown are the molecules regulating the spatial and 
temporal specificity of plastic changes by mediating and modulating the balance between 
stability and plasticity of mature neuronal networks. In this context, I focused in my study 
on two promising candidates regulating this balance: the myelin associated inhibitor Nogo-
A as a suppressor and the neurotrophin BDNF as a promoter of synaptic plasticity.  
Recent studies indicate that Nogo-A signalling restricts functional and structural plasticity 
in the adult CNS. The present study was aimed at shedding some light in the acute 
regulation of structural plasticity by Nogo-A signalling and possibly underlying modulation 
of the actin cytoskeleton in this context. Furthermore, the still largely unexplored 
physiological relevance of the Nogo-A activity in regulating structural plasticity at spines 
was assessed during learning and its behavioural outcome in vivo. 
BDNF signalling is involved in regulating numerous aspects of functional and structural 
plasticity in the mature CNS. Accordingly, in vitro experiments applying exogenous BDNF 
suggest a major role of BDNF in modulating neuronal architecture and structural plasticity 
at dendritic spines. On the other hand, in vivo the effects of endogenous BDNF in 
modulating the structure of neurons have been shown to be limited and to depend on the 
developmental stage, the brain area as well as the cell-type. The aim of this study was to 
clarify whether these contradictory results are the consequence of a different role of 
exogenous versus endogenous BDNF or whether they derive from comparing in vitro 
versus in vivo experiments.  
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3 Material and Methods  
3.1 Mice strains 
To examine the physiological role of Nogo-A in the mouse hippocampus as well as the 
influence of Nogo-A on spatial reference memory, either C57Bl/6 wild type or nogo-a 
deficient mice (nogo-a KO; Simonen et al., 2003; Dimou et al., 2006) were used. Briefly, to 
obtain mice where expression of Nogo-A is selectively abolished, parts of the nogo exons 
2 and 3 and the intron in between were exchanged for a PGK-neo (phosphoglycerate 
kinase-neomycin resistance) gene. 
3.2 Organotypic hippocampal slice cultures techniques 
3.2.1 Preparation of organotypic hippocampal slice cultures 
Hippocampal organotypic cultures were prepared from postnatal day 5 (P5) C57Bl/6 wild-
type (WT) mice as previously described (Michaelsen-Preusse et al., 2014; Stoppini et al., 
1991). The mice were decapitated with surgical scissors and the skin and bone was 
completely removed with forceps to expose the brain. The brain was horizontally cut 
(caudal to rostral) with a sharpened spatula starting between the Superior Colliculus and 
the Cerebellum (Figure 5A). The brain section was transferred upside down into the 
chilled drop of preparation solution (Figure 5B). The Cerebellum and Colliculus were 
gently detached and the meninges covering the hippocampi were carefully removed 
(Figure 5C). The Hemispheres were separated with a sharpened spatula along the midline 
(Figure 5D), and the exposed hippocampi were rolled out (Figure 5E) and separated from 
the cortex (Figure 5F). The hippocampi were dissected in ice-cold sterile Gey’s balanced 
salt solution (GBSS). The hippocampi were transferred onto a teflon disc of the tissue 
chopper, and sliced transversally at a thickness of 400 µm using a McIllwain tissue 
chopper. After an incubation of 30 min at 4°C the slices were placed on Millicells CM 
membrane inserts (Millipore) and cultivated in medium in a 37°C, 5% CO2, 99% humidity 
environment. To reduce the number of non-neuronal cells, a mixture of antimitotic drugs 
(cytosine arabinoside, uridine, and fluorodeoxyuridine; 10-6 – 10-7 M each; Sigma-Aldrich) 
was applied for 24 h three days after preparation and 50% medium was changed one a 
week. The medium was supplemented after 7-10 DIV with 1.25 μg/ml Fungizone as well 
as 100 U Penicillin and 100 μg/ml Streptomycin. 
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3.2.2 Single cell DNA electroporation 
In particular CA3 Neurons in the stratum pyramidale (sp) were electroporated of 
organotypic slice cultures 20-22 DIV (Figure 6A) and B. They showed a clear layered 
organisation stratum radiatum (SR) and stratum oriens (so) and especially the dense cell 
body layer stratum pyramidale (sp; Figure 6B). For the electroporation the Axoporator 
800A (Axon Instruments / Molecular Devices Corp.) and an upright fluorescence 
microscope (Zeiss examiner) with a 4x Objective (air, NA 0.1, Zeiss) and a 40x Objective 
(water, NA 0.8, Zeiss) equipped with a differential interference contrast (DIC) video 
camera were used. For the single cell DNA electroporation a total DNA concentration of 
150 ng/µl were used for eGFP-ß-actin (eGFP-actin) and for the co-electroporation equal 
amounts of eGFP-actin and mCherry-F (a modified version of mCherry carrying the 20-
amino-acid farnesylation signal from c-Ha-Ras derived from eGFP-F, Clontech). The DNA 
was diluted in sterile electroporation buffer 24 h before the electroporation, centrifuged at 
13,000 × g for 10 min and stored at 4°C. Right before the electroporation the 
centrifugation was repeated (13,000 × g for 10 min) and only the supernatant was filled 
into the patch pipet (approximately 4 μl) using the microloader tips (Eppendorf). The slices 
were kept in pre-warmed (37°C) sterile 1x Hank's Buffered Salt Solution HBSS 
(supplemented with 1.25 μg/ml Fungizone as well as 100 U Penicillin and 100 μg/ml  
Figure 5: Dissection of the hippocampus 
for slice culture preparation.  
A Shows how a spatula sharpened along the 
longer edge is used as a knife to perform a 
horizontal cut to separate the upper part of 
the brain, containing the hippocampi from the 
lower one.  
B Shows the separated part of the brain from 
below containing the cortical hemispheres 
with inside the two hippocampi (yellow 
arrows). The grey lines show how the forceps 
are placed to hold the brain and the red arrow 
the direction along which the colliculi have to 
be removed. C After removing the colliculi the 
hippocampi are completely exposed (yellow 
arrows). D Shows how the two hemispheres 
are separated along the midline. E Shows 
how one hemisphere is held with a forceps 
through the cortex while a rounded spatula is 
used to flip the hippocampus.  
F The yellow arrow shows how the 
hippocampus is separated from the cortex. 
Adapted from Michaelsen-Preusse et al., 
2014. 
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Figure 6: Single cell electroporation.           
A schema of the hippocampus slice culture showed dentate gyrus (DG) and in the CA3 area the 
position of the electroporation. B transmitted light image of a 21 DIV hippocampal slice culture 
showed the dense and well-defined cell body layers especially in the dentate gyrus (DG) and in the 
CA3 area. The insert (left) showed the preserved layer organisation (stratum radiatum, SR and 
stratum oriens, so) and especially the dense cell body layer (stratum pyramidale, sp) in the CA3 
region. C Shows five electroporated CA3 pyramidal neurons expressing both mCherry-F and 
eGFP-actin. C’ Confocal image consisting of stacks of multiple optical sections showing the 
morphology of a mid-apical dendritic tree of a CA3 neuron expressing mCherry and eGFP-actin. 
Note all the dendrites are highly covered with dendritic spines and the cells does not show any sign 
of degeneration. Scale bar is 20μm. D maximum projection of confocal images showed with high 
magnification a part of a mid-apical dendrite, there spine shape (mCherry-F) and the actin content 
(eGFP-actin) colocalize within dendritic spines (merge). Scale bar 2 µm. 
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Streptomycin) and electroporated with one train of 5V, 200Hz, 100 ms, square pulses of 1 
ms. The tip resistance of the electrode (GC150F-10, O.D. 1.5 mm x I.D. 0.86 mm, Harvard 
Apparatus (Kent): tip diameter 1-2 µm) was 5-10 MΩ at a pressure of 10-20 mlbar 
controlled by a pressure gauge (GDH200, Greisinger). The slices were used for FRAP 
measurements 24-72 h after the single cell electroporation. The electroporated CA3 
neurons were used for experiments if they didn’t show any sign of degeneration such as 
swelling of the cell body, fragmentation or retraction of the dendrites (Figure 6C and C’). 
The fluorescence intensity in pyramidal neurons was high enough to completely label both 
the basal and the apical dendritic tree and allowed detailed visualization of dendritic 
spines (Figure 6D; Michaelsen-Preusse et al., 2014). 
 
Table 1: Plasmids used in this study (organotypic hippocampal slice cultures) 
Plasmid    Description    Reference   
 pmCherry-F  farnesylated red fluorescent protein mcherry 
(CMV promoter)    
Shaner et al., 
2004; O'Brien, 
2007  
peGFP-actin  enhanced green fluorescent protein fused to ß-
actin (CMV promoter) 
Clontech 
 
3.2.3 Treatment of hippocampal slice cultures 
The loss-of-function for the Nogo-A signalling was obtained using specific antibodies or 
blockers as follows: (1) A Nogo-A specific blocking antibody (11C7, mouse IgG1), raised 
against a peptide corresponding to the rat Nogo-A sequence amino acids 623–640 (NiG-
Δ20 region; Oertle et al., 2003). The 11C7 antibody is monospecific for Nogo-A in 
Western blots and shows no cross-reactivity with other Nogo variants (Dodd et al., 2005; 
Oertle et al., 2003). The Nogo-A function-blocking ability of the 11C7 antibody was 
confirmed in vitro as well as in vivo (Liebscher et al., 2005; Wiessner et al., 2003). 
Furthermore, (2) a function-blocking antibody against the Nogo receptor NgR (goat anti-
Nogo receptor affinity-purified goat IgG; R&D Systems), (3) a specific blocker for the 
sphingosine-1-phosphate receptor 2 (S1PR2; JTE-013; Tocris, 5 μM in DMSO) and (4) a 
selective inhibitor of the Rho-associated protein kinase p160ROCK (y-27632 
dihydrochloride, Tocris, 100 µM in H2O) were used. A mouse IgG1 anti BrdU antibody was 
used as control. All antibody solutions were freshly diluted to a final concentration of 5 µg / 
ml in carbogenated ACSF containing 0.01% BSA. For inhibitors solved in DMSO or H2O, 
an equal amount of solvent was used as control. The Nogo-A gain-of-function approach 
was performed diluting the inhibitory peptide Nogo-A-Δ20 (Oertle et al., 2003) to a 
concentration of 5 μg/ml in carbogenated ACSF containing 0.01% BSA.  
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Table 2: Antibodies and Reagents used in this study (organotypic hippocampal slice cultures) 
Description   
Work 
dilution 
Source 
αNogo-A, 11C7 (mouse IgG1)  5 µg / ml  Schwab, Zurich 
αBrdU (mouse IgG1)  5 µg / ml  Schwab, Zurich 
αNogo receptor NgR (goat IgG1) 5 µg / ml  R&D Systems 
αsphingosine-1-phosphate receptor 2 (S1PR2), JTE-
013 
5 µm Tocris 
αRho-associated protein kinase p160ROCK, y-27632 
dihydrochloride 
100 µm Tocris 
inhibitory peptide Nogo-A-Δ20  5 μg/ml  Schwab, Zurich 
 
3.2.4 Neuron selection in organotypic slice culture 
The experiments in were performed at single spines of secondary or tertiary mid-apical 
dendritic branches of CA3 hippocampal neurons of organotypic slice culture. The 
overexpression of eGFP-ß-actin or mCherry-F resulted in the intense labeling of the entire 
dendritic arbor, as well as of all dendritic spines. Only cells without any sign of 
degeneration were selected for imaging and spines with an obvious head clearly 
separated from the dendrite were used. 
3.3 Imaging 
3.3.1 Fluorescence Recovery after Photobleaching (FRAP) 
All FRAP experiments were performed 24-72 hours after electroporation (21-23 DIV) at 
single spines of secondary or tertiary dendritic mid-apical branches of CA3 hippocampal 
neurons. Only spines with an obvious head clearly separated from the dendrite were 
selected for the FRAP experiments. The slices were kept at 32 °C in an open imaging 
chamber with a continuous perfusion (1 ml / min) of ACSF (carbogenate with 95% O2 and 
5% CO2) for 30 min before starting the experiment. Siliconized tubings were used and 
prewashed with ACSF containing 0.01% BSA to prevent sticking of the antibodies to the 
tubing and the chamber (Chen et al., 1999). The Olympus system BX61WI FluoView 1000 
(FV1000) was used to excite eGFP-ß-actin with an excitation wavelength of 488 nm. The 
power of the excitation laser was adjusted to a low level (1-2%; 5-8 µW) to reduce 
photobleaching as much as possible still achieving a good signal-to-noise ratio. Scan 
speed was set to 8 µs per pixel and a line averaging of two (Kalman filtering) were used 
for an image size of 640 × 128 pixels (final pixel size of 76nm) with a 60x water immersion 
objective (NA1.0). To increase the z-section’s depth the pinhole was opened to 400 µm 
and the gain and the offset were set to zero. The photobleaching of a single spine was 
performed using the SIM scanner unit Olympus FV5-LDPSU at an excitation wavelength 
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of 405 nm and a power of 28-32% (2.3-3 mW) for 28-30 ms. To determine the baseline 
and the fluorescence recovery 5 images were taken at two second intervals before and 55 
after bleaching. In some experiments, the morphology of spines labelled with mCherry-F 
was imaged using the 594 nm laser line with a scanning speed of 12.5 µs, a line 
averaging of 2 (Kalman filtering) and a final pixel size of 60 nm. The minimal z-stack depth 
was set ensuring that all the spines of interests were included in the image and scanned 
the selected dendritic stretch at 0.35 µm increments along the z-axis (maximum of 15 to 
20 z-planes). First the FRAP and then the spine morphology imaging was performed for 
the selected dendrite at an interval of 180 min. 
 
3.3.2 Analysis of dendritic spine density and morphology 
Confocal images were deconvolved using AutoQuantX2 (Media cybernetics, Inc.) and 
analysed with ImageJ (US National Institutes of Health). Dendritic spine density was 
counted in three dimensions by determining the number of spines per unit of dendritic 
length using the multipoint selection tool and the segmented line. The spine morphology 
was also analysed in three dimensions using the segmented line tool to measure 
maximum head width and the spine length (from the base at the dendrite its tip). 
The statistical analysis was performed using GraphPad Prism. The data were analysed 
using a one-way ANOVA followed by a post-hoc Tukey's Multiple Comparison Test. 
Values of p < 0.05 were considered significant and plotted as follows *p < 0.05; **p < 0.01; 
***p < 0.001. All data are shown as mean ± standard error of the mean (SEM). 
 
3.3.3 Analysis of the FRAP experiment 
Images were analysed using the Olympus software FV1000, by drawing defined regions 
of interest (ROI) around the bleached spine (the free Area tool was used). For the 
background and bleaching correction four ROIs were placed next to the bleached spine 
and on the underlying dendrite respectively (Figure 7A) using the Ellipse tool. The 
average relative intensity of the ROIs was measured with the Series Analysis tool 
(Olympus FluoView FV1000) and exported into Microsoft Excel. The mean background 
(BG) ROIs (Figure 7A, ROIs B–E in green) and the bleaching correction (BL) ROIs (Figure 
7A, ROIs F–I in blue) were calculated for each time point and plotted against time (Figure 
7). The mean BL pre-bleaching was calculated using the five pre-bleaching images (time 
points −5 to −1) and a double normalization was used to correct for the loss of signal due 
to both the bleaching pulse and the bleaching during imaging (Phair et al., 2004).  
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Figure 7: Analysis of the intensity values of the FRAP experiment         
A representative image of a dendrite stretch (CA3 Pyramidal neuron) labelled with eGFP-actin and 
including the spine used for the FRAP experiment. The region of bleaching (red ROI, A) as well as 
the regions for the background (green ROIs, B, C, D, E) and bleaching correction (blue ROIs, F, G, 
H, I) are shown. Scale bar 5 µm. B the original fluorescence intensity values are plotted against the 
time for the ROIs in A. C the normalized fluorescence intensity including the background correction 
(green) is plotted vs. the time. The effect of applying a “bleaching correction” is shown in blue. The 
nonlinear fitting of the FRAP curve is shown in grey.  
For each time point the normalized fluorescent intensity Fi was calculated (Fs fluorescent 
intensity of the bleached spine per time point (Figure 7, ROI A, red)).  
 
𝐹𝑖 = (𝐹𝑠 − 𝐵𝐺)
𝐵𝐿 𝑝𝑟𝑒𝑏𝑙𝑒𝑎𝑐ℎ𝑖𝑛𝑔 − 𝐵𝐺
𝐵𝐿 𝑎𝑓𝑡𝑒𝑟 𝑏𝑙𝑒𝑎𝑐ℎ𝑖𝑛𝑔 − 𝐵𝐺
 
 
The fluorescent intensity of each time point (Fi) was normalized by dividing it through the 
mean fluorescent intensity (Fi) before bleaching derived from the baseline time points −5 
to −1. The turnover time (recovery half-time t1/2) was calculated as the time in seconds at 
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which the fluorescence intensity reached half of its maximal pre-bleaching value. Based 
on the recovery curve the actin cytoskeleton dynamics within dendritic spines were 
divided into different actin fractions (Star et al., 2002; Zito et al., 2004). The ‘immobile 
fraction’ represents the stable actin fraction (𝑓𝑠, Figure 8A, red) within each spine. The 
‘mobile actin fraction’ consists of a dynamic (𝑓𝑓, Figure 8A, green) and a monomeric 
(1 − 𝑓𝑠 − 𝑓𝑓, Figure 8, blue) actin pool. The net recovery after photobleaching 𝐹(𝑡) is 
given by the equation below (were t is the time and λ is the time constant, inverse of the 
turnover rate; Star et al., 2002; Zito et al., 2004): 
𝐹(𝑡) = 1 − 𝑓𝑠 − 𝑓𝑓𝑒 −
𝑡
𝜆
 
The statistical analysis and nonlinear curve fitting (based on F(t)) of the fluorescence 
intensity were done using GraphPad Prism 5 by a 2-way repeated analysis of variance 
(ANOVA) inter-subject test followed by a two-tailed Student’s t-test. For the actin fractions 
and the turnover time an unpaired two-tailed Student’s t-test were used. Values of 
p  <  0.05 were considered significant and plotted as followed *p < 0.05; **p < 0.01; 
***p <  0.001. All data are indicated as mean ± standard error of the mean (SEM). 
Different control conditions and pharmacological agents were used to modulate actin 
dynamics within dendritic spines to validated the FRAP technique and the analysis. First 
cytopasmatic eGFP (26.9 kDa) showed a fast recovery after photo bleaching with a 
turnover time t1/2 of 0.34 ± 0.04 s and almost 100% recovery within 3 seconds after 
bleaching (Figure 8B). The turnover time for eGFP-actin (ß-actin fusion protein, 72 kDa) is 
23.09 ± 2.25 s and displayed a stable actin fraction of 16.30 ± 2.01% (Figure 8C). The 
comparison of these results show a 68 fold increase of the turnover time and indicate that 
the eGFP-actin are not freely diffusible within the spine. The polymerization dynamics of 
actin filaments are governed by many factors including actin binding proteins. Therefore it 
was tested whether 15 min application of 2 μM cytochalasin D or 1 µM jasplakinolide 
influence the actin filament dynamic and if this could be revealed by the FRAP 
experiments. Cytochalasin D is a barbed end capping molecule that prevents actin 
polymerization (Cooper, 1987) and it was shown to reduce the actin turnover within 
dendritic spines (Star et al., 2002). Indeed, the turnover time was significantly increased 
99.36 ± 2.72 s and cytochalasin D shifted the actin fraction towards the stable actin 
fraction (Figure 8C), by capping the barbed ends and the exchange of monomeric actin 
occurred only at the pointed end of the actin filaments (Cooper, 1987; Pollard et al., 2000). 
Complementary the application of the actin filament–stabilizing compound jasplakinolide 
(Bubb et al., 1994) converted nearly all actin 93.24 ± 1.04% to a stable form and 
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Figure 8: FRAP model to distinguish three actin fractions.         
A the distribution of actin fractions is colour coded and illustrated for a FRAP curve and a dendritic 
spine (adapted from Star et al., 2002; Honkura et al., 2008). The stable actin fraction in red , the 
dynamic fraction in green, and the monomeric fraction in blue. The turnover time (recovery half-
time t1/2) is shown in orange in the FRAP curve. B fluorescence recovery curve after 
photobleaching for cytoplasmatic eGFP at single spines. C Fluorescence recovery curve after 
photobleaching for eGFP-actin at single spines under control conditions, 15min application of 
cytochalasin D (2 µM) and jasplakinolide (1 µM). 
completely prevented recovery of actin after photobleaching (Figure 8C). These results 
together with previously published data support a model in which filament turnover 
determines the time course of fluorescence recovery after photobleaching and not a 
model in which recovery of fluorescence is determined by diffusion of filaments or 
unbound eGFP-actin (Star et al., 2002; Zito et al., 2004).  
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3.4 Preparation of acute hippocampal slices and DiOlistics 
Hippocampal slices were prepared from the male wild-type C57Bl/6 and nogo-a KO mice 
at day 3 or 9 after the Morris water maze (MWM) training and control mice without MWM 
training. In brief, the mice were decapitated and the brain was quickly transferred for three 
minutes into ice-cold carbogenated (95% O2, 5% CO2) artificial cerebrospinal fluid 
(ACSF). The cerebellum and a part of the forebrain were removed; the hemispheres were 
separated, the striatum was removed and each hippocampus was gently rolled out with a 
spatula and separated from the cortex. One hippocampus was immediately frozen in liquid 
nitrogen and kept at -80°C for biochemical analysis. The other hippocampus was cut in 
400μm thick transversal hippocampal acute slices (transversally to the longitudal axis) 
with the vibratome (VT 1200S; Leica). After an incubation phase of 1h in ACSF at room 
temperature the slices were fixed in 4% PFA overnight at 4°C and then washed with 
Phosphate Buffered Saline (PBS). The Diolistic was performed as previously described 
(Rauskolb et al., 2010). Briefly tungsten particles (50 mg; 1.7 µm in diameter; Bio-Rad) 
were mixed on a glass slide, with a 100 µl dye solution containing 3 mg of lipophilic dye 
DiI (Life Technologies) in 100µl of methylene chloride (Sigma-Aldrich; Grutzendler et al., 
2003) and let dry. The dried dye-coated particles were removed from the glass slide, 
resuspended in 3 ml distilled water, and further diluted during sonication to a final 
concentration of 1:70. Finally, the solution containing the tungsten microcarriers was filled 
into Tefzel tubing (Biorad) previously briefly washed with a PVP containing solution 
(polyvinyl-pyrrolidone, 0.05 mg/ml in ethanol; Bio-Rad). To ensure homogenous 
distribution of the tungsten particles the tubing was continuously rotated while drying. The 
tubing was cut into 1 cm long bullets which were stored at room temperature. Dye-coated 
particles were delivered to the hippocampal slices using a hand held gene gun (Bio-Rad; 
Helios Gene Gun System) at a pressure of 90 psi (one shot per hippocampal slice). A 
membrane filter with a poor size of 3 μm (Millipore) was inserted between the barrel 
aligner and the slice to prevent large clusters of particles from damaging and staining 
the tissue. The slices were kept in PBS at room temperature for 2-3 days for the dye to 
diffuse. The slices were post fixed in 4% PFA and washed with PBS before being 
mounted using an anti-fading aqueous mounting medium (Fluoro-Gel Emsdiasum). 
 
3.4.1 DiI imaging 
Mid-apical dendritic stretches from CA3 neurons were imaged with a BX61WI FluoView 
1000 (FV1000) Olympus confocal microscope. Image stacks were acquired using a 40x 
oil objective (NA1.3), z-step of 0.5 µm and a pixel size of 130 nm. For details of the 
analysis and statistics see 3.4.2: Analysis of dendritic spine density. 
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3.5 Morris water maze task 
The Morris water maze (MWM) task was used to test spatial learning in rodents. It is 
based on the navigation in an open swimming arena equipped with distal cues to locate a 
submerged escape platform (Morris, 1984, 1981). Spatial learning is evaluated across 
repeated trials and days whereas reference memory is examined in a probe trail 
measuring the preference for the target quadrant when the platform is absent (Vorhees 
and Williams, 2006). The MWM experiments were used to assess spatial reference 
memory in adult male C57Bl/6 wild-type (WT) mice and Nogo-A -/- mice 3 month old 
(Simonen et al., 2003). An escape platform 10 cm in diameter was placed in a circular 
plastic pool (160 cm in diameter and 60 cm high) filled up to 30 cm with opaque water 
(Titandioxid, Euro OTC Pharma; water temperature 20°C). Three distal visual cues 
(triangle, circle and stripes) were positioned around the pool. The mice were maintained in 
a 12:12h light/dark cycle and all tests were performed under indirect light. 
 
Figure 9: Organisation, pretraining and time course of the Morris water maze training.  
A Overview over the time course of the pertaining and the MWM training including the PTs at day 3 
and 9. B Top view of the basin, divided in four quadrants via the cardinal point N north, E east, S 
south, W west. Blue triangle mark the starting position of the Morris water maze task, red triangle 
the release position of the probe trail (PT) and the grey circle the position of the hidden platform.    
C Pretraining mean latency of WT C57Bl/6 versus nogo-A KO mice over three days of the 
pretraining.  
For the pre-training (3 days) the platform was clearly visible above the water surface and 
marked with a coloured mark. This served to familiarize the animals with the water maze 
and the experimenter. For the pre-training two trials for 90 s were performed and the 
release position on the opposite site of the visible platform was changed in a pseudo 
randomized order. The mice were carefully guided by the experimenter to the platform if 
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they failed to locate it within 90s. The mice had to remain 15 s on the platform before 
being returned to their home cage. WT C57Bl/6 and nogo-A KO mice learned equally to 
swim to the visible platform (Figure 9C). Only animals of (both mice species WT and 
nogo-a KO) that showed active swimming behaviour and no thighmotaxis at the last day 
of pretraining were used (after 2 days of recovery) for the MWM task. To assess spatial 
reference memory, the mice were trained to locate the hidden platform (1cm below the 
water surface) for 8 consecutive days (days 1–8, Figure 9A). The platform location was 
fixed, in the middle of quadrant NW and the release position (SW, S, E, NE) was changed 
in a pseudorandom order (Figure 9B). Each trial (4 per day with an interval of 3-5 min) 
was recorded and analysed by the tracking software VideoMot2. At day 3 and 9 of the 
acquisition phase reference memory was assessed by removing the platform and allowing 
the animal to freely swim for 45 s (starting position PT Figure 9B). All procedures 
described in the present study had been conducted in accordance with the applicable 
European and National regulations (Tierschutzgesetz) and approved by the responsible 
authority (Nds. Landesamtes für Verbraucherschutz und Lebensmittelsicherheit, LAVES 
Niedersachsen; Permit Number: 33.12 42502-04-13/1230; 31.7.2013). 
 
3.5.1 Morris water maze data analysis 
The recorded swim paths were analysed using Microsoft Excel and Matlab (The 
Mathworks, USA). As an index for spatial memory formation both in WT C57Bl/6 and 
Nogo-A deficient mice the escape latency was analysed. Reference memory in the probe 
trial was measured as the percentage of time spent in each quadrant and the number of 
crossings over the former platform location. The mice showed a series of different search 
patterns ranging from random to spatially precise or highly efficient. For qualitative 
aspects of spatial memory formation we analysed the individual search strategies used by 
the mice to locate the hidden platform (Brody and Holtzman, 2006; Garthe et al., 2009; 
Wolfer et al., 2001). Classification of searching behaviours was performed using a 
parameter-based algorithm, which allows the comparisons between the contributions of 
each strategy reliably (Figure 10; Garthe et al., 2009). The classification procedure was 
implemented as a script in Matlab and distinguished the following searching strategies: 
random search, scanning, chaining (all hippocampus independent) and the hippocampus 
dependent strategies: direct search, focal search and direct swimming were pooled and 
named direct search (Figure 10; Garthe et al., 2009). Statistical analysis was performed 
using IBM SPSS Statistics 20 software and the experimenter was blind to the genotype  
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Figure 10: Algorithm-based classification of search strategies used during the Morris 
water maze task.              
A criteria used in the classification of the search pattern, the basin was divided into distinct zones 
(annulus zone and goal corridor), distance to pool centre (dpc) to calculate the respective 
searching strategy. B the search patterns were identified using an algorithm-based classification 
(with Math lab). The xy-coordinates over the time were used to calculate the respective searching 
strategy in the outlined order. Direct swimming, focal search and directed search were categorized 
as direct search or as a hippocampus dependent searching pattern. Chaining scanning and 
random search were categorized as hippocampus independent searching pattern. Modified after 
Garthe et al., 2009. 
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both during the experiment and the analysis. The latency values were tested with a 2-way 
repeated analysis of variance (ANOVA). Scores obtained in the strategy analysis were 
analysed using 2-way repeated ANOVA followed by a non-parametric Mann–Whitney U-
test. Quadrant preferences during the probe trials were analysed using a one-way ANOVA 
followed by a post-hoc Tukey's Multiple Comparison Test (GraphPad Prism). Values of p 
< 0.05 were considered significant and plotted as followed *p < 0.05; **p < 0.01; 
***p < 0.001. All data are indicated as mean ± standard error of the mean (SEM). 
The parameters for the searching strategies are the following:  
 
Random search: 
o Search behaviour covering the entire pool surface. 
 > 60% surface coverage 
Scanning:  
o Search behaviour became increasingly restricted to the central pool. 
 <60% and >10% surface coverage 
 <0.7 dpc (distance to pool centre) 
For both random search and scanning any spatial or directional preference is absent. 
Chaining:  
o Search behaviour became increasingly restricted to the goal annulus zone. 
 >80% time in annulus zone  
 0.4 - 0.8 dpc  
Directed search: 
o Search behaviour became directional restricted in a triangular way pointing 
towards the platform. 
 80% in a 40° goal corridor (from the starting point) 
Focal search: 
o Search behaviour became directed to the platform, searching near to the 
platform. 
 <0.3 dpc to mean distance to the platform 
 <0.35 dpc to mean distance to swim path centroid  
 Direct swimming: 
o Search behaviour became directed to the platform. 
 90% in a 10° goal corridor (from the starting point)       
 Modified after Garthe et al., 2009.  
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3.6 Western Blot 
Tissues were homogenized with mechanical disruption and extracted on ice in RIPA 
buffer, pH 8.0, containing 0,1% SDS, 0,5% sodium deoxycholate (DOG), 1% NP-40 
Nonidet P40 and protease inhibitors cocktail (Roche). Samples were incubated on ice for 
40–60 min, and debris was pelleted by centrifugation (15,000 × g for 15 min at 4 °C). Total 
protein concentration of cleared lysates was measured by Bredford protein assay. Equal 
protein concentrations (20 μg per lane) from three animals per group (not-trained, 3 day 
training and 9 day training) were separated on 7.5% gels and transferred to polyvinylidene 
difluoride (PVDF) membranes. Membranes were blocked in tris-buffered saline / Tween 
with 5% milk powder and incubated with rabbit anti-Nogo antiserum Bianca (1:60,000) and 
mouse anti-tubulin antibody (1:2000; Sigma-Aldrich) overnight at 4 °C. The membranes 
were then washed in tris-buffered saline/Tween and subjected to secondary HRP 
conjugated antibodies goat anti-rabbit or goat anti-mouse (1:2000; Sigma-Aldrich) diluted 
in TBS-T for 90 min at room temperature. Immunoreactivity was visualized by 
chemoluminescence (Luminata, Millipore). For quantification the same samples were run 
independently three times. Densitometry of bands was conducted in EasyWin32 using the 
tubulin as loading control. 
3.7 Primary hippocampal culture techniques 
3.7.1 Preparation of primary hippocampal cultures 
Primary hippocampal cultures were prepared from C57Bl/6 mice at embryonic day 18. 
Glass coverslips (13 mm diameter) were prepared in advance and were first incubated in 
a 10 M NaOH solution (5-6 h), sterilized at 225 °C for 6 h and coated with 0.5 mg/ml poly-
L-lysine hydrobromide (Sigma) in boric acid buffer (overnight at 4°C or 3 h at 37 °C). 
Embryos were decapitated and the brains were kept in ice-cold Gey’s balanced salt 
solution supplemented with glucose and adjusted to pH 7.2. After dissection the 
hippocampi were incubated for 10 min in trypsin/EDTA at 37°C and then mechanically 
dissociated with a Pasteur pipette. Cells were plated at high density (105/well) on the poly-
L-lysine-coated coverslips (13 mm) and kept in Neurobasal medium (Lifetechnologies) 
supplemented with 2% B27 (Lifetechnologies) and 1% Glutamax at 37°C, 5% CO2, and 
99% humidity. For the neurite out growth assay after 3 days in vitro (DIV), the cells were 
plated at a density of 104 cells per well. Furthermore, for experiments were the synaptic 
activity was manipulated (e.g. with high Magnesium, 3.5 mM Mg2+) and their controls, the 
cells were plated at a density of 70,000 cells per well and kept in Neurobasal medium 
(Gibco) supplemented with 2% BSA (Gibco), 200 μM L-Glutamin and 1% 100 × N2 (Life 
Technologies) at 37°C, 5% CO2, and 99% humidity. 
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3.7.2 Transfection of primary hippocampal neurons 
Primary hippocampal neurons were transfected after 14 and 21 DIV with a farnesylated 
form of the enhanced green fluorescent protein (fEGFP) using Lipofectamine 2000 
according to the manufacturer’s protocol. To label F-actin the primary hippocampal 
cultures were co-transfected with fEGFP and an expression plasmid for the Lifeact 
peptide fused to a red fluorescent protein (RFP-LA; Riedl et al., 2008, 2010). Briefly, 0.8 
μg DNA for transfection of a single plasmid or, for a co-transfection 0.4 µg pfEGFP and 
0.6 µg pRFP-LA and 2 μl Lipofectamine 2000 per well were mixed in 100 µl Neurobasal 
medium without supplements (NB-) and added after 20 min incubation at room 
temperature to the cultures drop-wise. The conditioned medium of the primary cultures 
was previously exchanged too NB-. After 50 min of incubation the transfection medium 
was exchanged for the original Neurobasal medium. The cultures were kept for 24 h at 
37°C, 5% CO2, and 99% humidity before the treatment. 
Table 3: Plasmids used in this study (primary hippocampal culture) 
Plasmid    Description    Reference   
 pEGFP-F  farnesylated enhanced green fluorescent protein 
(CMV promoter)    
 Clontech   
pRFP-
Lifeact-N1 
red fluorescent protein fused to lifeact      
(CMV promoter)  
Riedel et al.,2008 
 
3.7.3 Treatment of primary hippocampal neurons 
Twenty-four hours after transfection, 1/3 of the culture medium was exchanged for a 
medium containing 0.1% Bovine Serum Albumine (BSA, 0.1% BSA/1x PBS) as a control 
treatment or 0.1% BSA combined with BDNF (Recombinant Human BDNF, 40 ng/ml, 
R&D Systems), BDNF blocking antibodies (BDNF-Abs, 1:500, M. Sendtner, Wuerzburg 
Germany) or TrkB receptor bodies (TrkB-Fc, Recombinant Human TrkB-Fc, 500 ng/ml, 
R&D Systems). BSA was added to the medium to prevent BDNF or the antibodies from 
sticking to the plastic (Chen et al., 1999). In a second set of control experiments the 
cultures were kept in Neurobasal medium (NB) without addition of BSA. As no significant 
difference between the two control conditions could be observed only the BSA control was 
used in the result part. After 24 h of treatment the cultures were fixed in 4% 
paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB), washed and mounted with an 
anti-fading aqueous mounting medium (Fluoro-Gel Emsdiasum). In a second set of 
experiments neuronal activity was reduced in primary hippocampal cultures by increasing 
the Mg2+ concentration in the medium. Indeed, Mg2+ decreases the activation of voltage-
gated channels thereby reducing neuronal excitability (Dribben et al., 2010; Mayer and 
Westbrook, 1987). To avoid effects on the early developmental stages Mg2+ concentration 
in the medium was increased starting at 7 DIV from 1.5 to 3.5 mM by adding MgCl2 (50% 
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medium change, NB with 5.5 mM MgCl2), fresh medium was added once a week (13 and 
20 DIV; 50% medium change, NB with 3.5 mM MgCl2). The treatment with BDNF or TrkB 
receptor bodies was performed for 24 h either in low (1.5 mM) or high (3.5 mM) Mg2+ 
containing medium. 
Table 4: Antibodies and Reagents used in this study (primary hippocampal culture) 
Description   
Work 
dilution 
Source 
Recombinant Human BDNF 40 ng / ml R&D Systems 
Recombinant Human TrkB-Fc Chimera 500 ng / ml R&D Systems 
αBDNF antibodies (BDNF-Abs) 1:500 
Sendtner, 
Würzburg 
 
3.7.4 Immunohistochemistry 
Primary hippocampal cultures (6 or 23 DIV) were fixed with 4% PFA, washed with PBS 
and incubated in a solution 0.2% Triton X-100, 10% goat serum and 0.1% BSA in 
phosphate buffer (PBS) to permeabilize the membrane and block unspecific binding sites. 
A rabbit polyclonal antibody anti-c-fos (Santa Cruz Biotechnology, Inc., sc-52; dilution 
1:500), a mouse monoclonal antibody anti-CaMKII (Lifetechnologies, dilution 1:500), a 
rabbit polyclonal anti-MAP2 (Abcam, dilution 1:500) or a primary rabbit monoclonal anti-
phospho-TrkA (Tyr674/675) / TrkB (Tyr706/707) antibody (Cell Signaling Technology; 
dilution 1:200) were diluted in blocking solution (10% goat serum, 0.1% BSA in PBS and 
0.2% Triton X-100) and incubated at 4 °C overnight. Secondary anti-rabbit or anti-mouse 
antibodies conjugated with Cy2, Cy3, or Cy5 (Jackson Immuno Research) were diluted 
1:500 in PBS and incubated for 2 h at room temperature. Alexa Fluor 350 phalloidin 
(Lifetechnologies) was diluted 1:50 in PBS and incubated for 3 h at room temperature to 
selectively stain F-actin. Finally, cultures were counterstained with DAPI (4',6-diamidino-2-
phenylindole; Biotium) diluted 1:1000 in PBS for 5 min, washed and mounted using an 
anti-fading aqueous mounting medium (Fluoro-Gel Emsdiasum). 
Table 5: Antibodies used in this study (primary hippocampal culture) 
Antigen  Organism  
Work 
dilution 
Source 
αCaMKII 
(Ca2+/calmodulin dep. kinase II)  
mouse  1:500 Lifetechnologies 
α-c-fos (Inc., sc-52) rabbit 1:500 
Santa Cruz 
Biotec. 
MAP2 (microtubule associated protein) rabbit 1:500 Abcam 
Alexa Fluor 350 phalloidin 
 
1:50 Lifetechnologies 
anti-phospho-TrkA (Tyr674/675) / TrkB 
(Tyr706/707) 
rabbit 1:200 
Cell Signaling 
Tec. 
Mouse/rabbit Cy2/Cy3/Cy5  goat  1:500 
Jackson 
Immuno Res. 
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3.7.5 Neuron selection in primary hippocampal cultures 
The transfection of the fEGFP expression plasmid under the control of the CMV promoter 
resulted in the intense labeling of the entire dendritic arbor as well as of all dendritic 
spines of individual pyramidal neurons. Only non-overlapping labelled pyramidal neurons 
were selected for our analysis allowing for an unambiguous reconstruction of the entire 
dendritic tree as well as the analysis for the spine density. Degenerating neurons were 
identified according to the presence of retraction bulbs and fragmentation of the dendritic 
processes and excluded from the analysis. Due to a recent report showing that Mg2+ (5 to 
10 mM) increase neuronal apoptosis in primary hippocampal neurons (Dribben et al., 
2010), special care was taken in selecting neurons kept in high magnesium medium 
(3.5 mM). Indeed, all neurons selected for the analysis showed a healthy cell body and 
dendritic tree with no signs of apoptosis. 
 
3.7.6 Imaging of primary hippocampal cultures  
The neurons selected for analysis were imaged using an Axioplan 2 microscope equipped 
with an ApoTome module (Zeiss). Each neuron was first imaged using a 20x objective 
(1.25 numerical aperture (NA). For the analysis of the spine density and spine morphology 
defined dendritic stretches were imaged using a 63x objective (1.32 NA) acquiring three-
dimensional stacks z-sectioned at 0.5 µm. 
 
3.7.7 Calcium imaging with primary hippocampal cultures 
Primary hippocampal cultures 16 and 23 DIV were loaded with calcium indicator by 
incubating them for 15 min with the indicator solution (50 μg Oregon Green 488 BAPTA-1 
AM (Lifetechnologies), dissolved in 50 μl DMSO and 2.5% Pluronic acid) at 37°C, 5% 
CO2, and 99% humidity. The cells were then transferred to HBSS (Hanks balanced salt 
solution) and kept 45 min at 37°C, 5% CO2, and 99% humidity. The coverslips were then 
transferred to the recording chamber, continuously perfused with HBSS and kept at 32°C. 
The live imaging was performed using an Olympus BX61WI microscope system (Cell^M 
software) and a CCD camera (VisiCam QE, Visitron Systems). Images were recorded at 
6.67 Hz for 75 sec with an Olympus 20x water immersion objective (0.95 NA, XLUMPLAN 
FL, Olympus), whereby a pixel resolution of 0.77 μm / pixel was achieved. A frame rate of 
150 ms and an exposure time of 61 ms were used. Primary hippocampal cultures were 
treated with BSA (0.1% BSA/1x PBS) or BDNF (Recombinant Human BDNF, 40 ng/ml, 
R&D Systems) by a 5 min bath-application. The analysis of calcium transients was 
performed using ImageJ (NIH) and calculating the fluorescence changes as average of all 
pixels within regions of interests (ROIs). The ROIs were set around the cell bodies of the 
neurons. For the background subtraction the ROI was drawn on a neighboring area 
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containing neuropil. The resulting changes in the intracellular calcium concentration are 
represented as ΔF/F0 in percent, where F0 is the fluorescence at resting conditions   
(ΔF/F0 = (F - F0) / F0) taken before the application of BDNF (Lang et al., 2006). In addition, 
changes in the fluorescence intensity for the whole ΔF-stack were visualize using the 
plugin ‘reslice’ of the ImageJ Software to generate a pseudo-line scan . In the pseudo-line 
scan the y-axis corresponds to the respective line drawn on the stack whereas the x-axis 
corresponds to time. 
 
3.7.8 Data analysis of primary hippocampal cultures 
For the selected neurons dendritic complexity and length was analysed using a Sholl 
analysis (Sholl, 1953). The neurons were traced using the Neurolucida software 
(MicroBrightField), and the Sholl analysis was obtained with Neuroexplorer software 
(MicroBrightField), calculating the cumulative number of dendritic intersections at 10 µm 
interval distance points starting from the cell body. The total number of crossings for each 
cell was used as an index for total dendritic complexity. For 6 DIV neurons the total 
neurite length, number of primary neurites and number of branching points of were 
analysed by tracing MAP2 labelled neurites using the NeuronJ (Meijering et al., 2004) 
plugin for ImageJ (NIH) Software. Spine density was measured for portions of selected 
second or third order dendrite branches. The number of spines and the dendritic length 
were measured using the ImageJ software. The number of spines was normalized per 
micrometer of dendritic length and a minimal length of 250 µm of dendrite per cell was 
analysed. The maximal spine head diameter and maximal spine length (from the dendritic 
shaft to the spine head tip) were measured on three-dimensional stacks using the ImageJ 
(NIH) software. To examine the actin content in dendritic spine heads the mean 
fluorescent intensity of RFP-lifeact was measured with the area selection tool of ImageJ 
and normalized to the mean fluorescent intensity of the dendritic shaft (for normalization of 
the RFP overexpression, Figure 23B, indicated with the arrow heads). RFP-Lifeact and 
the immunocytochemistry for c-fos and phosphorylated TrkB were imaged keeping a 
constant exposure time. The mean fluorescent intensity values for the 
immunocytochemistry of c-fos and phosphorylated TrkB were measured with ImageJ 
(NIH) and normalized to the control condition. The analysis was done without knowledge 
of the treatment performed. The statistical analysis was performed using GraphPad Prism. 
The data obtained were compared between two different experimental conditions using an 
unpaired two-tailed Student's t-test. Data including more than 2 different groups were 
analysed using a One-Way ANOVA followed by a post-hoc Tukey's Multiple Comparison 
Test. Values of p = 0.05 were considered significant and plotted as follows *p < 0.05; **p < 
0.01; ***p < 0.001. All data are indicated as mean ± standard error of the mean (SEM).  
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3.8 Solutions and media 
All reagents used in this thesis have been distributed by AppliChem, Invitrogen, 
PAA, Roth or Sigma. Exceptions were described separately.  
 
Organotypic cultures: 
Gey’s Balanced Salt Solution pH 7.4 (GBSS) 
Component      Molarity [mM] 
CaCl2 * 2 H2O  1.5 
KCl  5.0 
KH2PO4  0.22 
MgCl2 * 6 H2O  1.0 
MgSO4 * 7 H2O  0.28 
NaCl  1.37 
Na2HCO3  2.7 
Na2HPO4  0.86 
D-Glucose  5.5 
Filtered sterile and kept at 4°C. 
 
Kynurenic acid  
Dissolved 946 mg Kynurenic acid in 5 ml 1 M NaOH; added 45 ml dH2O; filtered 
sterile; 
prepared 1 ml fractions and stored at -20°C. 
 
 
Glucose (50%) 
Glucose was dissolved in dH2O 1:1 while heating, filtered sterile in warm state and 
stored at -20°C. 
 
Preparation solution pH 7.2 
GBSS  98 ml  
Glucose (50%) 1 ml  
Kynurenic acid  1 ml  
Adjusted pH to 7.2 (1 M HCl) and filtered sterile. 
 
Medium 
BME  100 ml  
HBSS  50 ml  
Equine donor serum  50 ml  
L-Glutamin (200 mM) 1 ml 
Glucose (50%)  2 ml  
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Antimitotics  
1M Uridine,        2.42 mg / 10 ml H2O 
1M Cytosin-β-D-Arabinofuranosid Hydrochlorid,   2.79 mg / 10 ml H2O 
1M 5-Fluoro-2´-Deoxyuridin,     2.46 mg / 10 ml H2O 
Stock solutions 1:1; sterile filtered and stored at -20°C. 
Antibiotics and Fungicides 
From DIV 7 on the medium was supplemented with 1.25 μg/ml Fungizone, 100 U 
Penicillin and 100 μg/ml Streptomycin. 
 
Fungizone 
Stock solution: 250 μg Fungizone/ml, diluted 1:200 = 1.25 μg Fungizone/ml culture 
medium or HBSS, 250 μl Fungizone Stock solution in 50 ml culture medium or 
HBSS. 
 
Penicillin–Streptomycin 
Stock solution: 5,000 U Penicillin–5,000 μg streptomycin /ml, diluted 1:50 = 100 U 
Pen–100 μg Strep / ml culture medium or HBSS, 1 ml Pen–Strep in 50 mL culture 
medium or HBSS. 
 
Primary cultures:  
Preparation solution pH 7.2 
 
GBSS 98 ml  
Glucose  1 ml  
Adjusted pH to 7.2 (1 M HCl) and filtered sterile. 
 
Medium normal Magnesium 1.5mM 
Neurobasal  50 ml  
B27  2 ml  
GlutaMAX (200 mM)  125 μl  
 
Medium high Magnesium 3.5mM 
Neurobasal  50 ml  
B27  1 ml  
L-Glutamin (200mM)  125 μl  
N2 (100x)  500 μl  
 
Borate-Buffer pH 8.5 (Glass coverslips) 
Dissolved 1.24 g boric acid and 1.9 g borax in 400 ml sterile H2O and adjusted pH 
to 8.5. 
 
Poly-L-Lysin stock solution 
Dissolved 10 mg/ml in H2O, stored at -20°C. 
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Cell and Molecular Biology: 
ACSF (Artificial Cerebrospinal Fluid) used for live imaging experiments. 
Component  Molarity [mM]  
NaCl 124 
KCl 4.9 
MgSO4*7H2O 2.0 
CaCl2*2H2O 2.0 
KH2PO4 1.2 
NaHCO3 25.6 
D-Glucose 10.0 
 
ACSF used for the preparation of acute brain slices. 
Component  Molarity [mM]  
NaCl  125.0  
KCl  2.5  
NaH2PO4 * H2O  1.25  
MgCl2 * 6H2O  2.0  
NaHCO3  26.0  
D- Glucose  25.0  
CaCl2 * 2H2O  2.0  
 
DNA electroporation buffer  
Component  Molarity [mM]  
NaCl  135  
KCl  5.4  
MgCl2 
CaCl2  
1.0 
1.8  
Hepes 5.0 
Adjust pH of 7.2 and stored at 4°C. 
 
Hank's Buffered Salt Solution - HBSS (500ml) 
 
HBSS 10x    50  ml   
NaHCO3 175 mg 
CaCl2 * 2 H2O 147 mg 
Filled up with dH2O, sterile filtered and stored at 4°C. 
 
Phosphate buffered saline (PBS) 
Component  Molarity [mM]  
KCl  2.7  
KH2PO4  1.5  
NaCl  
Na2HPO4  
137  
10.4  
 
4% PFA in 0.2 M Phosphat Buffer pH 7.4 
dH2O  500 ml  
PFA  40   g   
0,2 M Phosphat  500 ml  
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4 Results 
Learning and memory processes are correlated to both functional and structural changes 
at dendritic spines and axonal boutons (Bailey and Kandel, 1993; Caroni et al., 2012; 
Kasai et al., 2010; Lamprecht and LeDoux, 2004). Alterations in the size and shape of 
dendritic spines are correlated with their strength of synapses and heavily depend on 
remodelling of its underlying actin cytoskeleton (Dillon and Goda, 2005; Hotulainen and 
Hoogenraad, 2010; Okamoto et al., 2009). Interestingly, spine dynamics are tightly 
regulated by extracellular signals and most signalling pathways linking synaptic activity to 
spine morphology regulate actin dynamics (Hotulainen and Hoogenraad, 2010). In this 
context, I examined the role of two different molecules: the myelin associated protein 
Nogo-A and the neurotrophin BDNF (Brain-derived neurotrophic factor) in modulating or 
regulating the actin cytoskeleton and structural synaptic plasticity in the mature 
hippocampal network. 
In the first part of my work, I addressed the question of whether Nogo-A signalling acutely 
controls the actin cytoskeleton dynamics at individual dendritic spines of hippocampal 
pyramidal neurons in vitro. Next, I examined whether Nogo-A is involved in regulating 
structural plasticity upon learning and memory processes in vivo. In the second part of my 
work, I asked whether BDNF signalling affects activity-dependent structural plasticity of 
mature hippocampal neurons in vitro.  
 
4.1 Nogo-A modulates the actin cytoskeleton within dendritic spines 
and is involved in regulating structural plasticity upon learning  
4.1.1 Nogo-A signalling transiently modulates actin cytoskeleton dynamics 
within dendritic spines to regulate their architecture 
Recent studies demonstrated an important role of Nogo-A signalling in suppressing 
structural and functional plasticity in the mature and uninjured neuronal circuit of the CNS 
(for reviews see: Kempf and Schwab, 2013; Mironova and Giger, 2013; Schwab, 2010). 
These effects of Nogo-A are mediated via two extracellular domains and their receptors: 
Nogo-66 domain acting via the Nogo-66 receptor 1 (NgR1; Fournier et al., 2001) and 
Nogo-A-Δ20 via the sphingosine 1-phosphate receptor 2 (S1PR2; Kempf et al., 2014). In 
this study I applied a series of gain- or loss-of-function approaches for Nogo-A to 
investigate its role in modulating the actin cytoskeleton dynamics within dendritic spines of 
CA3 pyramidal neurons in 3-week-old organotypic hippocampal WT cultures. Filamentous 
actin is concentrated in dendritic spine heads (Figure 11A, left) and plays an important 
role in regulating structural and functional plasticity (Dillon and Goda, 2005; Hotulainen 
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and Hoogenraad, 2010; Matus, 2000; Okamoto et al., 2009). To determine if Nogo-A may 
influence the actin cytoskeleton dynamics fluorescence recovery after photobleaching 
(FRAP) was performed at individual dendritic spines of eGFP-actin expressing CA3 
pyramidal neurons (Figure 11A, left). To distinguish possible early and late effects of actin 
dynamics, FRAP was performed 20 and 180 minutes after the application of different 
treatments. An anti-BrdU mouse IgG1 antibody was used as control. 
 
Figure 11: Nogo-A neutralisation affects transitory the actin cytoskeleton within dendritic 
spines of hippocampal pyramidal neurons.          
A Maximum projection consisting of stacks of multiple optical sections, pseudo colour encodes for 
fluorescence intensity of the eGFP-actin content within dendritic spine of CA3 hippocampal 
pyramidal neuron. Scale bar, 2 µm (left) and the time series before and after bleaching of a single 
dendritic spine (time point of bleaching at 0s). Scale bar, 1 µm (right). B Fluorescence recovery 
curve after photobleaching for eGFP-actin at single spines under control conditions or Nogo-A Abs 
treatment after 20 and 180 min. Numbers of dendritic spines are indicated for each treatment. 
Analysis of the C turnover time, D dynamic actin fraction, E stable actin fraction and F monomeric 
actin fraction for control conditions compared to Nogo-A neutralisation after 20 and 180 min 
respectively. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01; ***p < 0.001. 
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The actin cytoskeleton of single dendritic spines was imaged at 2 s intervals over 2 min 
before bleaching. The eGFP-actin fluorescence was constant and completely disappeared 
upon bleaching (Figure11A, right). Under control conditions the fluorescence intensity 
rapidly recovered after photobleaching and reached a plateau at 85% of the original pre-
bleaching fluorescence after 110s. No significant differences in the fluorescence recovery 
profile could be observed between the two time points used (20 and 180 min; Figure 11B). 
Similar to previous data, this indicates that under control conditions 85% of the actin within 
dendritic spines exists in a mobile state and only a small fraction of 15% is stable 110 s 
after bleaching (Figure 11E; Star et al., 2002). Mobile actin consists in 70% dynamic actin 
fraction (Figure 11D) and 15% monomeric G-actin fraction (Figure 11F). No differences in 
mobile actin could be observed between the two time points (20 and 180 min; Table S1) 
under control conditions. Furthermore, the turnover time (recovery half-time t1/2; Figure 
11C) was about 20 seconds both after 20 or 180 minutes of treatment (Table S1) and was 
in line with previous data (Stamatakou et al., 2013). Nogo-A was neutralised by bath 
application of the Nogo-A function blocking antibodies (Abs) 11c7 raised against the 
Nogo-A-Δ20 domain (Liebscher et al., 2005; Maier et al., 2009; Oertle et al., 2003). The 
actin cytoskeleton dynamics of single dendritic spines showed a dramatic change both 
after 20 and 180 min of Nogo-A neutralisation when compared to respective control 
conditions. Starting 6 s after bleaching the recovery curve recorded after 20 min of Nogo-
A Abs treatment showed significantly lower intensity values than under control conditions. 
The significant differences in the recovery curve were maintained up to 110 s after 
bleaching (Figure 11B, control vs. Nogo-A 20 min p < 0.01). Also, when the FRAP 
experiment was performed 180 min after Nogo-A Abs treatment, the recovery curve 
showed significant lower intensity values between 10 and 76 s after bleaching in 
comparison to the control (Figure 11B, control vs. Nogo-A 180 min p < 0.05). To quantify 
the actin cytoskeleton dynamics within dendritic spines, the turnover time was calculated 
and showed a significant increase for both 20 min and 180 min Nogo-A neutralisation in 
comparison to controls (Figure 11C, Table S1, control vs. Nogo-A 20 min p < 0.001 and 
control vs. Nogo-A Abs 180 min p < 0.05). Moreover, the stable actin fraction was 
significantly increased after 20 min Nogo-A neutralisation in comparison to the control 
(Figure 11E, Table S1, control vs. Nogo-A Abs 20 min p < 0.05) while after 180 min of 
blocking Nogo-A the stable actin fraction was unaltered when compared to control 
condition (Figure 11E, Table S1). The analysis of the dynamic (Figure 11D) and 
monomeric actin fractions (Figure 11F) showed no significant changes between the 
controls and Nogo-A Abs treatment at both time points (Table S1).  
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Figure 12: The stable actin fraction correlates with changes in spine length.        
Confocal image consisting of stacks of multiple optical sections showing the morphology of a mid-
apical dendritic stretch of a CA3 neuron, there spine shape A1 (mCherry-F) and the actin content 
A2 (eGFP-actin) colocalize (arrow head) within dendritic spines A3 (merge). Scale bar 2 µm. 
Maximum projection of confocal images of spine morphology (mCherry-F) of two time points 0 min 
before and after 180 min Nogo-A neutralisation A4. Scale bar 2 µm. A5 enlargement of one 
dendritic spines (highlighted with an arrow A4) with an increase in spine length (red line shows the 
measurement) after 180 min Nogo-A neutralisation. Scale bar 1 µm. B normalized spine length 
(left) and spine head width (right) before and after 180 min Nogo-A blocking. C only spine shown 
an elongation in length were included for further analysis. Fluorescence recovery curve after 
photobleaching for eGFP-actin at single spines before and after Nogo-A Abs treatment of 180 min. 
Numbers of dendritic spines are indicated for each condition. D spine with an increase in length 
displayed a correlation between spine length changes and the stable actin fraction (left, R
2
=0.45, 
p < 0.05) but not with the turnover time (right). E the spine length changes of spine with no 
changes or decrease in spine length were not correlated to the stable actin faction (left) and the 
turnover time (right). Data are presented as mean ± SEM. *p < 0.05.  
Results | 48 
 
NgR1 had been shown to regulate the experience-dependent turnover of dendritic spines 
and axonal varicosities in the somatosensory cortex (Akbik et al., 2013). In addition, acute 
function blocking of Nogo-A plays a crucial role in the regulation of dendritic spine number 
and spine size in 3-weeks old hippocampal slice cultures (Kellner et al., under review). 
The transient stabilization of the actin cytoskeleton possibly supports the morphological 
changes occurring at the dendritic spine after acute Nogo-A neutralisation. To test this 
theory single cell electroporation was used to co-transfect CA3 pyramidal neurons with 
mCherry-F, to visualize the neuron’s architecture and eGFP-actin (Figure 12A1 and A2) 
and simultaneously monitor changes in morphology and actin dynamics within the same 
dendritic spine. As expected eGFP-actin was specifically accumulated within the spine 
heads visualized with mCherry-F (Figure 12A3). The FRAP experiment as well as the 
imaging of the spine morphology was done before and after 180 min Nogo-A 
neutralisation (Figure 12A4). Spine morphology was analysed by measuring spine length 
and head width and displayed a significant increase of the spine length after 180 min 
Nogo-A neutralisation versus the normalized control (Figure 12A5, 2B left, Table S1, 
control vs. Nogo-A Abs 180 min p < 0.05). The head width wasn’t influenced by the Nogo-
A neutralisation (Figure 12B, right, Table S1). To assess the correlation between 
elongation and actin stabilization, only spines with a significant increase in length were 
further included in the analysis. The fluorescence recovery curve for eGFP-actin within 
selected spines showed lower intensity values after Nogo-A Abs treatment than the one 
recorded before (Figure 12C). Next, I examined whether the changes in the stable actin 
fraction were correlated to the spine elongation after Nogo-A neutralisation. Interestingly, 
the amount of stable actin within the selected spines was significantly correlated to the 
changes in spine length (Figure 12D left, Table S1, R2=0.45, p < 0.05). The turnover time 
didn’t show any correlation to the changes in spine length (Figure 12D right, Table S1). A 
correlation between the stable actin fraction and changes in spine length was only visible 
for spines that underwent elongation but not for spines that did not change or decreased 
in length (Figure 12E left Table S1). Also for spines without a change or decrease in 
length, the turnover time wasn’t correlated to the changes in spine length (Figure 12E 
right, Table S1). These observations support the hypothesis that the morphological 
changes at spines observed up on Nogo-A loss-of-function are driven by an increase in 
the stable actin fraction within individual dendritic spines of CA3 hippocampal neurons.  
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4.1.2 Analysis of the signalling mediating activity of Nogo-A in regulating 
actin dynamics within spines 
The actions of Nogo-A are mediated by two different inhibitory extracellular domains: 
Nogo-66 and Nogo-A-Δ20. First I’ll focus on the Nogo-66 domain which signals via the 
Nogo-66 receptor 1 (NgR1; Fournier et al., 2001). An acute application of the Nogo-22 
peptide in mature dissociated neurons was shown to reduce the gain and increase the 
loss of dendritic spines (Akbik et al., 2013). To further characterize this mechanism a 
specific function blocking antibody against the Nogo receptor (NgR Abs; Petrinovic et al., 
2010) was tested for its ability to modulate actin cytoskeleton dynamics within dendritic 
spines. No significant difference could be observed between the recovery profiles of the 
control conditions anti-BrdU mouse IgG1 of the two time points (20 and 180 min; Figure 
13A). Moreover, under control conditions the turnover time (about 20 seconds, Figure 
13B) and the different actin fractions dynamic 70%, stable 16% and monomeric 14% 
(Figure 13C, D, E) were not significantly different between the two time points (Table S1). 
 
Figure 13: Nogo receptor blocking affects the actin cytoskeleton within dendritic spines of 
hippocampal pyramidal neurons.                           
A Fluorescence recovery curve after photobleaching for eGFP-actin at single spines under control 
conditions or NgR Abs treatment after 20 and 180 min. Numbers of dendritic spines are indicated 
for each treatment. Analysis of the B turnover time, C dynamic actin fraction, D stable actin fraction 
and E monomeric actin fraction for control conditions compared to NgR blocking after 20 and 180 
min respectively. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01; ***p < 0.001. 
 
Similar to the Nogo-A loss-of-function experiments, blocking of NgR led to a significantly 
slower fluorescence recovery starting after 8 s and up to 110 s after photobleaching 
compared to the control conditions both after 20 and 180 min of treatment (Figure 13A, 
controls vs. NgR Abs 20 and 180 min p < 0.01). The turnover time was significantly 
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increased after 20 and 180 min blocking of the NgR in comparison to the control at the 
respective time points (Figure 13B. Table S1, controls vs. NgR Abs 20 and 180 min 
p < 0.01). The inhibition of the NgR after 20 min led to a significant decrease in the 
dynamic actin fraction versus the control conditions (Figure 13C, Table S1, control vs. 
NgR Abs 20 min, p < 0.05) no significant change could be observed after 180 min NgR 
Abs treatment. Similarly the stable actin fraction was transiently increased after 20 min 
NgR blocking versus control and slightly higher after 180 min (Figure 13D, Table S1, 
control vs. NgR Abs 20 min p < 0.001). The monomeric actin fraction was slightly reduced 
after NgR blocking at both time points (Figure 13E, Table S1). In summary, the acute 
inhibition of the NgR reproduced the stabilization of the actin cytoskeleton observed within 
dendritic spines upon a loss-of-function for Nogo-A (Figure 11B). To further characterize 
the mechanisms mediating the actions of Nogo-A, I next focused on the sphingosine 1-
phosphate receptor 2 (S1PR2) which has been recently described to specifically bind the 
Nogo-A-Δ20 domain (Kempf et al., 2014). Interestingly, Nogo-A-Δ20 S1PR2 signals via 
the G protein G13, leukemia-associated Rho guanine exchange factor (RhoGEF) LARG 
and activates RhoA to mediate inhibition of neurite outgrowth and cell spreading (Kempf 
et al., 2014). Thus, an acute inhibition of the S1PR2 may also influence actin dynamics 
within dendritic spines of CA3 hippocampal neurons. No significant difference could be 
observed between the kinetics of the recovery for eGFP-actin under control conditions 
(DMSO) at 20 and 180 min (Figure 14A). Moreover, the turnover time (Figure 14B) as well 
as the different actin fraction dynamic, stable and monomeric (Figure 14C, D, E) were not 
significantly different between the two time points (Table S1). A 20 min inhibition of the 
S1PR2 via the application of a specific antagonist (JTE-013) caused a significantly slower 
recovery after photobleaching of eGFP-actin starting 36 s after bleaching and up to 110 s 
when compared to the controls (Figure 14A control vs. JTE-013 20 min p < 0.05). Blocking 
the S1PR2 over 180 min led to a slightly slower increase of the fluorescent intensity 
values after photobleaching starting already after 10 s and up to 110 s in comparison to 
the control (Figure 14A, control vs. JTE-013 180 min p < 0.05). Moreover, 20 min S1PR2 
inhibition had no significant effect on the turnover time in comparison to the control 
whereas after 180 min the turnover was significantly increased (Figure 14B, Table S1, 
control vs. JTE-013 180 min p < 0.05). The JTE-013 application resulted after 20 and 180 
min in a significant reduction of the dynamic actin fraction in comparison to the controls 
(Figure 14C, Table S1, controls vs. JTE-013 20 and 180 min p < 0.05). The slower 
recovery observed upon S1PR2 
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Figure 14: Blocking the sphingosine 1-phosphate receptor 2 affects the actin cytoskeleton 
within dendritic spines of hippocampal pyramidal neurons.                    
A Fluorescence recovery curve after photobleaching for eGFP-actin at single spines under control 
conditions or S1PR2 blocking after 20 and 180 min. Numbers of dendritic spines are indicated for 
each treatment. Analysis of the B turnover time, C dynamic actin fraction, D stable actin fraction 
and E monomeric actin fraction for control conditions compared to S1PR2 blocking after 20 and 
180 min respectively. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01. 
 
inhibition could be accounted for a significant increase in the stable actin fraction for both 
time points in comparison to the relative control conditions (Figure 14D, Table S1, control 
vs. JTE-013 20 min p < 0.05, control vs. JTE-013 180 min p < 0.01). The monomeric actin 
fraction wasn’t altered in comparison to the control for both time points (Figure 14E, Table 
S1). Taken together, also the acute blocking of the S1PR2 led to a significant alteration of 
the actin dynamics within dendritic spines of CA3 neurons and seemed to be stronger and 
longer lasting then blocking either Nogo-A or the Nogo receptor. 
 
4.1.3 Application of the active Nogo-A-Δ20 peptide 
To further investigated the role of Nogo-A in modulating actin cytoskeleton dynamics 
within dendritic spines I used a gain-of-function approach by applying the Nogo-A-Δ20 
peptide (Delekate et al., 2011), the most active portion of the Nogo- specific inhibitory 
domain (Oertle et al., 2003). The soluble peptide Nogo-A-Δ20 was shown to be fast 
internalized into signalling endosomes upon binding (Joset et al., 2010). The continued 
peptide application is supposed to result in a clearance of the receptor complex from the 
surface resulting in a long-term dominant negative effect (Delekate et al., 2011; Kempf et 
al., 2014). In addition, the neurite outgrowth inhibitory and growth cone collapsing activity 
of Nogo-A-Δ20 depend on its ability to modulate actin dynamics via the small GTPase 
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RhoA and Rac1 (Joset et al., 2010; Kempf et al., 2014; Niederöst et al., 2002). Therefore, 
I addressed whether an acute application of Nogo-A-Δ20 peptide might influence actin 
cytoskeleton dynamics within dendritic spines in comparison to a 0.01% BSA containing 
ACSF solution (control) treatment. The control conditions exhibited a fast recovery of the 
fluorescent intensity after photobleaching with a turnover time of about 24 seconds (Figure 
15A, B, Table S1) indicating equivalent actin dynamics as for previous control treatments 
(Table S1). The application of the Nogo-A-Δ20 peptide for 5 min (gain-of-function) 
resulted in a significantly faster recovery after photobleaching in comparison to the 
control, starting 14 seconds after the bleaching and up to 110 seconds the intensity values 
were significantly increased in comparison to the control (Figure 15A control vs. Nogo-A-
Δ20 5 min p < 0.05). On the contrary, after 20 min incubation with Nogo-A-Δ20 peptide 
 
Figure 15: Application of the Nogo-A-Δ20 peptide affects the actin cytoskeleton within 
dendritic spines of hippocampal pyramidal neurons.                  
A Fluorescence recovery curve after photobleaching for eGFP-actin at single spines under control 
conditions or Nogo-A-Δ20 peptide application of 5 and 20 min. Numbers of dendritic spines are 
indicated for each treatment. Analysis of the B turnover time, C dynamic actin fraction, D stable 
actin fraction and E monomeric actin fraction for control conditions compared to Nogo-A-Δ20 
peptide application of 5 and 20 min. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01; 
***p < 0.001. 
(loss-of-function) the intensity values of the recovery curve were significantly decreased in 
comparison to the control starting 58 s after bleaching (Figure 15A, control vs. Nogo-A-
Δ20 20 min p < 0.05). Accordingly, while the turnover time was significantly decreased 
after 5 min Nogo-A-Δ20 peptide incubation, a 20 min incubation resulted in its increase in 
comparison to the control (Figure 15B, Table S1, control vs. Nogo-A-Δ20 5 min p < 0.05). 
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For the dynamic actin fraction the 5 min application of Nogo-A-Δ20 caused an increase 
and after 20 min a significant decrease in comparison to control conditions (Figure 15C, 
Table S1, control vs. Nogo-A-Δ20 20 min p < 0.05). The incubation with the Nogo-A-Δ20 
peptide affected the stable actin fraction by decreasing it after 5 min and significantly 
increasing it after 20 min relative to the control (Figure 15D, Table S1, control vs. Nogo-A-
Δ20 20 min p < 0.05). The monomeric actin fraction was not significantly altered (Figure 
15E, Table S1). In summary, after 5 min Nogo-A-Δ20 peptide application the actin 
cytoskeleton became more dynamic (gain-of-function), while after an incubation of 20 min 
the actin cytoskeleton was stabilized (loss-of-function). Overall, these observations 
indicate that Nogo-A acutely modulates the actin cytoskeleton within dendritic spines of 
CA3 hippocampal pyramidal neurons by destabilizing it in a rapid and transitory manner. 
 
4.1.4 Blocking the Rho-kinase ROCK 
The neurite outgrowth inhibitory and growth cone collapsing activity of Nogo-A depend on 
its ability to activate the small GTPase RhoA (Kempf et al., 2014; Niederöst et al., 2002). 
To further determine the Nogo-A actions on the actin cytoskeleton, the effector  
 
Figure 16: Blocking the Rho-kinase ROCK didn’t affects the actin cytoskeleton within 
dendritic spines of hippocampal pyramidal neurons.                      
A Fluorescence recovery curve after photobleaching for eGFP-actin at single spines under control 
conditions or blocking of the Rho-kinase ROCK after 20 and 180 min. Numbers of dendritic spines 
are indicated for each treatment. Analysis of the B turnover time, C dynamic actin fraction, D stable 
actin fraction and E monomeric actin fraction for control conditions compared to the blocking of the 
Rho-kinase ROCK after 20 and 180 min respectively. Data are presented as mean ± SEM. 
*p < 0.05. 
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Rho- kinase ROCK was inactivated by the application of the specific blocker Y27632 
(Kinases et al., 2000) and the actin dynamics of single dendritic spines were analysed. 
The FRAP experiment was performed 20 and 180 min after ROCK inhibition. No 
difference between control conditions (H2O control) at 20 and 180 min could be found. 
The fluorescent intensity after photobleaching for the controls was progressively 
increasing with a turnover time of about 22-23 seconds and a dynamic actin fraction of 67-
 70% (Figure 16A, B, C; Table S1). Interestingly, the FRAP curve didn’t display any 
significantly difference after 20 and 180 min of ROCK inactivation in comparison to the 
respective control conditions (Figure 16A). Also the turnover time and the monomeric 
actin fraction were unchanged after Y27632 treatment (Figure 16B and E; Table S1). 
Whereas 20 min after the beginning of the ROCK inhibition the dynamic actin fraction 
showed a significant reduction and the stable actin fraction a significant increase versus 
the control (Figure 16C, D, Table S1, control vs. Y27632 20 min p < 0.05). Both actin 
fractions were not significantly altered after 180 min of ROCK inhibition in comparison to 
the control conditions (Figure 16C, D, Table S1). Overall, the acute blocking of the Rho-
kinase ROCK display a transient mild stabilization of the actin cytoskeleton as previously 
shown upon the neutralisation of the Nogo-A signalling.  
 
4.1.5 Nogo-A enhances learning and memory acquisition in vivo 
The activity- and experience-dependent changes in the number, size and shape of 
dendritic spines have been associated to learning processes in the mouse somatosensory 
and visual cortex (Holtmaat and Svoboda, 2009). Interestingly, the Nogo receptor 
signalling was shown to regulate experience dependent structural plasticity as well as 
learning in two paradigms linked to structural changes in the somatosensory cortex and 
hippocampus (Akbik et al., 2013; Karlén et al., 2009). Acutely interfering with Nogo-A 
signalling results in an increase in dendritic spine number and length in CA3 hippocampal 
neurons (Kellner et al., under review) correlated to a rapid regulation of the dynamics of 
the spine actin cytoskeleton. To investigate whether Nogo-A is involved in regulating 
learning and memory processes at the behavioural level, I tested spatial memory 
acquisition and reference memory formation analysing learning in the Morris water maze 
(MWM) paradigm (Vorhees and Williams, 2006) and testing male wild type (WT) and 
nogo-a knockout (KO) mice in two independent probe trails at day 3 and 9 (Figure 17). 
Indeed, spatial learning abilities as tested in the Morris water maze are thought to be 
dependent on the hippocampus (Morris et al., 1982). After a pretraining of two days the 
mice were trained for 8 consecutive days to locate a platform hidden in the middle of 
quadrant NW and the release position (SW, S, E, NE) was changed in a 
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pseudorandom way. The escape latency improved equally in WT C57Bl/6 and nogo-a KO 
mice during the 8 days training period (Figure 17A, WT (day 1) 36.65 ± 4.61 s to (day 8) 
6.58 ± 1.03 s, F7,105=13,23; p < 0.001 and nogo-a KO (day 1) 28.53 ± 4.30 s to (day 8) 
6.59 ± 2.02 s, F7,91=5.91; p < 0.001). Reference memory formation was determined by 
analysing the preference for the target quadrant north-west (NW) when the platform was 
removed (probe trials).To assess whether the lack of Nogo-A might have already an effect 
on the early phase of spatial memory acquisition, the first probe trial was performed after 
2 days of training (day 3). While WT mice didn’t show any quadrant preference at this time 
point nogo-a KO mice showed a highly significant preference for the NW quadrant in 
comparison to the other quadrants (Figure 17B, Table S2, quadrant preference NW: WT 
30.04 ± 3.31% and nogo-a KO 38.95 ± 2.75%, p < 0.001). Analysis of the number of 
platform crossings showed a slight increase at this time point for the mice lacking nogo-a 
in comparison to WT mice (Figure 17B’, Table S2). A second probe trial was performed 
after 8 days of training (day 9). At this time point, the search behaviour across the four 
quadrants was comparable between the two genotypes, both showing a significant 
Figure 17: Nogo-a KO mice display a 
transitory effect in spatial learning in 
the Morris water maze.         
A Escape latency to reach the hidden 
platform during acquisition of 8 days for 
WT and nogo-a KO mice. n= number of 
mice. Performance of search behaviour, 
shown as percent time spent in each 
quadrant and the number of annulus 
crossings, on probe trial at day 3 (B and 
B’) and the probe trial at day 9 (C and C’) 
of the Morris water maze task (target 
quadrant NW). Data are presented as 
mean ± SEM. ***p < 0.001 
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preference for the NW quadrant (Figure 17C, Table S2, quadrant preference NW: WT 
47.79 ± 4.39%, p < 0.001 and nogo-a KO 60.12 ± 3.93, p < 0.001). The analysis of the 
number of platform crossings at day 9 exhibited for both genotypes an equal increase in 
comparison to day 3, without a difference between the two groups (Figure 17C’, Table 
S2). Taken together, these data demonstrate that formation of a reference memory during 
spatial learning is accelerated in mice lacking nogo-a in comparison to WT as it is already 
present after 3 days of training. However, at later time points (day 9) during training in the 
water maze no difference in spatial learning could be observed between the two 
genotypes. To evaluate the qualitative aspects of spatial learning the searching strategies 
applied to find the platform were analysed. This approach allows differentiating between 
hippocampus-dependent, allocentric versus hippocampus-independent, egocentric search 
strategies (Garthe and Kempermann, 2013). Over the acquisition period both WT and 
nogo-a KO mice used progressively less hippocampus-independent and more 
hippocampus-dependent strategies (Figure 18A’, Table S3, WT: F7,105= 7.58 p < 0.001; 
nogo-a KO: F7,91= 10.34 p < 0.001). Interestingly, at days 3 of the training period nogo-a 
KO mice used less hippocampus-independent (Figure 18A, arrow, Table S3, WT 71.88 ± 
7.17% vs. nogo-a KO 57.14 ± 5.52%; p=0.122 ns) and more hippocampus-dependent 
strategies than WT mice (Figure 18A’, arrow, Table S3, WT 28.13 ± 7.17% vs. nogo-a KO 
42.86 ± 5.52%; p=0.122 ns).To perform a more detailed analysis the searching strategies 
were classified in four categories: direct search, chaining, scanning and random search 
(Figure 18B; Garthe et al., 2009). The contribution of the direct search increased equally 
in both groups of mice during the acquisition period of 8 days (Figure 18B and B’), 
whereas the contribution of random search decreased (Figure 18B and B’). The 
percentage of chaining used during the 8 days training in the MWM for both was constant 
for both genotypes without any significant difference between WT and nogo-a KO mice 
(Figure 18B and B’). The contribution of the scanning strategy increased progressively to 
day 3 and was than stable up to day 8 without showing any significant difference between 
the two genotypes. To summarise the results: no significant differences could be observed 
between WT and nogo-a KO for the escape latency during the acquisition period of 8 days 
in the MWM. Interestingly, however, nogo-a KO mice formed a reference memory 
considerably earlier than WT mice as revealed by the probe trail performed at day 3. On 
the contrary, there wasn’t any significant difference in reference memory between the two 
genotypes when the probe trial was performed at day 9. Moreover, the contribution of 
hippocampus-dependent searching strategy was higher in nogo-a KO mice than in WT 
specifically at day 3 bot not at day 8 of the training. The detailed analysis of the four 
searching strategies during the 8 days of MWM didn’t show any significant differences 
between WT and nogo-a KO mice. 
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Figure 18: Qualitative analysis of spatial learning in nogo-A knockout mice.            
Classification of A hippocampus independent and A’ hippocampus-dependent searching strategies 
(contribution in percent) over 8 days of the Morris water maze task are displayed (arrows highlight 
day 3) for WT and nogo-a KO mice. n= number of mice. The searching strategies (direct search, 
chaining, scanning, random search) are colour coded and the contribution of the respective 
strategy in percent are presented for each day of the MWM task for B WT and B’ nogo-a KO mice. 
Data are presented as mean ± SEM.  
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4.1.6 Nogo-A modulates structural plasticity at spines               
during leaning in vivo 
Recent studies have provided evidence that learning is correlated to specific changes at 
dendritic spines which are suggested to provide a structural substrate for memory storage 
and learning processes (Caroni et al., 2012). Indeed, long-term in vivo imaging in the 
mouse somatosensory and visual cortex studies reveal that activity and experience-
dependent alteration in the number and structure of dendritic spines are associated to 
learning processes and long-lasting memories (Holtmaat and Svoboda, 2009). To assess 
whether the effect of deleting nogo-a on reference memory formation in the MWM is 
correlated to structural changes at spines, dendritic spine density for the apical dendrite of 
hippocampal CA3 neurons was analysed during and after training in the MWM and 
compared to the one of not trained mice. A diolistic approach was used to label the 
neurons (Figure 19A) including their dendritic spines with DiI (Figure 19A’; Rauskolb et al., 
2010). The spine number was compared between WT and nogo-a KO mice under  
 
Figure 19: Nogo-A regulates structural 
plasticity upon learning.    
A acute hippocampus slice stained with DiI, 
highlighted a mid-apical dendritic stretch covered 
with spines A’. Scale bar 2 µm. B Spine density 
of mid-apical CA3 neurons for WT and nogo-a 
KO mice, control (without MWM training) and 
after 3 or 9 days of the Morris water maze task. 
C Normalized Nogo-A proteins levels of WT 
mice control (without MWM training) and after 3 
or 9 days of the Morris water maze task. Data 
are presented as mean ± SEM. *p < 0.05, 
**p < 0.01. 
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three different conditions: (1) control untrained, (2) after 3 day MWM and (3) after 9 days 
of MWM training (Figure 19B). While the spine number for WT neurons did not show any 
difference between not-trained and 3 days training, it was significantly higher at 9 days in 
comparison to 3 days training (Figure 19B, WT (day 3) 1.36 ± 0.07 vs. WT (day 9) 1.63 ± 
0.05 spines / µm p < 0.05). Interestingly, in the nogo-a KO mice the number of dendritic 
spines transiently increased already after 3 days MWM training. The spine density 
increase in the nogo-a KO mice (day 3) is significant in comparison to WT control and WT 
3 days training (Figure 19B, Table S3, WT (Control) 1.41 ± 0.06 and WT (day 3) 1.36 ± 
0.07 spines / µm vs. nogo-a KO (day 3) 1.70 ± 0.06, p < 0.05). The increase in spine 
number wasn’t maintained in nogo-a KO mice at day 9 of the MWM training (Figure 19B, 
Table S3). An increase of the number of dendritic spine has been correlated to learning 
and memory processes (Xu et al., 2009; Yang et al., 2009a). While here spine density in 
CA3 hippocampal neurons was significantly increased in nogo-a KO after 3 days of MWM 
training, in WT mice it was significantly increased only at day 9 of the MWM training. 
Indeed, this is correlated with the performance in the probe trial early at day 3 which 
revealed that the nogo-a KO mice form a reference memory significantly faster than WT 
mice, and the initial and transient advantage of nogo-a KO mice in forming a reference 
memory is disappeared after 9 days of training. 
Previous studies in aged rats reported an increase in Nogo-A expression in the 
hippocampus is correlated to cognitive decline and deficits of spatial learning and memory 
(Vanguilder et al., 2012). However, Nogo-A levels were reported to be activity-dependent 
down-regulated in the dentate gyrus (Mingorance et al., 2004) but not in the CA1 or CA3 
region of the hippocampus (Karlsson et al., 2013). In this context also Nogo-A protein 
levels in WT mice hippocampi after MWM training were quantified. A significant increase 
in Nogo-A levels was detected at day 3 of the MWM training but not at day 9 in 
comparison to control untrained mice (Figure 19C, Table S3, control 1 ± 0.08 vs. 3 days 
training 1.57 ± 0.08, p < 0.01). In summary, nogo-a KO mice showed a transitory 
improved learning which was correlated with a significant increase in the spine density at 
day 3. However, in WT mice Nogo-A levels were transitory increased after 3 days of 
training correlated to delayed increase in spine density at day 9. Therefore it is suggestive 
to conclude that endogenous Nogo-A restricts structural plasticity in the hippocampus 
upon learning.   
Results | 60 
 
4.2 The BDNF effects on dendritic spines of mature hippocampal 
neurons depend on neuronal activity 
4.2.1 Endogenous BDNF regulates dendritic spine density and morphology 
in mature primary hippocampal neurons 
After studying a molecule, limiting synaptic plasticity, I also studied BDNF as a 
paradigmatic molecule which might meditate and promote functional and structural 
changes. A clear inconsistency exists between previous work showing a significant effect 
of the application of exogenous BDNF in modulating the dendritic architecture of 
hippocampal neurons in vitro (Ji et al., 2005, 2010; Tyler and Pozzo-miller, 2001) and data 
from our group and others showing that a global deprivation of BDNF throughout the CNS 
in vivo results in only minimal morphological alterations of mature hippocampal neurons 
(Minichiello et al., 1999; Zakharenko et al., 2003; Rauskolb et al., 2010, for a review see 
Zagrebelsky and Korte, 2013). In this context, I analysed under standardised and 
controlled culture conditions the role of BDNF in modulating dendritic spine number and 
morphology as well as dendritic architecture of primary hippocampal neurons. To map the 
action of BDNF I used different gain- and loss-of-function experiments in developing, 
young and mature primary neurons and examined the role of BDNF in an activity-
dependent manner. The dendrite and dendritic spine architecture of mature 3-week-old 
(22 DIV) primary hippocampal neurons (Papa et al., 1995), expressing a membrane 
targeted farnesylated EGFP (fEGFP; Figure 20B) were analysed upon the application of 
either a gain- or loss-of-function approach for BDNF (Figure 20A,B). The neurons included 
in the analysis were identified as excitatory by their pyramidal like morphology (Figure 
21A) and by the expression of the Ca2+/calmodulin-dependent protein kinase (CaMKII; 
Figure 20B’). While 22 DIV fEGFP-expressing neurons treated for 24 hours with 
exogenous BDNF showed no obvious alterations in dendritic spine density when 
compared to controls (Figure 20B), treating the neurons with BDNF function blocking 
antibodies (BDNF-Abs) led to a strong reduction in dendritic spine density (Figure 20B). 
This observation was confirmed by the quantification of dendritic spine density showing no 
significant difference between BDNF and control treated cells (Figure 20C Table S4). On 
the other hand, a significant reduction in dendritic spine density was observed for neurons 
treated with BDNF blocking antibodies (Figure 20C, Table S4; control vs. BDNF-Abs, 
p < 0.001; BDNF vs. BDNF-Abs p < 0.001). These observations suggest that while the 
endogenous BDNF may be crucial for the maintenance of dendritic spines in mature 
primary hippocampal neurons, exogenous BDNF does not play a role in this context. Next, 
I assessed whether BDNF regulates spine morphology in mature hippocampal neurons by 
analysing the effects of adding or blocking BDNF on dendritic spine length and head  
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Figure 20: BDNF signalling regulates dendritic spine density and morphology in mature 
primary hippocampal neurons. A Experimental timeline. DIV23 hippocampal neurons were 
treated for 24 h before fixation. B High-magnification image of typical dendritic stretches from 
control (left), BDNF (middle) and BDNF antibodies (right) treated neurons. Scale bar, 5 μm. B’ 
Representative image of a typical DIV23 fEGFP expressing hippocampal neuron show a close up 
of the cell body labelled with fEGFP (left) or with an immunohistochemistry against CaMKII (middle) 
merged to show colocalization (right): scale bars are 50 μm. C Graphs comparing dendritic spine 
density between BSA (control), BDNF and BDNF antibodies (BDNF-Abs) treated DIV22 
hippocampal neurons. D Histogram comparing the spine head width between hippocampal 
neurons upon BSA (control), BDNF or BDNF antibodies (BDNF-Abs) treatment. E Histogram of the 
dendritic spine length in control, BDNF or BDNF antibodies (BDNF-Abs) treated neurons. F Graph 
showing the binning of spines according to their spine head width and comparing the proportion of 
spines within each category in response to a BSA (control), BDNF or BDNF antibodies (BDNF-Abs) 
treatment. G Graph showing the binning of spines according to their spine length and comparing 
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the proportion of spines within each category in response to a BSA (control), BDNF or BDNF 
antibodies (BDNF-Abs) treatment. The number in the columns represents the number of cells 
analysed. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01; ***p < 0.001. 
width. When compared to the controls spine head width as well as spine length (Figure 
20B) did not show any major difference after a 24 hour treatment with BDNF. On the other 
hand, neurons treated with BDNF blocking antibodies showed clearly longer and thinner 
spines than control neurons (Figure 20B). Indeed, quantification of spine morphology 
upon BDNF antibody treatment showed a significant decrease in spine head width (Figure 
20D, Table S4; control vs. BDNF-Abs and BDNF vs. BDNF-Abs, p < 0.05) associated to a 
significant increase in dendritic spine length (Figure 20E, Table S4; control vs. BDNF-Abs 
p < 0.01, BDNF vs. BDNF-Abs p < 0.001). Treatment with exogenous BDNF did not result 
in any significant change in dendritic spine head width (Figure 20D, Table S4). Under 
these conditions dendritic spine length was only slightly reduced when compared to 
controls but significantly lower than in neurons treated with BDNF blocking antibodies 
(Figure 20E, Table S4; BDNF vs. BDNF-Abs, p < 0.001). Next, dendritic spines were 
separated according to their spine shape into four categories based on their head width. A 
significant increase in spines with a small head (Figure 20F; <0.3 μm; control vs. BDNF-
Abs p < 0.001, BDNF vs. BDNF-Abs p < 0.01) accompanied by a significant decrease in 
larger spine heads (Figure 20F; ≥0.5 μm <1 μm; control vs. BDNF-Abs p < 0.01, BDNF vs. 
BDNF-Abs p < 0.001) was observed when a treatment with BDNF blocking antibodies was 
compared to a control treatment or to a treatment with exogenous BDNF (Figure 20F). 
Application of BDNF (gain-of-function experiment) did not result in any significant 
alteration in spine head size when compared to the control conditions (Figure 20F). 
Binning the spines according to their length did not show any difference for BDNF treated 
neurons but resulted in a significant alteration in spine length distribution upon BDNF 
antibody treatment (loss-of-function; Figure 20G). While under these conditions spines 
shorter than 1.5 μm were significantly decreased (Figure 20G; ≥0.5 μm <1 μm p < 0.01 to 
the BDNF treatment; ≥1 μm <1.5 μm p < 0.05 to the control), those longer than 1.5 μm 
were significantly increased in comparison to the control conditions or the BDNF treatment 
(Figure 20G; p < 0.01 to the control, p < 0.001 to BDNF treatment). Finally, the effects of 
either a gain- or a loss-of-function for BDNF on dendritic architecture were analysed using 
a Sholl analysis to compare dendritic complexity (Sholl, 1953; Figure 21A). No significant 
differences in the detailed analysis of dendritic complexity and length using the Sholl 
analysis could be observed between the three different treatments (Figure 21B; control, 
BDNF, BDNF-Abs). Accordingly, also total dendritic complexity was not significantly 
different in BDNF or BDNF- antibody-treated cells versus control cells (Figure 21C, Table 
S4).  
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Figure 21: Dendritic complexity of mature primary hippocampal neurons in not regulated by 
BDNF signalling. A Representative image of a typical DIV23 fEGFP expressing hippocampal 
neuron used in the experiments. B Graph plotting dendritic complexity in relation to the distance to 
the cell body of hippocampal neurons under control conditions or treated with BDNF or BDNF 
antibodies (BDNF-Abs). C Histogram of the total number of intersections for BSA (control), BDNF 
and BDNF antibodies (BDNF-Abs) treated neurons. The number in the columns represents the 
number of cells analysed. Data are presented as mean ± SEM. 
Taken together, these results demonstrate that the exogenous application of BDNF, in 
mature primary hippocampal neurons, does not influence dendritic spine density, 
morphology and dendrite complexity. On the other hand, the loss-of-function experiments 
show that the endogenous BDNF is essential for maintaining spine density and the mature 
morphology of dendritic spines in primary hippocampal neurons.  
 
4.2.2 Endogenous BDNF regulates dendritic spine density and morphology 
in young primary hippocampal neurons  
In the next series of experiments I tested whether the different effects of exogenous 
versus endogenous BDNF on neuronal structure might depend on the age of the treated 
primary hippocampal neurons. To this aim, I analysed whether a gain- or a loss-of-
function approach for BDNF regulates the dendritic architecture or spine number and 
morphology in 2 weeks-old primary hippocampal neurons (15 DIV; Figure 22A). When 15 
DIV fEGFP-expressing neurons treated for 24 hours with BDNF were compared to control 
neurons, no obvious difference in dendritic spine density or morphology could be 
observed. Accordingly, the quantification of spine density did not result in any significant 
difference between BDNF treated and control neurons (Figure 22B, Table S4). However, 
as for mature hippocampal neurons, also here the application of BDNF blocking 
antibodies led to a highly significant reduction in dendritic spine density (Figure 22B, Table 
S4; control vs. BDNF-Abs and BDNF vs. BDNF-Abs p < 0.001). Next, I assessed whether 
BDNF regulates spine morphology  
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Figure 22: BDNF signalling regulates dendritic spine density and morphology in young 
primary hippocampal neurons. A Experimental timeline. DIV16 hippocampal neurons were 
treated for 24 h before fixation. B Graphs comparing dendritic spine density between control, BDNF 
and BDNF-antibodies (BDNF-Abs) treated DIV16 hippocampal neurons. C Histogram comparing 
the spine head width between hippocampal neurons upon BSA (control), BDNF or BDNF 
antibodies treatment. D Histogram of the dendritic spine length in BSA (control), BDNF or BDNF 
antibodies (BDNF-Abs) treated neurons. E Graph showing the binning of spines according to their 
spine head width and comparing the proportion of spines within each category in response to a 
BSA (control), BDNF or BDNF antibodies (BDNF-Abs) treatment. F Graph showing the binning of 
spines according to their spine length and comparing the proportion of spines within each category 
in response to a BSA (control), BDNF or BDNF antibodies (BDNF-Abs) treatment. G Graph plotting 
dendritic complexity in relation to the distance to the cell body of hippocampal neurons under 
control conditions or treated with BDNF or BDNF antibodies (BDNF-Abs). G′ Histogram of the total 
number of intersections for BSA (control), BDNF and BDNF antibodies (BDNF-Abs) treated 
neurons. The number in the columns represents the number of cells analysed. Data are presented 
as mean ± SEM. *p < 0.05, **p < 0.01; ***p < 0.001. 
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comparing the maximal spine head width and spine length between different treatments. 
Application of exogenous BDNF for 24 hours did not result in any significant alteration of 
the spine head width (Figure 22C, Table S4) and length (Figure 22D, Table S4) in 
comparison to the control condition. Interestingly, while the loss-of-function experiments 
did not result in any significant change in spine head width (Figure 22C, Table S4) a 
significant increase in dendritic spine length could be observed after application of BDNF 
blocking antibodies in comparison to both, the control and the BDNF treatment (Figure 
22D, Table S4; control vs. BDNF-Abs and BDNF vs. BDNF-Abs p < 0.001). Binning the 
spines according to their head width and comparing the different treatments within each 
spine head category resulted in a significant increase in the proportion of spines with a 
small head for the BDNF blocking antibody treatment only when compared to the BDNF 
treatment (Figure 22E; BDNF vs. BDNF-Abs p < 0.05). No significant changes could be 
observed for the spine head width distribution upon BDNF application (Figure 22E) when 
compared to the control condition. Binning the spines according to their length showed for 
neurons treated with BDNF blocking antibodies a significant decrease in the shorter spine 
category (Figure 22F; <0.5 μm, control vs. BDNF-Abs p < 0.01, BDNF vs. BDNF-Abs 
p < 0.001; and ≥0.5 μm <1 μm, control vs. BDNF-Abs p < 0.01, BDNF vs. BNF-Abs 
p < 0.001) accompanied by a significant increase in longer spines (Figure 22F; >1.5 μm, 
control vs. BDNF-Abs p < 0.01, BDNF vs. BDNF-Abs p < 0.001). Finally, I also analysed 
whether the effect of BDNF on dendrite architecture might be age dependent. However, 
also for 15 DIV hippocampal neurons when either a BDNF or a BDNF antibody treatment 
was compared to the controls, no significant alteration in dendritic complexity could be 
observed for the Sholl analysis (Figure 22G). Accordingly, I did not observe any significant 
differences in total complexity between the different treatments (Figure 22G′, Table S4).  
All in all the results described above indicate that endogenous BDNF is necessary for 
dendritic spine growth and the regulation of spine length in developing primary 
hippocampal neurons. Interestingly, maintaining the spine head width in younger 
hippocampal neurons does not dependent on endogenous BDNF signalling.  
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4.2.3 Endogenous BDNF regulates actin concentration                           
within dendritic spine 
The actin cytoskeleton is involved in regulating cell mobility and morphology. Actin is 
highly enriched within the dendritic spine head, (for a review see: Cingolani and Goda, 
2008), for that reason I tested whether BDNF may regulate actin in dendritic spines in 
order to shape and change spine morphology. To test this hypothesis RFP-Lifeact (Riedl 
et al., 2008, 2010) was used to detect possible changes in the F-actin content in dendritic 
spines upon changes in BDNF signalling. The RFP-Lifeact expression plasmid was co-
transfected with fEGFP and resulted in 99.7% colocalization of RFP-Lifeact within spines 
(Figure 23A,B) as well as with F-actin labelled using Alexa Fluor 350 Phalloidin (Figure 
23B). In line with our observations above the exogenous application of BDNF for 24 hours 
to 22 or 15 DIV primary hippocampal neurons did not result in any change in the 
normalized mean fluorescent intensity for RFP-Lifeact in comparison to the control group 
(Figure 23C,D, Table S4). However, in the loss-of-function experiments the treatment with 
BDNF blocking antibodies resulted in a highly significant decrease in the F-actin content 
within the head of dendritic spines both in 16 DIV (Figure 23D, Table S4; control vs. 
BDNF-Abs p < 0.001, BDNF vs. BDNF-Abs p < 0.001) and 23 DIV primary hippocampal 
neurons (Figure 23D, Table S4; control vs. BDNF-Abs p < 0.01, BDNF vs. BDNF-Abs       
p < 0.001). Taken together, these results show that endogenous BDNF modulates the 
actin cytoskeleton within dendritic spines as well as their morphology. 
Figure 23: Actin content within 
dendritic spines. A Maximal intensity 
projection of a representative dendrite of 
hippocampal neurons expressing fEGFP 
(above) and RFP-Lifeact (middle) 
merged to show colocalization (below). 
Scale bar, 2 μm. B High magnification 
images showing a single dendritic spine 
expressing fEGFP (above) and RFP-
Lifeact (middle) and merged to show 
their colocalization in the spine head 
(below) Scale bar, 2 μm. C Histogram 
plotting the normalized mean fluorescent 
intensity for RFP-Lifeact within the spine 
head of DIV23 BSA (control), BDNF and 
BDNF antibodies (BDNF-Abs) treated 
neurons. D Histogram showing the 
normalized mean intensity for RFP-
Lifeact within the spine head of DIV16 
hippocampal neurons. The number in 
the columns represents the number of 
cells analysed. Data are presented as 
mean ± SEM. **p < 0.01; ***p < 0.001.  
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4.2.4 Mature primary hippocampal neurons are responsive to an acute 
treatment with exogenous BDNF  
The results, so far, clearly support a role for endogenous BDNF in the hippocampus by 
completely reproducing in vitro the mild alterations observed in the morphology of 
hippocampal neurons upon a global BDNF deprivation in vivo (Rauskolb et al., 2010). On 
the other hand, the data fail to replicate previous work showing an effect of BDNF 
application in regulating dendrite and spine architecture (Ji et al., 2005; Tyler and Pozzo-
miller, 2001). To address this discrepancy I first confirmed that the BDNF used in this 
study is indeed active and that it is able to elicit clear neuronal responses in primary 
hippocampal neuronal cultures. To this aim I tested three critical events known to occur 
upon a BDNF application: (1) activation of the TrkB receptor was tested by analysing its 
phosphorylation levels (Ji et al., 2010); (2) calcium imaging was used to test the ability of 
BDNF to induce local calcium transients in hippocampal neurons (Berninger et al., 1993) 
and (3) immunohistochemistry was used to visualize the activation of the immediate early 
gene (IEG) c-fos (Marty et al., 1996). An immunohistochemistry against phosphorylated 
TrkB receptor performed 15 min after BDNF application (Figure 24A) showed an obvious 
increase in the levels of TrkB receptor phosphorylation when compared to control treated 
neurons (Figure 24B). This observation was confirmed by a significant increase in the 
normalized intensity for the phospho-TrkB immunohistochemistry (Figure 24C, Table S5; 
control vs. BDNF p < 0.001) 
 
Figure 24: TrkB receptor phosphorylation.                           
A Experimental timeline. DIV22 primary hippocampal neurons were treated 15 min with BDNF 
before fixation. B Images of primary hippocampal cultures (22 DIV) treated with either BSA 
(control, left) or BDNF (right) and stained with an anti-phospho-TrkB receptor antibodies. Scale bar, 
40 μm. C Histogram showing the normalized fluorescence intensity for the phospho-TrkB receptor 
under control conditions or treated with BDNF. D Graph showing the number of phospho-TrkB 
positive hippocampal neurons in control and BDNF treated hippocampal primary cultures. The 
number in the columns represents the number of analysed experiments. Data are presented as 
mean ± SEM. **p < 0.01; ***p < 0.001. 
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as well as by a clear shift in the proportion of positive versus negative cells for phospho-
TrkB. Indeed, upon BDNF treatment significantly more neurons resulted to be positive for 
phospho-TrkB immunohistochemistry and significantly less to be negative for it (Figure 
24D, Table S5; control vs. BDNF p < 0.01). The activation of the PLCγ signalling pathway 
upon BDNF binding to the TrkB receptor leads to an increase in the intracellular calcium 
levels (Blum and Konnerth, 2005; Minichiello, 2009; Segal and Greenberg, 1996) and was 
specifically shown for hippocampal cultures (Berninger et al., 1993; Canossa et al., 1997; 
Finkbeiner et al., 1997). Here, the frequency of global calcium transients as readout for a 
neuronal response to an acute BDNF application was analysed 
 
Figure 25: Local calcium transients in hippocampal neurons.                      
A Experimental timeline. DIV22 primary hippocampal neurons were treated 5 min with BDNF 
during calcium imaging. B Pseudo line-scan showing the global calcium transients occurring in 
hippocampal primary cultures before, during and after BDNF applications. C Graph showing the 
frequency of calcium transients in hippocampal primary neurons before, during and after BDNF 
application. The number in the columns represents the number of analysed experiments. Data are 
presented as mean ± SEM. *p < 0.05. 
 
(Figure 25A; Lang et al., 2007; Lohmann, 2009). A clear increase in the frequency of 
calcium transients in DIV22 primary hippocampal neurons could be observed upon the 
acute application of BDNF (Figure 25B; Gödecke, 2012). Indeed, at a quantitative analysis 
the frequency of calcium transients resulted to be significantly increased after BDNF 
treatment in comparison to a control treatment (Figure 25C, Table S5; BDNF vs. control p 
< 0.05). The increase in the frequency in calcium transients upon BDNF application was 
transient as 10 min after BDNF washout the frequency was back to the pre-treatment 
levels (Figure 25C, Table S5; Gödecke, 2012). Finally, to verify that the application of 
BDNF leads to the expression of IEGs immunohistochemistry for c-fos was used. This 
IEG is known to be activated upon an acute treatment with BDNF (Figure 26A; Marty et 
al., 1996; Gascon et al., 2005). An immunohistochemistry for c-fos showed a clear 
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colocalization between c-fos and the nucleus of neurons (Figure 26B). Quantitative 
analysis performed 3 hours after the stimulation with BDNF (Figure 26A) showed 
significantly higher intensity values for the c-fos immunohistochemistry (Figure 26C, Table 
S5; p < 0.01) and a significant increase in the number of c-fos positive cells in comparison 
to control (Figure 26D, Table S5; p < 0.001). In summary, these observations indicate that 
the BDNF used in these experiments is active and leads to the activation of the TrkB-
receptor, an increase in the frequency of calcium transients and an activation of 
transcription (up regulation of the immediate early gene c-fos) in mature primary 
hippocampal neurons.  
 
Figure 26: Activation of the immediate early gene c-fos.                        
A Experimental timeline. DIV22 primary hippocampal neurons were treated for 3 h with BDNF 
before fixation. B Images of primary hippocampal cultures (22 DIV) treated with either BSA 
(control, above) or BDNF (below) and stained with an anti-c-fos antibody. Scale bar, 20 μm.           
C Graph comparing the normalized mean intensity for the immunohistochemistry against c-fos in 
control or BDNF treated hippocampal primary neurons. D Histogram of the number of c-fos positive 
neurons in control and BDNF treated hippocampal cultures. The number in the columns represents 
the number of analysed experiments. Data are presented as mean ± SEM. **p < 0.01; ***p < 0.001. 
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4.2.5 Exogenous BDNF regulates neurite outgrowth and complexity in 
young primary hippocampal neurons  
Previous studies have revealed BDNF to promote neurite outgrowth and dendritic 
complexity in developing cortical neurons (McAllister et al., 1995; Shimada et al., 1998). In 
view of the lack of effects on dendritic architecture observed in my work upon BDNF 
application to either DIV15 or DIV22 hippocampal primary neurons, we tested whether the 
effect of BDNF on dendrites might be age-dependent (Thieme, 2011). Indeed, BDNF has 
been shown to regulate neurite outgrowth in development hippocampal neurons (Ji et al., 
2005, 2010). Therefore, young hippocampal neurons 3 DIV were treated with either a 
gain- or a loss-of-function approach for BDNF.  
After 3 days of treatment (Figure 27A) an immunohistochemistry for Microtubule-
associated protein 2 (MAP2) was used to visualize the developing neurites (Figure 27B; 
up control, middle BDNF, lower TrkB-Fc). Morphometric analysis for neurite growth was 
performed by quantifying three parameters: total neurite length, number of primary 
neurites and number of branching points (Figure 27C–E, Table S6). The total neurite 
length was higher after BDNF application than in control treated neurons (Figure 27C, 
Table S6; BDNF vs. control, p < 0.001). Interestingly, the loss-of-function experiments with 
either a BDNF-Abs or TrkB-Fc did not show any significant difference in neurite length 
when compared to the control conditions (Figure 27C, Table S6). The specificity of the 
TrkB-Fc in neutralising BDNF was determined by a co-application of BDNF and TrkB-Fc. 
Quantitative analysis revealed that application of TrkB-Fc completely prevented the 
positive effect of a BDNF treatment on total neurite length (Figure 27C, Table S6). The 
number of primary neurites after BDNF application showed a slight increase when 
compared to the control (Figure 27D, Table S6; BDNF vs. control, p < 0.01), whereas the 
treatment with BDNF-Abs or TrkB-Fc did not alter their number (Figure 27D, Table S6). 
The significant increase in primary neurites observed after BDNF treatment could be 
prevented by a co-treatment with TrkB-Fc (Figure 27D, Table S6).            
Next, we determined whether a BDNF application might affect neurite complexity by 
analysing the number of branching points of MAP2 labelled processes. Indeed, a BDNF 
treatment resulted in a 2-fold increase in complexity in comparison to control (Figure 27E, 
Table S6; BDNF vs. control, p < 0.001). On the contrary, treatment with BDNF-Abs or 
TrkB-Fc did not influence the number of branching points when compared to the control 
(Figure 27E, Table S6). Additionally, the positive effect of BDNF on neurite complexity 
was prevented by a co-treatment with BDNF and TrkB-Fc (Figure 27E, Table S6). These 
results suggest that the application of BDNF promotes neurite outgrowth by increasing 
both neurite elongation and branching in developing DIV3 hippocampal primary neurons 
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(Thieme, 2011). The two loss-of-function approaches for BDNF did not affect the neurite 
architecture of primary hippocampal neurons (3–6 DIV) during their early development.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27: Exogenous BDNF regulates neurite complexity.          
A Experimental timeline. BSA (control), BDNF, BDNF antibodies (BDNF-Abs) or TrkB receptor 
bodies (TrkB-Fc) were applied on DIV3 hippocampal neurons for 72 h. B Micrographs showing 
MAP2 positive BSA (control; above), BDNF (middle) or BDNF antibodies (BDNF-Abs; below) 
treated primary hippocampal neurons. Scale bar, 25 μm. C Histogram comparing neurite length of 
DIV6 hippocampal neurons after application of BSA (control), BDNF, BDNF antibodies 
(BDNF-Abs), TrkB receptor bodies (TrkB-Fc) or combined BDNF and TrkB receptor bodies 
(TrkB-Fc). D Histogram comparing the number of primary neurites of DIV6 hippocampal neurons 
after application of BSA (control), BDNF, BDNF antibodies (BDNF-Abs), TrkB receptor bodies 
(TrkB-Fc) or combined BDNF and TrkB receptor bodies (TrkB-Fc). E Histogram comparing the 
number of branching points for the dendrites of DIV6 hippocampal neurons after application of BSA 
(control), BDNF, BDNF antibodies (BDNF-Abs), TrkB receptor bodies (TrkB-Fc) or combined BDNF 
and TrkB receptor bodies (TrkB-Fc). The number in the columns represents the number of cells 
analysed. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01; ***p < 0.001.  
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4.2.6 Role of neuronal activity in regulating the sensitivity of mature 
hippocampal neurons upon exogenous BDNF application  
BDNF synthesis and release have been shown to occur in an activity-dependent way 
(Gärtner and Staiger, 2002; Thoenen, 1991). Therefore, one possible explanation for the 
discrepancies in the effect of BDNF application on neuronal morphology in vitro (Ji et al., 
2005, 2010; Rauskolb et al., 2010) may lie in the different levels of neuronal activity in the 
primary cultures. Indeed, in cultures with a higher neuronal activity the levels of 
endogenous BDNF may be already high and thus mask the effects of BDNF application. 
To test this hypothesis primary hippocampal neurons were kept for 2 weeks in a medium 
containing a higher concentration of Magnesium (3.5 mM Mg2+; Figure 28A) to reduce 
neuronal activity and the effects of a 24 hour treatment with BDNF (in NB medium with 
low, 1.5 mM Mg2+) on the number and structure of dendritic spines were analysed. 
Calcium imaging was used to compare the levels of neuronal activity in hippocampal  
  
Figure 28: High Mg
2+
 concentration reduces 
neuronal activity. A Experimental timeline. 
Primary neurons were cultivated for 2 weeks in 
high (3.5 mM Mg
2+
) medium and treated with BSA 
(control), BDNF or TrkB-Fc in low (1.5 mM Mg
2+
). 
B Graph comparing the frequency of calcium 
transients in hippocampal primary neurons 
cultivated in high or low Mg
2+
 containing medium. 
C Graph comparing the amplitude of calcium 
transients in hippocampal primary neurons 
cultivated in high or low Mg
2+
 containing medium. 
D Graph plotting dendritic complexity in relation to 
the distance to the cell body of hippocampal 
neurons under control (1.5 mM) Mg
2+
 conditions 
or high (3.5 mM) Mg
2+
. D’ Histogram of the total 
number of intersections in hippocampal primary 
neurons cultivated in control or high Mg
2+
 
containing medium. The number in the columns 
represents the number of cells analysed. Data are 
presented as mean ± SEM. ***p < 0.001. 
 
Results | 73 
 
neurons grown under high Mg2+ to those of neurons grown under control (low Mg2+) 
conditions. While no significant difference could be detected regarding the amplitude of 
global calcium transients between the two groups (Figure 28C, Table S7), their frequency 
was significantly decreased in neurons kept in high Mg2+ when compared to control 
neurons (Figure 28B, Table S7; p < 0.001) suggesting a long-term reduction in neuronal 
activity. While no significant differences in dendritic complexity could be observed 
between the two different culturing conditions (Figure 28D,D’, neurons kept in 1.5 vs. 3.5 
mM Mg2+; Table S7). A significantly lower dendritic spine density could be observed when 
comparing control neurons kept in high Mg2+ with control neurons kept in low Mg2+ 
medium (Figure 29B, Table S7; p < 0.001). On the other hand, no significant differences in 
spine density could be detected upon a BDNF or a TrkB-Fc treatment for neurons grown 
under high Mg2+ conditions when compared to the control high Mg2+ conditions (Figure 
29B, Table S7). Next, a possible effect of BDNF on dendritic spine morphology was 
analysed. Interestingly, compared to control treated neurons BDNF treatment in cultures 
kept in high Mg2+ resulted in a slight increase in dendritic spine width (Figure 29C, Table 
S7) and a slight decrease in spine length (Figure 29D, Table S7), but the difference did 
not reach significance. No significant differences were observed both for the head width 
and for the length when TrkB-Fc treated cells in high Mg2+ were compared to high Mg2+ 
controls (Figure 29C, D, Table S7). To better clarify the mild spine head increase 
observed in neurons kept in high Mg2+ medium upon BDNF treatment spines were binned 
into four categories according to their head width. Comparing spine head width within 
each category showed a significant increase upon BDNF treatment in the proportion of 
spines with larger heads (Figure 29E; ≥0.5 μm <1 μm; p < 0.05) with a comparable 
significant decrease in the proportion of spine with small heads (Figure 29E; <0.3 μm; 
p < 0.05) when compared to control neurons cultivated in high Mg2+. No significant 
difference was observed between the control and TrkB-Fc treatments in any of the spine 
head width categories under the same conditions (Figure 29E). Comparing the effect of a 
control, a BDNF or a TrkB-Fc treatment within different categories of dendritic spine 
binned according to their length did not show any significant difference (Figure 29F). The 
data described above suggest that indeed a chronic reduction in neuronal activity during 
the cultivation time might reduce the endogenous BDNF levels in hippocampal primary 
neurons and thereby increase their sensitivity to an exogenous BDNF application to 
modulate dendritic spine morphology. 
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Figure 29: Exogenous BDNF in modulating dendritic spine morphology under reduced 
neuronal activity. A Experimental timeline. Primary neurons were cultivated for 2 weeks in high 
(3.5 mM Mg
2+
) medium and treated with BSA (control), BDNF or TrkB-Fc in low (1.5 mM Mg
2+
).     
B Graphs comparing dendritic spine density between neurons cultivated in low or high Mg
2+
 and 
treated with BSA (control), BDNF and TrkB receptor bodies (TrkB-Fc). C Histogram comparing the 
spine head width between primary hippocampal neurons cultivated in high Mg
2+
 and treated with 
BSA (control), BDNF and TrkB receptor bodies (TrkB-Fc). D Histogram of the dendritic spine length 
between primary hippocampal neurons cultivated in high Mg
2+
 and treated with BSA (control), 
BDNF and TrkB receptor bodies (TrkB-Fc). E Graph showing the binning of spines according to 
their spine head width and comparing the proportion of spines within each category in response to 
a BSA (control), BDNF or BDNF antibodies (BDNF-Abs) treatment. F Graph showing the binning of 
spines according to their spine length and comparing the proportion of spines within each category 
in response to a control, BDNF or TrkB receptor bodies (TrkB-Fc) treatment. The number in the 
columns represents the number of cells analysed. Data are presented as mean ± SEM. *p < 0.05, 
***p < 0.001. 
BDNF has been shown to modulate dendritic spine morphology upon activity-dependent 
synaptic plasticity Tanaka (Tanaka et al., 2008). To assess whether under these culture 
condition neuronal activity governs the BDNF effect on dendritic spine morphology, 
hippocampal primary neurons were kept for two weeks in a high Mg2+ (3.5 mM) medium 
and treated with BDNF in the same medium (Figure 30A) in order to reduce neuronal 
activity also during the BDNF treatment. Under these conditions a significantly lower 
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dendritic spine density could be observed when comparing control neurons kept in high 
Mg2+ to control neurons in low Mg2+ medium (Figure 30B, Table S7; p < 0.05). Moreover, 
dendritic spine density of neurons treated either with BDNF or with TrkB-Fc in high Mg2+ 
was significantly lower than in controls neurons (low Mg2+, Figure 30B, Table S7; BDNF 
vs. low Mg2+ control p < 0.05; TrkB-Fc vs. low Mg2+ control p < 0.001) but it was not 
significantly different than in not treated cells kept in high Mg2+.  
 
Figure 30: Reducing neuronal activity during the treatment blocks the effect of exogenous 
BDNF in modulating dendritic spine morphology. A Experimental timeline. Primary neurons 
were cultivated for 2 weeks in high Mg
2+
 medium and treated with BSA (control), BDNF or TrkB-Fc 
in high Mg
2+
. B Graphs comparing dendritic spine density between neurons cultivated in low or high 
Mg
2+
 and treated with BSA (control), BDNF and TrkB receptor bodies (TrkB-Fc) in high Mg
2+
.         
C Histogram comparing the spine head width between primary hippocampal neurons cultivated and 
treated in high Mg
2+
 with BSA (control), BDNF and TrkB receptor bodies (TrkB-Fc). D Histogram of 
the dendritic spine length between primary hippocampal neurons cultivated and treated in high 
Mg
2+
 with BSA (control), BDNF and TrkB receptor bodies (TrkB-Fc). E Graph showing the binning 
of spines according to their spine head width and comparing the proportion of spines within each 
category in response to a BSA (control), BDNF or BDNF antibodies (BDNF-Abs) treatment in high 
Mg
2+
. F Graph showing the binning of spines according to their spine length and comparing the 
proportion of spines within each category in response to a BSA (control), BDNF or TrkB receptor 
bodies (TrkB-Fc) treatment in high Mg
2+
. The number in the columns represents the number of 
cells analysed. Data are presented as mean ± SEM. *p < 0.05, ***p < 0.001. 
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Interestingly, both a BDNF treatment as well as a treatment with TrkB-Fc performed in 
high Mg2+ did not affect either activity also during the BDNF treatment. Under these 
conditions a significantly lower dendritic spine density could be observed when comparing 
control neurons kept in high Mg2+ to control neurons in low Mg2+ medium (Figure 30B, 
Table S7; p < 0.05). Moreover, dendritic spine density of neurons treated either with 
BDNF or with TrkB-Fc in high Mg2+ was significantly lower than in controls neurons (low 
Mg2+, Figure 30B, Table S7; BDNF vs. low Mg2+ control p < 0.05; TrkB-Fc vs. low Mg2+ 
control p < 0.001) but it was not significantly different than in not treated cells kept in high 
Mg2+. Interestingly, both a BDNF treatment as well as a treatment with TrkB-Fc performed 
in high Mg2+ did not affect either spine head width (Figure 30C, Table S7) or spine length 
(Figure 30D, Table S7) when compared to a control treatment in high Mg2+. Also binning 
the spines according to their head width (Figure 30E) or to their length (Figure 30F) did 
not show any alteration in the spine size distributions both for a BDNF and a TrkB-Fc 
applications compared to a control treatment performed in high Mg2+. In summary, the 
results above indicate that BDNF application indeed modulates dendritic spine 
architecture in an activity-dependent manner. 
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5 Discussion 
The main cellular mechanism of learning and memory processes in the adult brain is 
considered to be the plasticity of neurons, which is the ability to modify the function and 
morphology of their synaptic connection in response to changes in neuronal activity. The 
fine-tuning of synaptic connectivity involves a variety of extracellular molecules that 
regulate functional and structural plasticity in a precise spatial and temporal manner. The 
cytoskeleton within synapses is the common denominator on which different signalling 
pathways controlling synapse-morphology and -strength converge. Filamentous actin is 
the main constituent of the cytoskeleton in spines and its dynamics have been shown to 
underlie the tight balance between stability and plasticity of neuronal networks in the CNS. 
In this work I investigated the role of two molecules known to either restrict or promote 
synaptic plasticity and their signalling pathway in modulating the actin cytoskeleton as well 
as structural plasticity of dendritic spines at mature hippocampal neurons. In the first part I 
addressed the role of Nogo-A and its signalling in regulating the actin cytoskeleton within 
dendritic spines and thereby maintaining the balance between the plasticity and stability of 
the neuronal circuitry required to store long-term information in the mature CNS. I show 
that Nogo-A signalling rapidly modulates the spine actin cytoskeleton to control structural 
plasticity at dendritic spines of CA3 hippocampal pyramidal neurons. Interfering with 
Nogo-A signalling transiently increases F-actin stability within minutes and results in an 
increase in dendritic spine number and length (Figure 31). Moreover, my results support 
the notion that Nogo-A signalling regulates learning and memory processes in vivo 
possibly by restricting structural plasticity. In summary, these data provide a cellular 
mechanism underlying the action of Nogo-A in regulating synaptic plasticity and show an 
important function for Nogo-A in maintaining the balance between plasticity and stability 
for the proper functions of the mature CNS network. 
The second part of my work describes the necessity for endogens BDNF in the activity-
dependent maintenance of a mature spine phenotype in excitatory mature hippocampal 
neurons (Figure 32). Specifically, I analysed at defined maturation stages (development, 
young and mature) the dendritic architecture of hippocampal neurons and show that the 
effects exerted by BDNF in this context are dependent on the neuron's maturation stage. 
Furthermore, I also shed some light on why published in vivo and in vitro results 
concerning morphological effects of BDNF are often contradictory. 
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5.1 Nogo-A rapidly modulates actin dynamics to control structural 
plasticity of dendritic spines and regulates memory acquisition 
5.1.1 Use of FRAP to detect actin dynamics within mature dendritic spines 
Filamentous actin is the main constituent of the cytoskeleton in dendritic spines, and the 
modulation of actin dynamics, is controlled by different signalling pathways to determine 
spine number and morphology (Cingolani and Goda, 2008; Hotulainen and Hoogenraad, 
2010; Matus, 2000; Okamoto et al., 2009). Indeed, actin polymerization is supposed to 
generate a propulsive force toward the cell membrane (Mogilner and Oster, 1996) 
possibly generating force promoting the expansion of the spine head and thereby defining 
spine morphology (Honkura et al., 2008). Accordingly, the inhibition of actin 
polymerization by the application of latrunculin A induces spine shrinkage (Allison et al., 
1998; Korkotian and Segal, 2001; Okamura et al., 2004) leading to the hypothesis that the 
spine number and morphology might be continuously maintained in a precise balance 
between the propulsive force of the F-actin fraction and the mechanical pressure imposed 
by the surrounding neuropil (Honkura et al., 2008). To test whether Nogo-A signalling is 
involved in regulating actin dynamics and thereby controlling spine morphology 
I established an new technique to the lab - fluorescence recovery after photobleaching 
(FRAP) at individual spines of eGFP-actin expressing CA3 hippocampal pyramidal 
neurons. I used the FRAP technique in order to analyse actin turnover and to provide 
quantitative estimates of F-actin filament stability within single spines. By this means 
I could confirm earlier results: recovery of the fluorescence after photobleaching occurred 
in two distinct components (Star et al., 2002; Zito et al., 2004), showing that 85% of the 
actin within spines exists in a mobile state and only 15% in a stable fraction (within a time 
frame of 110 s). The mobile actin portion (85%) can be further subdivided in a 70% 
dynamic F-actin fraction and 15% monomeric G-actin fraction. Moreover, similar to 
previous data (Stamatakou et al., 2013), all control spines showed an average turnover 
time of about 20 s implying a fast treadmilling (highly dynamic exchange of monomers 
between filaments and monomers). My FRAP data support the view of a highly dynamic 
actin cytoskeleton within mature dendritic spines of CA3 pyramidal neurons in organotypic 
slices. Previous studies showed that the spine-head volume is proportional to the total 
amount of F-actin and specifically to the stable actin fraction (Honkura et al., 2008; 
Okamoto et al., 2004). To avoid that different spine sizes and by this different amounts of 
stable actin within spines may influence the FRAP results, only mushroom like spines with 
a clear head and on average the same spine head size were used for experiments. 
Moreover, a series of preliminary experiments was performed to demonstrate that the 
fluorescent recovery after photobleaching indeed visualizes the F-actin treadmilling.    
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As previously described from Star et al. (2002) and confirmed here, the fluorescent 
intensity values of cytoplasmic eGFP recovered within seconds and the application of 
Cytochalasin D or jasplakinolide resulted in a dramatic reduction of the actin turnover, 
indicating a fast diffusion in the organotypic slice within minutes (see Figure 8C). 
Moreover, the turnover time for the fluorescence recovery of cytoplasmic GFP (0.34 s) is 
significantly faster than the one for eGFP-actin (20 s) indicating that the latter is not freely 
diffusible within the spine. These observations indicate that the FRAP experiment used in 
this study reliably detect the actin turnover within single mature dendritic spines (Star et 
al., 2002). A weakness of the FRAP experiments is that the portion of monomeric G-actin 
is relative because it is determined by the first imaging time point after the bleaching 
which is set by the experimenter. Furthermore, the FRAP experiments are limited to only a 
few single dendritic spines and changes over time can only be displayed after a full 
recovery of the stable actin fraction in 15-20 min (Honkura et al., 2008). Yet, FRAP 
experiments allow to examine the turnover time and the different actin fractions (dynamic, 
stable and monomeric) of single dendritic spines (Michaelsen-Preusse et al., 2014; Star et 
al., 2002), which cannot be determined with any other imaging technique.  
 
5.1.2 Nogo-A restricts structural plasticity 
Recent studies started to elucidate the role of Nogo-A in structural plasticity in the adult 
and intact (uninjured) CNS (for reviews see: Kempf and Schwab, 2013; Mironova and 
Giger, 2013). In organotypic hippocampal slice cultures Nogo-A was shown to regulate 
axonal and dendritic architecture of mature pyramidal neurons via a receptor-mediated 
mechanism (Craveiro et al., 2008; Zagrebelsky et al., 2010). A similar result was obtained 
analysing a triple knockout of the Nogo receptor (NgR1/2/3; Wills et al., 2012). Moreover, 
the neutralisation of Nogo-A in organotypic hippocampal slice cultures shifted the spine 
type distribution towards a more immature phenotype (Zagrebelsky et al., 2010). Also the 
Nogo-A receptors NgR1 and PirB have been shown to regulate the experience-dependent 
turnover of dendritic spines and axonal varicosities in the somatosensory and visual 
cortex, respectively (Akbik et al., 2013; Djurisic et al., 2013). In our recent study we asked 
whether Nogo-A acutely regulates structural plasticity and what are the molecular 
mechanisms mediating this action of Nogo-A (Kellner et al., under review). The loss-of-
function experiments, performed by acutely blocking Nogo-A or the receptors NgR or 
S1PR2 revealed an increase in dendritic spine density and length within one hour of 
treatment (Figure 31). Accordingly, gain-of-function experiments by the application of the 
Nogo-A-Δ20 peptide showed a transitory decrease in spine length within minutes. The 
spine density increase after blocking NgR1 or S1PR2 remained lower than upon Nogo-A 
neutralisation possibly indicating a cooperative effect of the two receptors. Yet, no change 
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of the spine density after a chronic neutralisation of Nogo-A in CA3 pyramidal neurons 
were shown (Zagrebelsky et al., 2010), suggesting that the gained spines are not 
maintained over days. Similarly, while the analysis of spine morphology upon an acute 
Nogo-A neutralisation induced spine elongation without changes in spine head width its 
long-term neutralisation caused more stubby like spines (Zagrebelsky et al., 2010). This 
suggests that a chronic neutralisation of Nogo-A may conduct changes in the network 
homeostasis and finally may support changes in synaptic plasticity as a compensatory 
mechanism. This needs to be further examined with time-lapse imaging over days. Taken 
together, Nogo-A signalling acutely restrict structural plasticity at individual dendritic 
spines of CA3 pyramidal neurons on a fast timescale. 
 
5.1.3 Nogo-A signalling controls actin dynamics 
Nogo-A signalling triggers the activation of the small GTPase RhoA and suppression of 
Rac1 resulting in growth cone collapse and axonal repulsion (Kempf et al., 2014; 
Niederöst et al., 2002; Yiu and He, 2006). Inactivated RhoA is increased in nogo-a KO 
mice resulting in an increased LIMK1 phosphorylation via ROCK and in the deactivation of 
the actin severing protein cofilin (Montani et al., 2009). These signalling events in nogo-a 
KO mice, lead to increased growth cone motility through the increase in actin 
polymerization required for the formation and extension of filopodia in growth cones 
(Montani et al., 2009). Interestingly, in primary hippocampal neurons as well as in vivo 
NgR1 restricts dendritic and synaptic growth through RhoA activation, probably by limiting 
the number of synaptic contacts made during development (Wills et al., 2012). 
Furthermore the Nogo-A-∆20 peptide binds to S1PR2 and signals via the G protein G13, 
the Rho GEF LARG to activate RhoA (Kempf et al., 2014). The inhibitory effects of Nogo-
A on neurite outgrowth and oligodendrocyte-mediated growth cone collapse were also 
abolished by inactivating the Rho-kinase ROCK (Niederöst et al., 2002). These studies 
suggest that Nogo-A signalling may regulates the actin cytoskeleton via the RhoA–ROCK 
pathway. The inactivation of RhoA has been shown to result in more and longer spines 
suggesting that RhoA can repress the maintenance and elongation of spines (Tashiro et 
al., 2000). Here I showed that a similar regulation of actin dynamics via ROCK takes place 
within mature dendritic spines to control their architecture and thereby suppressing their 
structural plasticity. Neutralising Nogo-A signalling in mature hippocampal neurons results 
in the fast stabilization of the actin cytoskeleton shown by an increase in turnover time and 
in the stable actin fraction already after 20 minutes of Nogo-A or NgR1 and S1PR2-
receptor blockade (Figure 31). This stabilizing effect on the actin cytoskeleton is transient 
for the Nogo-A signalling via the NgR1. It is noteworthy that, blocking the S1PR2 leads to 
a strong and long lasting stabilizing effect on the actin cytoskeleton beyond 180 minutes.  
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Figure 31: Control of the actin cytoskeleton via Nogo-A signalling.                    
Scheme showing a dendritic spine within the stable F-actin (grey) and dynamic F-actin (red) under 
the gain- and loss-of-function of Nogo-A signalling. 
 
To block the S1PR2 I used the selective antagonist JTE-013 which was shown to 
counteract Nogo-A-∆20-mediated inhibition of neurite outgrowth and cell spreading 
(Kempf et al., 2014). Yet, to block Nogo-A and its receptors different antibodies and 
blockers were used whose kinetics and blocking efficiency may be not identical and 
therefore may lead to different outcomes in blocking the Nogo-A signalling. The long 
lasting effect on the actin cytoskeleton achieved by blocking the S1PR2 might be 
mediated also via RhoA signalling like the blocking of the NgR1 (Kempf et al., 2014). Yet, 
S1PR2 has also been shown to regulate Ca2+ homeostasis (Rapizzi et al., 2007; Spiegel 
and Milstien, 2003) and, a misregulation of the intracellular Ca2+ homeostasis might 
indirectly influence diverse molecular mechanism to alter actin dynamics (Oertner and 
Matus, 2005). Calcium activates cascades of kinases and phosphatases in dendritic 
spines, resulting in changes in cellular functions and leading to functional and structural 
plasticity (for review see: (Sala and Segal, 2014). Indeed, calcium triggers the activation of 
the CaMKII that can reorganize actin filaments, bundles them and consolidates the 
remodelled spine morphology (Okamoto et al., 2009). A transient rise in the calcium 
concentration in dendritic spines has been shown to lead to an increase in spine length 
(Korkotian and Segal, 1999). The stabilization of the actin cytoskeleton and the increase 
of the spine length after Nogo-A blocking (Figure 31) might be indirectly mediated by 
calcium. It is noteworthy, that the application of Nogo-A-∆20 leads in the growth cone to a 
release of Ca2+ from internal stores necessary to induce growth cone collapse (Bandtlow 
et al., 1993). The gain-of-function approaches by the application of Nogo-A-Δ20 or Nogo-
66 peptides reduce the amplitude of post-tetanic stimulation (Delekate et al., 2011) or LTP 
(Raiker et al., 2010). Interestingly, here I showed a decrease of the actin turnover time 
directly after Nogo-A-Δ20 application and thereby a more mobile actin cytoskeleton 
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(Figure 31). A longer incubation of the peptide upon 20 min correlates with a stabilization 
of the actin cytoskeleton which were also achieved by neutralising Nogo-A (loss-of-
function experiments). Joset and colleagues (2010) described an internalization of the 
Nogo-A-Δ20 starting 15 min after application of the peptide on neuronal cells. The binding 
of Nogo-A-Δ20 to its receptor leads to endocytosis and thereby to a loss-of-function of the 
S1PR2 complex (Kempf et al., 2014; Schwab, 2010). This biphasic action after Nogo-A-
Δ20 application of a transient destabilization followed by a stabilization of the actin 
cytoskeleton within dendritic spines supports previous observations in LTP experiments 
(Delekate et al., 2011). 
As indicated above Nogo-A signalling might regulate actin dynamics in dendritic spines via 
RhoA, ROCK signalling (Mironova and Giger, 2013). Rex and colleges showed that the 
inhibition of ROCK upon LTP induction leads to a dysregulation of cofilin and a lack of 
LTP maintenance (Rex et al., 2009). Also here I show that the inhibition of ROCK leads to 
a transient stabilization of the actin cytoskeleton. Nevertheless, this effect is mild in 
comparison to the effect achieved with the inhibition of the Nogo-A action, suggesting that 
the timing of the direct ROCK inhibition might be different or the inhibition is compensated. 
Indeed, ROCK activates via LIMK cofilin to regulate actin dynamics, the LIMK can also be 
regulated via PAK controlled by the Rho-GTPases Rac1 or Cdc42 to compensate the 
inhibition of ROCK. A further actin regulatory protein that may play an important role in 
this context is Myosin II, known to regulate the retrograde flow of G-actin and thereby 
possibly influencing the dynamics and organisation of the actin cytoskeleton (Medeiros et 
al., 2006). The inhibition of myosin II in mature hippocampal neurons results in a 
stabilization of the actin cytoskeleton within spines (Rex et al., 2010) and in an increase in 
spine number and spine length (Ryu et al., 2006; Schubert and Dotti, 2007). In nogo-a KO 
mice it has been observed that myosin II is down-regulated (Montani et al., 2009), 
correlating to an increase in neurite motility by regulating contractility of actin-bundles and 
the retrograde actin-flow within growth cones (Medeiros et al., 2006). In further 
experiments are needed to examine whether Nogo-A signalling might regulate Myosin II 
via the RhoA or PAK pathway. Although I cannot determine the detailed signalling 
pathway my data strengthen the view that Nogo-A controls structural plasticity at spines 
by regulating actin dynamics possibly via the RhoA-ROCK pathway and by this means it 
might regulate cofilin and Myosin II. A regulation of the Ca2+ homeostasis might contribute 
to the effect seen upon Nogo-A neutralisation to regulate dendritic spine dynamics. 
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5.1.4 Linking actin cytoskeleton dynamics to functional and structural 
plasticity 
Electrophysiological recordings revealed that Nogo-A and its receptors play a crucial role 
in restricting activity-dependent synaptic plasticity (Delekate et al., 2011; Kempf et al., 
2014; Lee et al., 2008; Raiker et al., 2010). Loss-of-function experiments of Nogo-A or of 
its receptors NgR1 or S1PR2 result in higher potentiation during LTP (Delekate et al., 
2011; Kempf et al., 2014), whereas in a gain-of-function approach the application of Nogo-
A-Δ20 or Nogo-66 peptides reduces the amplitude of post-tetanic stimulation (Delekate et 
al., 2011) or LTP (Raiker et al., 2010). We show in our current study an increase in spine 
density upon Nogo-A neutralisation associated with a higher number of new AMPA 
receptor clusters at spines suggesting an increase in active synapses (Kramer, 2013; 
Kellner et al., under review). Activity-dependent alterations in the strength of synapses are 
driven by a collaborative interaction between functional and structural changes (Matsuzaki 
et al., 2004a; Yuste and Bonhoeffer, 2001). Induction of LTP is accompanied by a rapid 
insertion of AMPA receptors and by their increased clustering at the surface of dendritic 
membranes (Kessels and Malinow, 2009; Lu et al., 2001; Pickard et al., 2001) underlying 
the associated increase in synaptic strength. Electron microscopy verified that AMPARs 
are located in the cytoskeleton shell of the spine (Harris and Stevens, 1989; Nusser et al., 
1998; Takumi et al., 1999). The inhibition of actin polymerization applying latrunculin A 
has been shown to block the functional expression of AMPARs (Kim and Lisman, 1999; 
Krucker et al., 2000) and at the same time reduces F-actin dynamics at spines (Honkura 
et al., 2008). Furthermore AMPARs are anchored via adaptor molecules to actin filaments 
(Lisman and Zhabotinsky, 2001) and ADF/cofilin mediates the actin dynamics to regulate 
AMPAR trafficking specifically during synaptic plasticity (Gu et al., 2010). In this way 
changes in the dynamics of the actin cytoskeleton modulates both synaptic strength and 
as discussed above structural changes at synapse. I showed an acute role of Nogo-A 
signalling in modulating the actin cytoskeleton within dendritic spines at a time scale of 
minutes and hours comparable to the effects observed on LTP and correlated with an 
increase in the number of dendritic spines (Kellner et al., under review). In addition, the 
transitory stabilization of the actin cytoskeleton after Nogo-A inhibition may support the 
new insertion of AMPARs probably via the regulation of ADF/cofilin, resulting in higher 
synaptic potentiation (Delekate et al., 2011). The stable actin fraction is related to the 
spine head width (Honkura et al., 2008) which has been shown to be correlated to 
synaptic strength: larger synaptic efficiency are accompanied with an increase in F-actin 
and bigger spine heads (Fischer et al., 1998; Huber et al., 2004; Kasai, 2003; Kopec et 
al., 2006; Okamoto et al., 2004). Indeed, Nogo-A neutralisation increases the stable actin 
fraction, still the spines head width is not altered. It must be pointed out that changes in 
Discussion | 84 
 
spine neck width can regulate the biochemical and electrical compartmentalization of the 
spine which is important for the diffusional coupling between the spine head and the 
dendritic shaft (Bloodgood and Sabatini, 2005; Tønnesen et al., 2014; Yuste, 2013). The 
spine neck contains long branched and linear longitudinal arranged actin filaments 
(Korobova and Svitkina, 2010). Interesting, myosin II induces contractility which could 
further regulate spine morphology and synaptic strength by controlling the spine neck 
width (Hotulainen and Hoogenraad, 2010; Ryu et al., 2006). Interestingly, the spine neck 
length is inversely correlated to the amplitude at the soma of an uncaged evoked 
potential, suggesting that the spine neck has a filter function for membrane potentials 
(Araya et al., 2006). The elongation of the spine neck might electrically isolates the 
synapse from the dendrites preventing large conductance changes in dendrites and could 
help the neuron integrate and independently modulate the strength of large numbers of 
synaptic inputs (Yuste, 2013). Certainly, Nogo-A neutralisation leads to an increase in the 
number of spines, to an increase in AMPARs clusters (Kellner et al., under review) and to 
a higher LTP (Delekate et al., 2011). Thus, the stabilization of the actin cytoskeleton may 
lead to an elongation of the spine and resulting in the electrical isolation of spines from the 
dendrite to compensate the consequences of an increasing number of synaptic inputs 
(Yuste, 2013) upon Nogo-A neutralisation. All in all, interfering with Nogo-A signalling 
pathway might transitory increase the actin cytoskeleton stability of mature dendritic 
spines resulting finally in longer spines.  
 
5.1.5 Nogo-A exerts a biphasic action in regulating memory acquisition   
and retention  
The strengthening of synaptic connections between neurons is widely considered to be 
essential for learning and memory formation in the CNS (Bailey and Kandel, 1993; Martin 
et al., 2000). Interestingly, changes in synaptic strength have been shown to accompany 
motor skill acquisition (Rioult-Pedotti et al., 1998, 2000) and Nogo-A down-regulation 
results in higher LTP in the motor cortex (Tews et al., 2013). Recent studies have 
delivered evidence that learning involves gain and loss of synapses leading to the 
formation of memory traces that influence behaviour (Caroni et al., 2012). Learning of 
motor skills leads to dendritic spine growth in the motor cortex (Xu et al., 2009; Yang et 
al., 2009a; Zemmar et al., 2014, under review) or in the dentate gyrus (O’Malley et al., 
2000) and increase in dendritic spine number is correlated to learning processes and 
memory formation. Nogo receptor 1 signalling (Kleene and Schachner, 2004) was shown 
to control learning and memory formation as well as experience dependent structural 
plasticity in the cortex in two independent learning paradigms (Akbik et al., 2013; Karlén et 
al., 2009). Therefore I explored the possibility whether Nogo-A might be involved in 
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processes of spatial learning and memory retention in the Morris water maze by regulating 
structural plasticity at spines of CA3 hippocampal neurons. First my data confirm previous 
results from Willi and colleagues (2009) showing that nogo-a KO and WT mice learn 
equally well to locate the hidden platform (Willi et al., 2009). Second I identified a crucial 
role for Nogo-A in the early phase of memory formation. Performing a probe trial at the 
end of the training period (day 9) revealed no difference in reference memory, in contrast 
during the early acquisition phase (day 3) nogo-a KO mice form a reference memory 
significantly faster than WT mice. This initial and transient advantage of nogo-a KO mice 
in forming a reference memory in the Morris water maze supports the role of Nogo-A in 
regulating the initial phase of memory acquisition. In the rat hippocampus the expression 
of Nogo-A or the Nogo receptor 1 are induced with age-related cognitive decline and 
correlate with deficits of spatial learning and memory (VanGuilder Starkey et al., 2013a, 
2013b; Vanguilder et al., 2012). The lack of an effect for nogo-a KO mice on the 
performance during training in the Morris water maze could be due to a generally mild 
phenotype in the nogo-a KO mice. Interestingly, the neutralisation of Nogo-A or NgR1 
function by blocking antibodies has been shown to be significantly more efficient in 
promoting axonal regeneration upon injury than the genetic deletion of the respective 
genes (Schwab and Strittmatter, 2014; Teng and Tang, 2005). Also the dendritic and 
axonal architecture of CA3 pyramidal neurons as well as dendritic spine density and 
dynamics (observation Zagrebelsky, unpublished data) are altered upon a neutralisation 
of Nogo-A but not in nogo-a KO hippocampal cultures (Zagrebelsky et al., 2010). Indeed, 
in the nogo-a KO mice other inhibitory factors like NogoB and MAG, Ephrin/Eph and 
Semaphorin/Plexin are up-regulated and may compensate the lack of Nogo-A (Kempf et 
al., 2013).  
It has been shown that learning of a new task or experiencing novel sensory stimulations 
are correlated with a phase of synaptic remodelling due to the rapid formation of new 
spines followed by the selective elimination of previously existing spines (Yu and Zuo, 
2011). These results, together with the observation that increased spine turnover or 
formation correlates with the performance upon motor learning suggest that spine 
plasticity plays an important role in the formation and maintenance of motor memories (Xu 
et al., 2009; Yang et al., 2009a). I showed that the initial advantage of nogo-a KO mice in 
forming a spatial reference memory in the Morris water maze is associated to an increase 
in dendritic spine density for CA3 pyramidal neurons already after 3 days of training. 
Interestingly, the delayed formation of a reference memory in WT mice correlates with a 
significant increase in dendritic spine density after 9 days of water maze training. Finally, 
the reference memory at probe trial of day 9 was comparable between the two genotypes 
and was correlated to similar spine density values due to a slight decrease in spine 
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density of nogo-a KO mice. This observation suggests that the new spines added during 
the learning processes are not maintained or that pre-existing spines are eliminated later 
on during training. Indeed, both spine gain and elimination processes are associated with 
motor learning and long-lasting synaptic reorganisation to stabilize neuronal connections 
(Caroni et al., 2012; Xu et al., 2009). Previous studies reported an activity-dependent 
down-regulation of Nogo-A and NgR1, and transgenic mice overexpressing NgR1 show 
impaired long-term spatial memory (Karlén et al., 2009 Mingorance et al., 2004). The 
activity-dependent down regulation of Nogo-A mRNA was shown for the dentate gyrus but 
not in the CA1 or CA3 region of the hippocampus (Karlsson et al., 2013; Mingorance et 
al., 2004). WT mice trained for 3 days in the Morris water maze showed a transitory 
significant increase in Nogo-A expression levels in the hippocampus which was not 
maintained up on day 9. The increase in Nogo-A expression levels in trained WT mice 
correlate with the delay in spine density increase in in the CA3 pyramidal neurons and in 
reference memory acquisition in WT mice when compared to nogo-a KO. Taken together, 
the data open the possibility that Nogo-A signalling restricts structural plasticity and 
provides a biphasic control of learning and memory processes at the acquisition and at 
the consolidation phase of hippocampus-dependent memory storage. 
 
5.2 The BDNF effects on neuronal architecture depend on the 
maturation stage and the neuronal activity 
5.2.1 BDNF/TrkB signalling regulates the architecture of mature 
hippocampal neurons 
While in the first part of my thesis I examined the role of Nogo-A in restricting structural 
plasticity in the second part of my work I analysed the role of BDNF as a positive regulator 
in maintaining the mature architecture of CNS neurons. The results obtained in my study 
are in line with previous work showing a surprising selectivity in the brain areas requiring 
BDNF-signalling for their post-natal development (Minichiello et al., 1999; Rauskolb et al., 
2010; Zakharenko et al., 2003). While a global lack of BDNF throughout the CNS impairs 
the proper post-natal growth of striatal medium spiny neurons, BDNF deprivation fails to 
cause major alteration in the structure of mature CA1 pyramidal neurons in the 
hippocampus. Yet, the dendritic spine type distribution is significantly shifted towards 
more immature types (Rauskolb et al., 2010). These results suggest a crucial but rather 
limited and specific effect of BDNF in maintaining the mature phenotype of dendritic 
spines without affecting the general architecture of hippocampal neurons. My 
observations in vitro show a similar effect upon the application of two loss-of-function 
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approaches for BDNF to hippocampal primary cultures (function blocking BDNF 
antibodies and TrkB receptor bodies) confirming a physiological role of the endogenous 
BDNF. Nevertheless, my experiment fail to reproduce previously published data showing 
a highly significant increase in dendritic spine density and alterations in spine morphology 
upon the application of exogenous BDNF to mature hippocampal primary neurons (Ji et 
al., 2005, 2010) or to hippocampal slice cultures (Tyler and Pozzo-miller, 2003, 2001). 
The discrepancy between the data presented here and other previously published data 
regarding the role of exogenous BDNF in regulating the architecture of mature 
hippocampal neurons may have different reasons. One possible explanation is the 
different animal species used for the experiment. While studies showing an effect of a 
BDNF loss-of-function either in vivo (Rauskolb et al., 2010) or in vitro (my study: Kellner et 
al., 2014) were performed in mouse derived cultures, most of the previous in vitro work 
describing an effect for a BDNF gain-of-function was done using rat hippocampal neurons 
(Tyler and Pozzo-Miller, 2001, 2003; Ji et al., 2005, 2010) suggesting a possible 
difference in the sensitivity to BDNF signalling in the two different species. In addition, 
different level of BDNF release from neurons into the medium could change the initial 
BDNF content and by this also the sensitivity to BDNF for the gain-of-function experiment. 
It is noteworthy that my gain-of-function experiments didn’t show any alterations of the 
spine density or morphology in primary rat hippocampal cultures performed in 
collaboration with the group S. Halpain (UCSD; Kellner, 2010). Implying that not the two 
different species but rather different culture conditions, may be responsible for this 
discrepancy. Indeed, culture conditions have been shown to possibly influence the 
expression levels as well as the cellular response to BDNF (Chapleau et al., 2008). Here I 
show that the levels of neuronal activity in the cultures determine the responsiveness to 
the exogenous or the endogenous BDNF. Low levels of neuronal activity during the 
cultivation period result in lower spine density values and an increased responsiveness of 
hippocampal neurons to the applications of exogenous BDNF (Figure 32). Indeed, the 
synthesis and secretion of BDNF have been shown to be directly correlated to neuronal 
activity (Gärtner and Staiger, 2002; Thoenen, 1991). Control neurons in previous 
publications showing a strong effect upon an exogenous BDNF application (Ji et al., 2005, 
2010) had a spine density which is about 10 times lower than the one measured here or 
described in vivo (De Simoni et al., 2003) and 5 times smaller than the one described for a 
more complex in vitro system like the organotypic slice cultures (De Simoni et al., 2003; 
Rauskolb et al., 2010). It should also be noted that in the culture system used here the 
levels of neuronal activity as well as the cellular responsiveness to BDNF were tested in 
different ways. It was tested by quantifying the changes in TrkB phosphorylation as well 
as the activation of the IEG c-fos, two critical events known to occur upon the acute 
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activation of BDNF signalling (Ji et al., 2005, 2010; Marty et al., 1996). Both 
immunohistochemistry of the primary neurons showed a clear response upon BDNF 
treatment. In line with previous studies the application of exogenous BDNF led to a 
response of the neuronal network via a transient raise of the intracellular calcium 
concentration (Berninger et al., 1993; Lang et al., 2007). In contrast, blocking intrinsic 
BDNF signalling was shown to reduce the frequency of spontaneously occurring calcium 
signals in developing rat hippocampal neurons (Lang et al., 2007). Overall, my 
observation indicated that mature primary hippocampal neurons under normal culture 
conditions (1.5 mM Mg2+) were responsive to application of exogenous BDNF even if they 
lack morphological effects observed in previous in vitro studies (Ji et al., 2005, 2010). 
 
5.2.2 Endogenous BDNF regulates dendritic spine morphology 
One important open question concerns the functional consequences of the observed 
structural changes at spines regulated by BDNF signalling. Interestingly, the dendritic 
spines morphology is associated to their compartmentalisation features and the respective 
functions in synaptic transmission (Matsuzaki et al., 2004b; Yuste et al., 2000). My results 
upon a BDNF loss-of-function confirm the structural alterations at spines observed already 
in vivo (Rauskolb et al., 2010). Specifically, the BDNF deprivation in mature primary 
neurons results in a decrease in dendritic spine density accompanied by a decrease in 
spine head width and an increase in spine length (Figure 32). The loss of the mature 
spines phenotype possibly results in a decrease and a weakening of synaptic connections 
under these conditions. Indeed, an increase in dendritic spines length has been shown in 
association with increased spine motility (Zito et al., 2004) and the spine head width is 
correlated with the size of the post-synaptic density and the number of AMPA receptors 
(Holtmaat and Svoboda, 2009). A shrinking of the spine head width has been correlated to 
the synaptic weakening occurring upon long-term depression induction (Zhou et al., 
2004). Moreover, the spine neck has been suggested to act as a diffusion barrier 
regulating the biochemical and electrical compartmentalization in the spine head (Holthoff 
et al., 2010; Sjöström et al., 2008; Tønnesen et al., 2014; Yuste, 2013). Indeed, spines 
with long necks have been shown to be electrically silent at the soma, although their 
heads are activated by an uncaging event (Araya et al., 2006) and a BDNF-dependent 
shortening of the spine neck was observed upon inducing long-term potentiation at single 
spines (Tanaka et al., 2008). It has been show that upon maturation the proportion of 
mushroom spines increases while the one of thin long spines decreases (De Simoni et al., 
2003). It will be important to explore the possibility that the structural changes of dendritic 
spines upon blocking intrinsic BDNF signalling may be accompanied by a weakening of 
synaptic strength and, a reduction of neuronal activity. It should also be noted that the 
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dendritic spine density and head width is lower in primary neurons 16 DIV in comparison 
to 23 DIV whereas the spine length is increased suggesting that dendritic spine 
maturation occurs between this time points. Indeed, it has been shown that primary young 
neurons change their morphology during the maturation process to a mature spine 
phenotype (Papa and Segal, 1996; Papa et al., 1995). Interestingly, the effects exerted by 
blocking BDNF signalling are in young primary neurons not as pronounced as in mature 
suggesting, that endogenous BDNF signalling plays a crucial role in maintaining the 
mature architecture of dendritic spines in excitatory neurons. 
 
5.2.3 Activity-dependent structural plasticity 
Increasing the strength of synaptic connections by inducing LTP in the CA3-CA1 
hippocampal pathway depends on the NMDAR activation and is correlated to an increase 
of spine head width, as well as the formation of new spines (Engert and Bonhoeffer, 1999; 
Maletic-Savatic, 1999; Matsuzaki et al., 2004a). The secretion and local synthesis of 
BDNF is activity-dependent, and transgenic mice with impaired activity-dependent release 
or synthesis of BDNF exhibit defects in both LTP and memory (An et al., 2008; Chen et 
al., 2006; Ninan et al., 2010). Here calcium imaging was used to test the effects of 
increasing the magnesium concentration in the culture medium on neuronal activity. So, I 
could confirm that manipulating magnesium concentration in the medium results in a long 
lasting reduction in neuronal excitability and network activity of primary hippocampal 
cultures (Dribben et al., 2010). While this reduction in neuronal activity does not influence 
dendritic morphology and complexity, it is accompanied by a significant decrease in 
dendritic spine density as well as by an increased cellular sensitivity to the application of 
exogenous BDNF (Figure 32). Whether the increased neuronal responsiveness to BDNF 
is due to an activity-dependent decrease in BDNF release from neurons or, as recently 
described from microglia (Parkhurst et al., 2013) will be very interesting to address. 
Indeed, changes in magnesium concentration have also been shown to possibly influence 
ATP release (Li et al., 1997) and could thereby indirectly influence BDNF release from 
microglia (Parkhurst et al., 2013; Trang et al., 2009). Moreover, it will be crucial to explore 
the possibility that different amounts of microglia may influence the BDNF levels in the 
primary hippocampal cultures and thereby their responsiveness to a BDNF exogenous 
application. My results show that reducing neuronal activity during the application of 
exogenous BDNF prevents morphological changes at dendritic spines pointing to an 
activity-dependent effect of BDNF on dendritic spines (Figure 32). This result is consistent 
with previous work showing that during the early development of cortical pyramidal 
neurons in ferrets, BDNF regulates dendritic architecture in an activity-dependent manner 
(McAllister et al., 1996). 
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Figure 32: BDNF signalling regulates structural plasticity of dendritic spines in an activity-
dependent manner. Scheme showing the effects of the gain- and loss-of-function of BDNF 
signalling on dendritic spines under three different neuronal excitability conditions. 1) basal 
neuronal excitability (1.5 mM Mg
2+
), 2) low neuronal excitability (3.5 mM Mg
2+
) before the treatment 
and 3) low neuronal excitability (3.5 mM Mg
2+
)
 
before and during treatment. Arrows: in red indicate 
structural changes, in blue no changes. 
Moreover, in cerebellar cultures, BDNF increases the spine density of Purkinje cells only 
in the presence of granule cells suggesting a crucial role of neuronal activity in mediating 
this BDNF effect (Shimada et al., 1998). In line with these observations are the results 
from Tanaka et al. (2008) showing that indeed the dependence of BDNF in regulating 
structural changes at dendritic spines is activity-dependent in mature hippocampal 
neurons. 
 
5.2.4 The actin cytoskeletal a targets of BDNF/TrkB signalling 
Finally, I could show that endogenous BDNF modulates the actin cytoskeleton within 
dendritic spines in parallel to regulating their morphology. Filamentous actin is highly 
abundant and the main cytoskeleton component within dendritic spines (Fifková and 
Delay, 1982; Matus et al., 1982). Moreover, activity-dependent as well as spontaneous 
structural changes of dendritic spines are dependent on the modulation of actin dynamics 
within spines (Cingolani and Goda, 2008; Fukazawa et al., 2003; Krucker et al., 2000; Lin 
et al., 2005). Noteworthy in this context is the observation that BDNF modulates actin 
regulatory binding proteins which control the turnover of the actin cytoskeleton as well as 
cytoskeleton-associated proteins like Arc, LIMK1 and Homer (Bramham, 2008; Messaoudi 
et al., 2002, 2007; Rex et al., 2007; Schratt et al., 2004). Remarkably, these proteins are 
known to promote actin polymerization required for spine head maturation (Meng et al., 
2002; Sala et al., 2001) and LTP consolidation (Bramham and Wells, 2007). Furthermore, 
the actin binding protein cortactin was shown to be involved in the maintenance of 
Discussion | 91 
 
dendritic spines (Hering and Sheng, 2003) and, interestingly, its localization at 
postsynaptic sites seems to be BDNF dependent (Iki et al., 2005). While the gain-of-
function approach performed in this study did not affect the F-actin content within dendritic 
spines, the loss-of-function experiment resulted in a significant decrease in the F-actin 
content. The results of Rex et al. (2007) showed that exogenous application of BDNF to 
rat hippocampal slices increased the number of F-actin labelled spines only when theta 
burst stimulation was applied. Moreover, the effect of theta burst stimulation on F-actin 
was completely abolished by a BDNF scavenger (TrkB-Fc; Rex et al., 2007) suggesting a 
role for the TrkB receptor in this context. On the other hand, BDNF might also modulate 
actin dynamics via the p75NTR. In a series of gain- and loss-of-function experiments it was 
previously shown that p75NTR negatively modulates dendritic spine density and 
morphology (Zagrebelsky et al., 2005), in addition to its effect on long-term depression 
(Rösch et al., 2005; Woo et al., 2005). It has been shown that signalling via the p75NTR 
controls the activity of the small GTPase RhoA, thereby regulating the actin cytoskeleton 
(Gehler et al., 2004; Yamashita and Tohyama, 2003; Yamashita et al., 1999) and possibly 
preparing it for processes of negative synaptic plasticity (spine loss and shrinkage). A 
recent study showed that BDNF signalling is required for the enlargement of the spine 
head mediated via Rac1 by a direct interaction between phosphorylated TrkB and Tiam1 
(Lai et al., 2012). Suggesting that BDNF signalling might regulate the actin cytoskeleton 
via the Rac1 or RhoA pathway dependent on the respective receptor activation and by 
this BDNF may modulate synaptic plasticity.  
 
5.2.5 Crosstalk between BDNF and Nogo-A signalling  
BDNF as a member of the neurotrophin family is known to be a growth-promoting factor in 
the developing CNS, leading to growth cone expansion and neurite elongation (Gehler et 
al., 2004; McAllister et al., 1996, 1995, 1999). On the other hand, Nogo-A is well-known 
as myelin-associated growth suppressor leading to growth cone collapse and neurite 
retraction (Chen et al., 2000; Niederöst et al., 2002; Oertle et al., 2003). These opposing 
effects can be explained by the different regulation of the actin cytoskeleton within the 
growth cone. As described above Nogo-A signalling is transmitted to RhoA and further 
downstream to ADF/cofilin leading to a destabilization of the actin cytoskeleton (Hsieh et 
al., 2006; Montani et al., 2009). Whereas BDNF stabilizes the actin cytoskeleton by 
reducing the phosphorylation of ADF/cofilin (Gehler et al., 2004). Interestingly, also an 
opposing regulation of neurite growth specific proteins and transcription factors was 
reported, as BDNF promotes the phosphorylation of CREB (Mayr and Montminy, 2001) 
while Nogo-A signalling decreases CREB phosphorylation (Joset et al., 2010; Schwab, 
2010). In the adult CNS BDNF levels are up-regulated by an increase of neural activity or 
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exercise (Vaynman and Gomez-Pinilla, 2005), conversely Nogo-A as well as the NgR1 
are down regulated (Griesbach et al., 2009; Josephson et al., 2003). This is also reflected 
by their action during LTP, where BDNF promotes and Nogo-A restricts synaptic plasticity 
(for reviews see: Gottmann et al., 2009; Kempf and Schwab, 2013; Park and Poo, 2012; 
Schwab, 2010; Zagrebelsky and Korte, 2013). It is noteworthy that the NgR1 and the 
p75NTR build a receptor complex which could antagonize the activation of the BDNF-TrkB 
signalling in a ‘yin and yang’ like mechanism (Boyd and Gordon, 2001; Schwab, 2010). 
BDNF signalling increases cyclic AMP (cAMP) while the NgR1-p75NTR complex reduces 
via a G-protein the cAMP levels (Filbin, 2003; Gao et al., 2003; Joset et al., 2010). This 
antagonistic regulation of cAMP regulate the protein kinase A (PKA) which can control the 
RhoA-ROCK pathway as well as gene transcription, necessary to mediate long-term 
synaptic plasticity (Filbin, 2003; Lu et al., 2005). Further evidence for a crosstalk in the 
adult CNS between Nogo-A and BDNF signalling pathways derive from studies showing 
that a pre-incubation with BDNF reduces the response of primary neurons to myelin 
inhibitors like Nogo-A (Gao et al., 2003; Raiker et al., 2010). Furthermore, after an injury 
BDNF application antagonizes the lesion-induced up-regulation of Nogo-A in the 
hippocampus (Chytrova et al., 2008). In the ngr1 KO mice Raiker et al. (2010) showed a 
constitutively elevated MAP kinase signalling (p-ERK) in the neocortex and hippocampus. 
The activation of the MAP kinase signalling can also be seen upon exogenous BDNF 
application in primary neurons (Ji et al., 2010) and is prevented by an application of 
Nogo-A (Raiker et al., 2010). On the other hand, Nogo-A and BDNF may interact in a 
cooperative manner: Karlén and colleagues (2009) hypothesise that the loss of the Nogo-
A signalling together with cell adhesion molecules (Kleene and Schachner, 2004) play an 
important role in regulating functional and structural plasticity through restriction. After 
neutralisation of plasticity restricting proteins like Nogo-A axonal boutons and dendritic 
spines become temporarily unstable and capable of rearrangements in response to 
plasticity promoting factor like local increased of BDNF levels. (Lu, 2003; Karlén et al., 
2009). Overall, the antagonistic relationship between the BDNF/TrkB and Nogo-A 
signalling pathway and function suggests a coordinated and highly regulated interaction; 
where BDNF signalling may suppresses Nogo-A action (or vice versa) and thereby 
maintain synaptic stability and plasticity. 
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5.3 Conclusions and outlook 
In the present study, I started by correlating changes in actin dynamics within dendritic 
spines mediated by Nogo-A and their receptors with structural changes in their 
morphology. I could show that Nogo-A signalling rapidly modulates the spine actin 
cytoskeleton to control structural plasticity at dendritic spines of CA3 hippocampal 
pyramidal cells. Moreover, my data show that Nogo-A restricts the early reference 
memory formation during spatial learning as tested in the Morris water maze and 
negatively regulates structural plasticity at spine density of hippocampal neurons in this 
context. Taken together, this study indicates a crucial physiological function for Nogo-A in 
regulating the balance between stability and plasticity of mature neuronal networks in the 
adult hippocampus. By this activity, Nogo-A is possibly contributing to the maintenance of 
the spatial and temporal specificity of structural plasticity needed during learning 
processes. 
The actin cytoskeleton was shown to be controlled by diverse signalling pathways to 
determine spine number, morphology and synaptic strength (Cingolani and Goda, 2008; 
Hotulainen and Hoogenraad, 2010; Matus, 2000; Okamoto et al., 2009). Actin, with its 
ability to transit between dynamic and stable states, is a prime candidate for mediating 
synaptic plasticity to ensure memory acquisition and consolidation (Lamprecht and 
LeDoux, 2004; Matus, 2000). Nogo-A signalling has been shown to modulate functional 
and structural plasticity in the adult CNS (Akbik et al., 2013; Delekate et al., 2011; Djurisic 
et al., 2013; Kempf et al., 2014; Lee et al., 2008; Mironova and Giger, 2013; Raiker et al., 
2010). However, the intracellular pathways downstream of Nogo-A signalling in mature 
neurons and their synapses still need to be elucidated. In this thesis I could show that 
blocking Nogo-A signalling restricts actin cytoskeleton dynamic within single mature 
dendritic spines. On the other hand, the FRAP method does not allow imaging 
simultaneously several dendritic spines before and after interfering with the Nogo-A 
signalling. To gain further inside into how the different spine types react and also to study 
changes in the equilibrium between G- and F-actin a fluorescent energy transfer (FRET) 
actin imaging technique could be used (Okamoto and Hayashi, 2006; Okamoto et al., 
2004). Moreover, single molecule detection techniques could be applied like Fluorescence 
correlation spectroscopy (FCS) or two-photon-FCS (2P-FCS) which belong to a class of 
non-invasive and extremely sensitive imaging techniques (Kim and Schwille, 2003; Kim et 
al., 2007). 2P-FCS provides access to the diffusion time, particle numbers and brightness 
of eGFP-actin in real time and allows fast temporal and high spatial resolution analysis of 
small F-actin filaments within dendritic spines (Chen and Kellner et al., under review). To 
combine these imaging techniques with the inhibition of the Nogo-A signalling would allow 
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to describe in detail its role in regulating the dynamics of actin filaments within dendritic 
spines and possibly to obtain some information about the signalling pathways mediating 
these effects. Indeed, to elucidate the intracellular pathways mediating the role of Nogo-A 
signalling in regulating actin dynamics within dendritic spines is crucial for understanding 
how Nogo-A restrict synaptic plasticity. Here I showed that ROCK inhibition mimics the 
effects seen after Nogo-A neutralisation on actin dynamics within spines pointing to a 
contribution of an actin cytoskeleton regulatory pathway involving the modulation via the 
RhoA/ROCK pathway and maybe the activation of cofilin via LIMK as recently shown from 
Bosch et al. (2014). To test whether Nogo-A signalling regulates the actin cytoskeleton via 
the above pathway, biochemical assays or the described imaging techniques could be 
used in combination with an acute blocking of RhoA with C3 transferase (Borasio et al., 
1989; Niederöst et al., 2002), LIMK with the inhibitor 1-16-peptide (Bosch et al., 2014) and 
cofilin with S3-peptide (Aizawa et al., 2001). Neutralising Nogo-A signalling induces an 
increase in dendritic spine density (Kellner et al., under review) and an increase of the 
stable actin fraction has which been shown to be sufficient to induce spinogenesis (Zito et 
al., 2004). The here observed stabilization of the actin cytoskeleton within preexisting 
spines up Nogo-A blocking cannot directly be correlated to the gain of new spines (Kellner 
et al., under review). It would be interesting to further examine how Nogo-A signalling 
regulates spinogenesis and whether the actin cytoskeleton is involved. In addition, an 
increased F-actin stabilization is sufficient to promote spine elongation (Zito et al., 2004). 
Here a significant positive correlation between the amount of stable actin and the change 
in length could be observed only for elongating spines. This indicates that Nogo-A acutely 
modulates dendritic spine shape by stabilizing the spine actin cytoskeleton in a rapid and 
transitory manner. Time-lapse imaging experiments monitoring the spine morphology and 
actin dynamics (e.g. with 2P-FCS) in parallel are necessary to further clarify this issue.  
In all experiments performed in this thesis Nogo-A signalling was blocked via a bath 
application of the respective antibodies or blockers resulting in a global loss-of-function for 
the entire network. Using this experimental design it is not possible to distinguish if the 
effect observed on dendritic spines of CA3 hippocampal neurons is due to a local action 
on individual synapse or is secondary to changes at the network level. To address this 
question, local applications by puffing Nogo-Ab blocking antibodies on defined dendritic 
stretches could be used. Furthermore, this approach will provide a precise temporal 
control on the Nogo-A neutralisation. Recent data show that Nogo-A neutralisation in 
primary hippocampal neurons results in the fast insertion of AMPA receptors at synaptic 
sites (Kellner et al., under review). To test the hypothesis of whether the changes in spine 
morphology and actin dynamics upon Nogo-A neutralisation are secondary to changes in 
network activity a pre-treatment with tetrodotoxin could be used to block neuronal activity. 
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Further time-lapse imaging and FRAP experiments comparing different levels in neuronal 
activity are necessary to test this hypothesis. Moreover, to test for a role of Nogo-A in 
regulating activity-dependent structural plasticity at spines, its neutralisation could be 
combined with the chemical induction of LTP. Several studies showed that Nogo-A and 
their receptors influence Hebbian forms of synaptic plasticity (Delekate et al., 2011; Kempf 
et al., 2014; Lee et al., 2008; Raiker et al., 2010). Nevertheless, it is not clear whether and 
how Nogo-A signalling is regulated in an activity-dependent manner. A local regulatory 
mechanism such as activity-dependent insertion, internalisation or cleavage at synaptic 
sites of Nogo-A or its receptors, may be achieved rapidly and with high temporal and 
spatial specificity allowing or restricting changes at individual synapses (Mironova and 
Giger, 2013). To address this question, an approach is required allowing to detect the 
movement of Nogo-A or its receptors at a single molecule level over time by 
simultaneously altering neuronal activity. 2P-FCS or photoactivation might be used at 
single synapses in cells expressing Nogo-A, NgR1 or S1P2R tagged either with eGFP or 
with a photoactivatable eGFP. To avoid unspecific effects due to the overexpression, the 
expression of the tagged molecules should be controlled by the correspondent 
endogenous promoter. 
Activity and experience-dependent changes in the shape and number of dendritic spines 
have been correlated to learning processes and memory formation (Holtmaat and 
Svoboda, 2009; O’Malley et al., 2000; Xu et al., 2009; Yang et al., 2009a). Whether the 
changes in spine density occurring upon Nogo-A neutralisation (Kellner et al., under 
review) might be correlated to an improvement in spatial learning was tested in the Morris 
water maze. In line with my observation, previous studies showed that nogo-a KO and WT 
mice learned equally well to locate the hidden platform during the Morris water maze test 
(Willi et al., 2008). Also the over expression of the Nogo receptor 1 revealed similar 
results but a probe trail performed after 39 days showed a clear impairment in long-term 
memory consolidation (Karlén et al., 2009). Finally, the early and transient advantage of 
nogo-a KO mice in forming a reference memory tested in the probe trail at day 3 indicates 
a role for Nogo-A in restricting the initial acquisition phase. To draw a conclusion about 
whether Nogo-A is needed for long-term memory consolidation a later 3rd probe trial 
beyond day 9 should be performed.  
In the second topic addressed in this thesis, I could elucidate the essential physiological 
functions of endogenous BDNF in maintaining dendritic spine density and a mature spine 
morphology in excitatory hippocampal neurons. Additionally I could confirm that BDNF is 
required for the activity-dependent structural plasticity of dendritic spines. In addition, 
results presented here shed some light on why published in vivo and in vitro results 
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concerning morphological effects of BDNF are often contradictory: while previous in vivo 
work showed a specific selectivity in the brain areas requiring BDNF-signalling for their 
post-natal development (Minichiello et al., 1999; Rauskolb et al., 2010; Zakharenko et al., 
2003), most of the in vitro work describes a strong effect for a BDNF gain-of-function 
(Tyler and Pozzo-Miller, 2001, 2003; Ji et al., 2005, 2010). My observations here suggest 
rather that different culture conditions and also different levels of neuronal activity are 
responsible for this discrepancy (Kellner et al., 2014). However, to finally demonstrate that 
the role of BDNF signalling on structural plasticity at spines is activity-dependent 
regulated, further experiments with electrical or chemical induced LTP combined with 
gain-or loss-of-function experiments are necessary. Microglia are myeloid cells that 
occupy all regions of the CNS and although their role has been extensively studied, their 
contribution to normal CNS function remains unclear. In a recent study Parkhurst et al., 
(2013) show that microglia promote learning-induced formation of synapses and that this 
effect is mediated by microglial BDNF. As a consequence, it is necessary to determine the 
quantity of microglia in the culture system to clarify if the discrepancies aforementioned 
are due to the content of microglia BDNF. Furthermore under high magnesium 
concentration (with low neuronal activity conditions) I observed an increased neuronal 
responsiveness to BDNF. Whether this effect is due to an activity-dependent decrease in 
BDNF release from neurons or, from microglia will be very interesting to address. 
The effects of endogenous BDNF in modulating the architecture of neurons seem to be 
depending on their developmental stage and for dendritic spines also on the brain region 
as well as the cell-type (Rauskolb et al., 2010; Zagrebelsky and Korte, 2013). Here, I 
focus only at excitatory hippocampal neurons. To clarify the cell type specificity of BDNF, 
it is required to analyse the effects of endogenous BDNF in vivo on excitatory and 
inhibitory neurons within the same brain regions. In my study I used fixed time points after 
the gain- and loss-of-function experiments. Consequently only the time point of fixation 
could be examined. Live imaging experiments would help to analyse fast events and 
provide more details about what kind of spines change their morphology and their 
temporal characteristics upon an alteration of BDNF signalling. Tanaka and colleague 
(2008) showed indeed with time-lapse imaging that the activity of BDNF in regulating 
structural changes at dendritic spines depends on activity. They artificially supplied the 
neurons with the cytoskeletal protein β-actin to observe activity-dependent spine head 
enlargements. Therefore it remains an open issue whether BDNF signalling contributes to 
acute structural changes under physiological conditions and whether the actin 
cytoskeleton in spines is a denominator on which BDNF signalling controls spine 
morphology. Furthermore, it is interesting to investigate how BDNF regulates actin 
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dynamics at individual dendritic spines by combing gain- and loss-of-function experiments 
for BDNF with FRAP experiments. 
Finally, BDNF and Nogo-A may interact in a cooperative manner to modulate the spatial 
and temporal specificity of functional and structural plasticity by promoting or restricting 
plasticity, respectively (Karlén et al., 2009). In this context it is interesting to do further 
experiments combining specific gain- and loss-of-function experiments for both BDNF and 
Nogo-A signalling pathways to further elucidate the fascinating mechanisms modulating 
synaptic plasticity versus synaptic stability in correlation to learning and memory 
processes. 
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7 Supplement 
7.1 Supplementary data 
Table S1: Summary of FRAP experiments addressing the role of Nogo-A in regulating 
actin dynamics. The table reports the values for the turnover time, dynamic-, stable- and 
monomeric- actin fraction treated neurons for the experiments described in Fig. 11-16. 
Figure 11-16. 
Treatment 
Cells/spines 
turnover time 
[sec] 
dynamic actin 
fraction [%] 
stable actin 
fraction [%] 
monomeric 
actin fraction 
[%] 
Control BrdU 20 min  
27 spines / 8 cells 
18.37 ± 0.90 70.25 ± 1.80 15.5 ± 1.64 14.26 ± 1.00 
Control BrdU 180 min  
22 spines / 7 cells 
20.09 ± 1.39 70.94 ± 2.44 15.21 ± 2.2 13.85 ± 1.71 
Nogo-A Abs (11c7) 20 min 
29 spines / 8 cells 
34.69 ± 2.62 64.63 ± 2.19 21.87 ± 2.36 13.5 ± 1.11 
Nogo-A Abs (11c7)  
180 min 29 spines / 8 cells 
32.07 ± 4.04 73.86 ± 2.73 14.97 ± 2.74 11.17 ± 1.00 
NgR1 Abs 20 min  
30 spines / 12 cells 
35.14 ± 4.90 63.19 ± 2.08 24.96 ± 1.95 11.85 ± 1.37 
NgR1 Abs 20 min  
27 spines / 11 cells 
30.24 ± 2.54 68.03 ± 2.14 20.52 ± 2.21 11.45 ± 0.95 
Control DMSO20 min 
15 spines / 7 cells 
20.67 ± 2.99 70.93 ± 2.88 13.25 ± 2.58 15.84 ± 1.70 
Control DMSO 180 min 21 
spines / 7 cells 
20.00 ± 1.47 70.34 ± 1.96 14.02 ± 1.63 15.64 ± 1.66 
S1P2R  Abs (JTE-013) 
20 min 20 spines / 9 cells 
29.75 ± 3.62 61.89 ± 2.41 23.01 ± 2.43 15.11 ± 1.50 
S1P2R Abs (JTE-013) 
180 min 22 spines / 8 cells 
30.45 ± 4.72 62.15 ± 2.86 23.58 ± 3.06 14.27 ± 1.40 
Control BSA before  
28 spines / 14 cells 
23.64 ± 2.00 69.60 ± 2.26 15.17 ± 2.20 15.23 ± 1.35 
Nogo-A-Δ20 5 min 11 / 14 17.14 ± 1.70 76.75 ± 3.36 8.71 ± 1.72 14.54 ± 2.31 
Nogo-A-Δ20 20 min 
25 spines / 14 cells 
25.84 ± 2.37 62.94 ± 1.79 24.36 ± 2.17 12.70 ± 1.46 
Control 20 min 
35 spines / 17 cells 
23.09 ± 2.25 70.52 ± 2.42 16.30 ± 2.01 13.19 ± 1.19 
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Control 180 min 
25 spines / 11 cells 
22.08 ± 2.21 66.91± 2.01 15.75 ± 1.91 17.34 ± 1.72 
ROCK inhibitor (Y27632) 
20 min  21 spines / 9 cells 
20.95 ± 1.96 62.34 ± 2.05 22.62 ± 2.09 15.04 ± 1.16 
ROCK inhibitor (Y27632) 
180 min 27 spines / 8 cells 
24.00 ± 2.39 67.49 ± 2.12 19.90 ± 2.12 12.61 ± 1.22 
 
 
Table S2: Summary of behaviour experiments addressing the role of Nogo-A in regulating 
learning and memory acquisition in the Morris water maze. The table reports the values 
for the escape latencies and the probe trails at day 3 and 9 for the experiments described 
in Fig. 17. 
Figure 17. 
Genotype day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 
WT time in [s] 
n= 16 mice 
 
36.65 ± 
4.61 
28.72 ± 
3.81 
21.89 ± 
3.31 
21.15 ± 
2.63 
15.96 ± 
3.63 
14.81 ± 
3.59 
10.03 ± 
2.09 
6.58 ± 
1.03 
nogo-a KO 
time in [s]      
n= 14 mice 
28.53 ± 
4.30 
23.76 ± 
3.30 
21.83 ± 
5.17 
19.99 ± 
4.11 
16.61 ± 
2.80 
12.67 ± 
2.42 
9.29 ± 
1.97 
6.59 ± 
2.02 
Genotype 
NE 
time [%] 
SE 
time [%] 
SW 
time [%] 
NW 
time [%] 
# of 
platform 
crossings 
WT PT day3 n=19 mice 
21.97 ± 
3.09 
21.70 ± 
3.62 
26.28 ± 
3.73 
30.04 ± 
3.31 
1.21 ± 0.28 
KO PT day3 n=15 mice 
22.87 ± 
2.31 
14.21 ± 
2.02 
23.96 ± 
1.70 
38.95 ± 
2.75 
1.87 ± 0.32 
WT PT day9 n=16 mice 
18.37 ± 
3.29 
12.80 ± 
2.77 
21.04 ± 
2.71 
47.79 ± 
4.39 
3.19 ± 0.58 
KO PT day9 n=14 mice 
13.76 ± 
2.80 
4.73 ± 1.52 
21.39 ± 
3.18 
60.12 ± 
3.93 
3.86 ± 0.58 
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Table S3: Summary of the behaviour experiments addressing the role of Nogo-A in 
regulating searching strategies in the Morris water maze. The table reports the values for 
the hippocampus-dependent and -independent search strategies (day 1-8) for WT and 
nogo-a KO mice described in Fig. 18 and the dendritic spine density before and after 3 
and 9 days of training described in Fig. 19. 
Figure 18 and 19. 
 Figure 18. day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 
WT hippocampus -
indep. [%] n= 16 mice 
78.13 
± 7.17 
81.25 
± 4.84 
71.88 
± 7.17 
67.19 
± 5.92 
65.63 
± 5.98 
51.56 
± 7.02 
54.69 
± 7.98 
37.50 
± 7.22 
nogo-a KO 
hippocampus-indep. 
[%] n= 14 mice 
85.71 
± 4.32 
78.57
± 5.78 
57.14 
± 5.52 
58.93 
± 6.74 
67.86 
± 6.11 
48.21 
± 8.06 
39.29 
± 6.26 
33.93 
± 8.12 
WT hippocampus-dep. 
[%] n= 16 mice 
21.88 
± 7.17 
18.75 
± 4.84 
28.13 
± 7.17 
32.81 
± 5.92 
34.38 
± 5.98 
48.44 
± 7.02 
45.31 
± 7.98 
62.50 
± 7.22 
nogo-a KO 
hippocampus-dep. 
[%] n= 14 mice 
14.29 
± 4.32 
21.43 
± 5.78 
42.86 
± 5.52 
41.07 
± 6.74 
32.14 
± 6.11 
51.79 
± 8.06 
60.71 
± 6.26 
66.07 
± 8.12 
Figure 19.         
Genotype 
not-trained 3 days training 9 days training 
WT C57Bl/6   cells 1.41 ± 0.06 n= 19 1.36 ± 0.07 n= 16 1.63 ± 0.05 n= 17 
nogo-a KO    cells 1.50 ± 0.09 n= 12 1.70 ± 0.06 n= 13 1.55 ± 0.05 n= 21 
WT C57Bl/6 normalized 
Nogo-A levels 
1 ± 0.08 n= 4 1.57 ± 0.01 n= 3 1.12 ± 0.17 n= 3 
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Table S4: The table reports the values for spine density, head width and length as well as 
the total number of dendritic intersections for control, BDNF and BDNF-Abs treated 
neurons for the experiments described in Fig. 20-22 (above and middle). The values for 
the normalized mean intensity for Lifeact of control, BDNF and BDNF-Abs treated neurons 
for the experiments described in Fig. 23 are given in the lower part. 
 
Figure 20 and 21. Control BDNF BDNF-Abs 
C. # of spines / µm 0.98 ± 0.04 (n=19) 0.96 ± 0.03 (n=22) 0.77 ± 0.03 (n=23) 
D. spine head width [µm] 0.49 ± 0.02 (n=19) 0.48 ± 0.01 (n=21) 0.43 ± 0.01 (n=18) 
E. spine length [µm] 1.14 ± 0.03 (n=19) 1.12 ± 0.03 (n=21) 1.33 ± 0.05 (n=18) 
Fig. 21 C. total # of 
intersections 
240.08 ± 38.51 
(n=13) 
205.25 ± 23.20 
(n=20) 
238.50 ± 26.81 
(n=18) 
Figure 22. Control BDNF BDNF-Abs 
B. # of spines /µm 0.84 ± 0.02 (n=25) 0.80 ± 0.05 (n=22) 0.59 ± 0.02 (n=23) 
C. spine head width [µm] 0.45 ± 0.01 (n=20) 0.47 ± 0.01 (n=19) 0.44 ± 0.02 (n=19) 
D. spine length [µm] 1.14 ± 0.03 (n=20) 1.18 ± 0.03 (n=19) 1.57 ± 0.06 (n=19) 
G’. total # of intersections 155.93 ± 7.51 (n=14) 
196.15 ± 18.44 
(n=14) 
166.29 ± 21.82 
(n=13) 
 
Figure 23 
Control BDNF BDNF-Abs 
C. 23 DIV normalized 
mean intensity [%] 
100.00 ± 4.46 (n=20) 104.16 ± 5.08 (n=19) 76.93 ± 3.16 (n=20) 
D.16 DIV normalized mean 
intensity [%] 
100.00 ± 4.63 (n=20) 94.91 ± 5.34 (n=22) 69.97 ± 2.74 (n=20) 
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Table S5: The table reports the values relative to the experiments described in Fig. 24-
26. Specifically, the normalized intensity for the phospho-TrkB immunohistochemistry and 
the number in percent of phospho-TrkB positive cells for control and BDNF treated 
neurons; the values for the normalized frequency of global calcium transients for control 
and BDNF treatments as well as the normalized mean intensity and the number of c-fos 
positive cells for control and BDNF treated neurons. The numbers in brackets indicate 
respectively the number of experiments. 
Figure 24-26. 
 
Control BDNF 
Fig. 24 C. normalized intensity 
 
1.00 ± 0.03 (n=7) 1.61 ± 0.08 (n=7) 
Fig. 24 D. # of +P TrkB positive cells [%] 0.68 ± 0.04 (n=7) 0.85 ± 0.04 (n=7) 
Fig. 25 C. normalized frequency 
of global calcium transients 
2 min after BDNF 0.82 ± 0.1(n=6) 1.26 ± 0.15 (n=7) 
 
10 min after   
washout 
0.83 ± 0.05 (n=5) 0.91 ± 0.16 (n=7) 
Fig. 26 C. normalized mean intensity 1.00 ± 0.06 (n=26) 
1.46 ± 0.13 
(n=21) 
Fig. 26 D. # of c-fos positive cells [%] 4.92 ± 1.43 (n=26) 
20.93 ± 2.63 
(n=21) 
 
Table S6: The values for total neurite length, the number of primary neurites and the 
number of branching points at neurites are shown for control, BDNF, BDNF-Abs, TrkB-Fc 
and TrkB-Fc + BDNF treated neurons for the experiments described in Fig. 27. The 
numbers in brackets indicate the number of cells analysed. 
Figure 27. Control BDNF BDNF-Abs TrkB-Fc 
TrkB-Fc + 
BDNF 
C. total 
neurite 
length [µm] 
167.73 ± 
5.72 (n=80) 
341.43 ± 
10.34 (n=73) 
193.56 ± 22.81 
(n=21) 
175.71 ± 4.24 
(n=80) 
168.51 ± 
15.50 (n=13) 
D. # of 
primary 
neurites 
4.56 ± 0.12 
(n=80) 
5.29 ± 0.14 
(n=73) 
5.14 ± 0.37 
(n=21) 
4.36 ± 0.15 
(n=80) 
4.15 ± 0.25 
(n=13) 
E. # of 
branch 
points 
1.64 ± 0.14 
(n=80) 
4.00 ± 0.25 
(n=73) 
1.57 ± 0.26 
(n=21) 
2.15 ± 0.18 
(n=80) 
1.69 ± 0.35 
(n=13) 
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Table S7: The table reports the values of the frequency of global calcium transients per second 
and the total number of intersections for control 1.5 mM Mg
2+
 and control 3.5 mM Mg
2+
 neurons 
shown in Fig.6. Spine density, the mean values for the spine head width and for spine length are 
shown for control neurons in 1.5 mM Mg
2+
, control, BDNF and TrkB-Fc treated neurons in 3.5 mM 
Mg
2+
 for the experiments are described in Fig. 28 -30. 
Figure 28 and 29. 
Control 1.5 
mM Mg
2+
 
control 3.5  
mM Mg
2+
 
BDNF 3.5 
mM Mg
2+
 
TrkB-Fc 3.5 
mM Mg
2+
 
Fig. 28 B. frequency of 
global calcium 
transients / sec 
0.18 ± 0.01 
(n=16) 
0.13 ± 0.01 
(n=16)   
Fig. 28 C. amplitude 
∆F/F0 [%] 
20.16 ± 1.26 
(n=16) 
22.51 ± 0.99 
(n=16)   
Fig. 28 D’. total # of 
intersections 
292.92 ± 26.28 
(n=13) 
324.46 ± 22.05 
(n=13) 
  
Fig. 29 B 
# of spines / µm 
0.68 ± 0.03 
(n=23) 
0.47 ± 0.02 
(n=22) 
0.52 ± 0.03 
(n=23) 
0.53 ± 0.03 
(n=26) 
Fig. 29 C 
spine head width [µm]  
0.45 ± 0.02 
(n=22) 
0.50 ± 0.02 
(n=21) 
0.48 ± 0.02 
(n=22) 
Fig. 29 D 
spine length [µm]  
1.20 ± 0.05 
(n=22) 
1.1 ± 0.07 
(n=21) 
1.17 ± 0.06 
(n=22) 
Figure 30. 
Control 1.5 
mM Mg
2+
 
Control 3.5 
mM Mg
2+
 
BDNF 3.5 mM 
Mg
2+
 
TrkB-Fc 3.5 
mM Mg
2+
 
B. # of spines / µm 
0.68 ± 0.03 
(n=23) 
0.54 ± 0.04 
(n=19) 
0.53 ± 0.03 
(n=20) 
0.43 ± 0.03 
(n=16) 
C. spine head width 
[µm]  
0.44 ± 0.01 
(n=15) 
0.46 ± 0.02 
(n=16) 
0.42 ± 0.01 
(n=10) 
D. spine length [µm] 
 
1.13 ± 0.05 
(n=15) 
1.20 ± 0.05 
(n=16) 
1.16 ± 0.05 
(n=10) 
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7.2 Abbreviations 
Abs antibodies 
ACSF  artificial cerebrospinal fluid 
BDNF  Brain-derived neurotrophic factor  
AMPA(R)  α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (receptor) 
ANOVA analysis of variance 
BrdU Bromdesoxyuridin 
BSA bovine serum albumin 
CA cornu ammonis  
CaMKII  Ca
2+/
calmodulin-dependent protein kinase II  
CNS central nervous system 
CREB  cyclic AMP response element binding protein 
DAPI 4',6-diamidino-2-phenylindole 
DIV days in vitro (post transplantation) 
DMSO Dimethylsulfoxid 
EGFP  enhanced green fluorescent protein  
FRAP fluorescence recovery after photobleaching 
GBSS  Gey’s balanced salt solution  
IEG immediate early gene 
KO  Knockout 
LIMK  LIM kinase 
LTD  long-term depression  
LTP  long-term potentiation  
MAP2  microtubule-associated protein 2 
MWM Morris water maze 
NgR  Nogo-66 receptor 
PBS phosphate buffered saline  
PSD  postsynaptic density 
p75
NTR
  pan neurotrophin receptor p75  
RFP red fluorescent protein 
RhoA small Rho A GTPases  
ROCK  Rho kinase  
ROI region of intres 
S1PR2  sphingosine 1-phosphate receptor 2 
TrkB  tropomyosin-related kinase receptor B 
vs versus 
WT  Wild type  
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